Scolaris Content Display Scolaris Content Display

مداخلات حرفه‌ای برای پزشکان عمومی به منظور مدیریت بالینی بیماری‌های عضلانی‌اسکلتی

Contraer todo Desplegar todo

Referencias

Becker 2008 {published data only}

Becker A, Leonhardt C, Kochen MM, Keller S, Wegscheider K, Baum E, et al. Effects of two guideline implementation strategies on patient outcomes in primary care: a cluster randomized controlled trial. Spine 2008;33(5):473‐80.

Bessette 2011 {published data only}

Bessette L, Davison KS, Jean S, Roy S, Ste‐Marie LG, Brown JP. The impact of two educational interventions on osteoporosis diagnosis and treatment after fragility fracture: a population‐based randomized controlled trial. Osteoporosis International 2011;22(12):2963‐72.

Bishop 2006 {published data only}

Bishop PB, Wing PC. Knowledge transfer in family physicians managing patients with acute low back pain: a prospective randomized control trial. Spine J 2006;6(3):282‐8.

Boyd 2002 {published data only}

Boyd JL, Holcomb JP, Rothenberg RJ. Physician treatment of osteoporosis in response to heel ultrasound bone mineral density reports. Journal of Clinical Densitometry 2002;5(4):375‐81.

Broadhurst 2007 {published data only}

Broadhurst NA, Barton CA, Rowett D, Yelland L, Matin DK, Gialamas A, et al. A before and after study of the impact of academic detailing on the use of diagnostic imaging for shoulder complaints in general practice. BMC Family Practice 2007;8:12.

Chassany 2006 {published data only}

Chassany O, Boureau F, Liard F, Bertin P, Serrie A, Ferran P, et al. Effects of training on general practitioners' management of pain in osteoarthritis: a randomized multicenter study. Journal of Rheumatology 2006;33(9):1827‐34.

Ciaschini 2010 {published data only}

Ciaschini PM, Straus SE, Dolovich LR, Goeree RA, Leung KM, Woods CR, et al. Community based intervention to optimize osteoporosis management: randomized controlled trial. BMC Geriatrics 2010;10:60.

Cranney 2008 {published data only}

Cranney A, Lam M, Ruhland L, Brison R, Godwin M, Harrison MM, et al. A multifaceted intervention to improve treatment of osteoporosis in postmenopausal women with wrist fractures: a cluster randomized trial. Osteoporos International 2008;19(12):1733‐40.

Dey 2004 {published data only}

Dey P, Simpson CW, Collins SI, Hodgson G, Dowrick CF, Simison AJ, et al. Implementation of RCGP guidelines for acute low back pain: a cluster randomised controlled trial. British Journal of General Practice 2004;54(498):33‐7.

Eccles 2001 {published data only}

Eccles M, Steen N, Grimshaw J, Thomas L, McNamee P, Soutter J, et al. Effect of audit and feedback, and reminder messages on primary‐care radiology referrals: a randomised trial. Lancet 2001;357(9266):1406‐9.
Ramsay CR, Eccles M, Grimshaw JM, Steen N. Assessing the long‐term effect of educational reminder messages on primary care radiology referrals. Clinical Radiology 2003;58(4):319‐21.

Engers 2005 {published data only}

Engerseta AJ, Wensing M, Van Tulder MW, Timmermans A, Oostendorp RA, Koes BW, et al. Implementation of the Dutch low back pain guideline for general practitioners: a cluster randomized controlled trial. Spine 2005;30(6):559‐600.

Feldstein 2006 {published data only}

Feldstein A, Elmer PJ, Smith DH, Herson M, Orwoll E, Chen C, et al. Electronic medical record reminder improves osteoporosis management after a fracture: a randomized, controlled trial. Journal of the American Geriatrics Society 2006;54(3):450‐7.

French 2013 {published data only}

French SD, McKenzie JE, O'Connor DA, Grimshaw JM, Mortimer D, Francis JJ, et al. Evaluation of a theory‐informed implementation intervention for the management of acute low back pain in general medical practice: the IMPLEMENT cluster randomised trial. PLoS ONE 2013;8(6):e65471.

Gormley 2003 {published data only}

Gormley GJ, Steele WK, Stevenson M, McKane R, Ryans I, Cairns AP, et al. A randomised study of two training programmes for general practitioners in the techniques of shoulder injection. Annals of the Rheumatic Diseases 2003;62(10):1006‐9.

Hazard 1997 {published data only}

Hazard RG, Haugh LD, Reid S, McFarlane G, MacDonald L. Early physician notification of patient disability risk and clinical guidelines after low back injury: a randomized, controlled trial. Spine 1997;22(24):2951‐8.

Hollingworth 2002 {published data only}

Hollingworth W, Todd CJ, King H, Males T, Dixon AK, Karia KR, Kinmonth AL. Primary care referrals for lumbar spine radiography:diagnostic yield and clinical guidelines. British Jornal of General Practice 2002;52(6):475‐80.

Huas 2006 {published data only}

Huas D, Pouchain D, Gay B, Avouac B, Bouvenot G, French College Of Teachers In General Practice. Assessing chronic pain in general practice: are guidelines relevant? A cluster randomized controlled trial. European Jourmal of General Practice 2006;12(2):52‐7.

Kerry 2000 {published data only}

Kerry S, Oakeshott P, Dundas D, Williams J. Influence of postal distribution of the Royal College of Radiologists' guidelines, together with feedback on radiological referral rates, on X‐ray referrals from general practice: a randomized controlled trial. Family Practice 2000;17(1):46‐52.

Lafata 2007 {published data only}

Lafata JE, Kolk D, Peterson EL, McCarthy BD, Weiss TW, Chen YT, et al. Improving osteoporosis screening:Results from a randomized cluster trial. Journal of General internal Medicine 2007;22(3):346‐51.

Leslie 2012 {published data only}

Leslie WD, LaBine L, Klassen P, Dreilich BM, Caetano P. Closing the gap in postfracture care at population level: a randomized controlled trial. Canadian Medical Association Journal 2012;184(3):290‐6.

Majumdar 2008 {published data only}

Majumdar SR, Johnson JA, McAlister FA, Bellerose D, Russell AS, Hanley DA, et al. Multifaceted intervention to improve diagnosis and treatment of osteoporosis in patients with recent wrist fracture: a randomized controlled trial. Canadian Medical Association Journal 2008;178(5):569‐75.

Rahme 2005 {published data only}

Rahme E, Choquette D, Beaulieu M, Bessette L, Joseph L, Toubouti Y, et al. Impact of a general practitioner educational intervention on osteoarthritis treatment in an elderly population. American Journal of Medicine 2005;118(11):1262‐70.

Robling 2002 {published data only}

Robling MR, Houston HL, Kinnersley P, Hourihan MD, Cohen DR, Hale J, et al. General practitioners' use of magnetic resonance imaging: an open randomized trial comparing telephone and written requests and an open randomized controlled trial of different methods of local guideline dissemination. Clinical Radiology 2002;57(5):402‐7.

Rosemann 2007 {published data only}

Rosemann T, Joos S, Laux G, Gensichen J, Szecsenyi J. Case management of arthritis patients in primary care: a cluster‐randomized controlled trial. Arthritis and Rheumatism 2007;57(8):1390‐7.
Rosemann T, Korner T, Wensing M, Genzichen J, Muth C, Joos S, et al. Rationale, design and conduct of a comprehensive evaluation of a primary care based intervention to improve the quality of life of osteoarthritis patients. The PraxArt‐project: a cluster randomized controlled trial. BMC Public Health 2005;5(19):77.

Roux 2013 {published data only}

Roux S, Beaulieu M, Beaulieu MC, Cabana F, Boire G. Priming primary care physicians to treat osteoporosis after a fragility fracture: an integrated multidisciplinary approach. Journal of Rheumatology 2013;40(5):703‐11.

Rozental 2008 {published data only}

Rozental TD, Makhni EC, Day CS, Bouxsein ML. Improving evaluation and treatment for osteoporosis following distal radial fractures. A prospective randomized intervention. Journal of Bone and Joint Surgery. American 2008;90(5):953‐61.

Schectman 2003 {published data only}

Schectman JM, Schroth WS, Verme D, Voss JD. Randomized controlled trial of education and feedback for implementation of guidelines for acute low back pain. Journal of General Internal Medicine 2003;18(10):773‐80.

Solomon 2007a {published data only}

Shu AD, Stedman MR, Polinski JM, Jan S, Patel M, Truppo C, et al. Adherence to osteoporosis medications after patient and physician brief education: post hoc analysis of a randomized controlled trial. American Journal of Managed Care 2009;15(7):417‐24.
Solomon DH, Katz JN, Finkelstein JS, Polinski JM, Stedman M, Brookhart MA, et al. Osteoporosis improvement: a large‐scale randomized controlled trial of patient and primary care physician education. Journal of Bone and Mineral Research 2007;22(11):1808‐15.

Stross 1985 {published data only}

Stross JK, Bole GG. Evaluation of an educational program for primary care practitioners, on the management of osteoarthritis. Arthritis & Rheumatism 1985;28(1):108‐11.

Watson 2008 {published data only}

McKenna C, Bojke L, Manca A, Adebajo A, Dickson J, Helliwell P, et al. Shoulder acute pain in primary health care: is retraining GPs effective? The SAPPHIRE randomized trial: a cost‐effectiveness analysis. Rheumatology (Oxford) 2009;48(5):558‐63.
Watson J, Helliwell P, Morton V, Adebajo A, Dickson J, Russell I, et al. Shoulder acute pain in primary healthcare: is retraining effective for GP principals? SAPPHIRE‐‐a randomized controlled trial. Rheumatology (Oxford) 2008;47(12):1795‐802.

Ashe 2004 {published data only}

Ashe M, Khan K, Guy P, Kruse K, Hughes K, O'brien P, et al. Wristwatch‐distal radial fracture as a marker for osteoporosis investigation: a controlled trial of patient education and a physician alerting system. Journal of Hand Therapy 2004;17(3):324‐8.

Corson 2011 {published data only}

Corson K, Doak MN, Denneson L, Crutchfield M, Soleck G, Dickinson KC, et al. Primary care clinician adherence to guidelines for the management of chronic musculoskeletal pain: results from the study of the effectiveness of a collaborative approach to pain. Pain Medicine 2011;12(10):1490‐501.

Fabiani 2004 {published data only}

Fabiani L, Giovannoni S, Casanica M, Scatigna M, Pulsoni R, Ventriglia G, et al. Efficiency of guidelines and educational program: a training process for the diagnosis of low back pain. Recenti Progressi in Medicina 2004;95(2):81‐6.

Feldstein 2007 {published data only}

Feldstein AC, Vollmer WM, Smith DH, Petrik A, Schneider J, Glauber H, et al. An outreach program improved osteoporosis management after a fracture. Journal of the American Geriatrics Society 2007;55(9):1464‐9.

Garala 1999 {published data only}

Garala M, Craig J, Lee J. Reducing general practitioner referral for lumbar spine X‐ray. Journal of Clinical Governance 1999;7(4):186‐9.

Gardner 2002 {published data only}

Gardner MJ, Flik KR, Mooar P, Lane JM. Improvement in the undertreatment of osteoporosis following hip fracture. Journal of Bone and Joint Surgery. American 2002;84‐A(8):1342‐8.

Gardner 2005 {published data only}

Gardner MJ, Brophy RH, Demetrakopoulos D, Koob J, Hong R, Rana A, et al. Interventions to improve osteoporosis treatment following hip fracture. a prospective, randomized trial. Journal of Bone and Joint Surgery. American 2005;87(1):3‐7.

Glazier 2005 {published data only}

Glazier RH, Badley EM, Lineker SC, Wilkins AL, Bell MJ. Getting a Grip on Arthritis: an educational intervention for the diagnosis and treatment of arthritis in primary care. Journal of Rheumatology 2005;32(1):137‐42.

Goldberg 2001 {published data only}

Goldberg HI, Deyo RA, Taylor VM, Cheadle AD, Conrad DA, Loeser JD, et al. Can evidence change the rate of back surgery? A randomized trial of community‐based education. Effective Clinical Practice 2001;4(3):95‐104.

Ioannidis 2008 {published data only}

Ioannidis G, Thabane L, Gafni A, Hodsman A, Kvern B, Johnstone D, et al. Optimizing care in osteoporosis: the Canadian quality circle project. BMC Musculoskelet Disord 2008;9:130.

Ioannidis 2009 {published data only}

Ioannidis G, Papaioannou A, Thabane L, Gafni A, Hodsman A, Kvern B, et al. The utilization of appropriate osteoporosis medications improves following a multifaceted educational intervention: The Canadian quality circle project (CQC). BMC Medical Education 2009;9:1.

McDonald 2003 {published data only}

McDonald PK, Winkle CA, Askew D. Evaluation of academic detailing within a coordinated care trial. Journal of Pharmacy Practice and Research 2003;33(2):114‐6.

Nazareth 2002 {published data only}

Nazareth I, Freemantle N, Duggan C, Mason J, Haines A. Evaluation of a complex intervention for changing professional behaviour: the Evidence Based Out Reach (EBOR) Trial. Journal of Health Services Research & Policy 2002;7(4):230‐8.

Rolfe 2001 {published data only}

Rolfe MK. The NEBPINY programme (Phase 1). Changing practice ‐‐ testing a facilitated evidence‐based programme in primary care. Journal of Clinical Governance 2001;9(1):21‐6.

Ruiz 2001 {published data only}

Ruiz Moral R, Munoz Alamo M, Alba Jurado M, Perula de Torres L. Effectiveness of a learner‐centred training programme for primary care physicians in using a patient‐centred consultation style. Family Practice 2001;18(1):60‐3.

Solomon 2007b {published data only}

Solomon DH, Polinski JM, Stedman M, Truppo C, Breiner L, Egan C, et al. Improving care of patients at‐risk for osteoporosis: A randomized controlled trial. Journal of General Internal Medicine 2007;22(3):362‐7.

Vernacchio 2013 {published data only}

Vernacchio L, Trudell EK, Hresko MT, Karlin LI, Risko W. A quality improvement program to reduce unnecessary referrals for adolescent scoliosis. Pediatrics 2013;131(3):e912.

Ajit 2004

Ajit KS. Invited commentary: educational interventions to address the core competencies in surgery. Surgery 2004;135(1):43‐7.

Arthritis Research UK 2011

Arthritis Research UK & the University of Manchester. A Heavy Burden: the occurrence and impact of musculoskeletal conditions in the UK today. www.inflammation‐repair.manchester.ac.uk/Musculoskeletal/aboutus/publications/heavyburden.pdf2011.

Badley 1994

Badley EM, Rasooly I, Webster GK. Relative importance of musculoskeletal disorders as a cause of chronic health problems, disability, and health care utilization: findings from the 1990 Ontario Health Survey. Journal of Rheumatology 1994;21(3):505‐14.

Berlin 1997

Berlin JA. Does blinding of readers affect the results of meta‐analyses? University of Pennsylvania Meta‐analysis Blinding Study Group. Lancet 1997;350(9072):185‐6.

Bywood 2008

Bywood PT, Lunnay B, Roche AM. Strategies for facilitating change in alcohol and other drugs (AOD) professional practice: a systematic review of the effectiveness of reminders and feedback. Drug and Alcohol Review 2008;27(5):548‐558.

Deeks 2011

Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011].The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.

EPOC 2002

Effective Practice, Organisation of Care (EPOC). EPOC taxonomy. epoc.cochrane.org/epoc‐methods; epoc.cochrane.org/epoc‐taxonomy2002.

EPOC 2013a

Effective Practice, Organisation of Care (EPOC). What study designs should be included in an EPOC review and what should they be called?. EPOC Resources for review authors; available from epoc.cochrane.org/epoc‐specific‐resources‐review‐authors2013.

EPOC 2013b

Effective Practice, Organisation of Care (EPOC). Good practice data extraction form. EPOC Resources for review authors; available from epocoslo.cochrane.org/epoc‐specific‐resources‐review‐authors2013.

EPOC 2013c

Effective Practice, Organisation of Care (EPOC). What are exploratory factors and why should they be included in protocols?. EPOC Resources for review authors; available at epoc.cochrane.org/epoc‐specific‐resources‐review‐authors2013; Vol. 2013.

EPOC 2013d

Effective Practice, Organisation of Care (EPOC). What outcomes should be reported in Cochrane Effective Practice and Organisation of Care (EPOC) reviews?. EPOC Resources for review authors; available at epoc.cochrane.org/epoc‐specific‐resources‐review‐authors2013.

EPOC 2013e

Effective Practice, Organisation of Care (EPOC). Analysis in EPOC reviews. EPOC Resources for review authors. Oslo: Norwegian Knowledge Centre for the Health Services2013; Vol. available at epoc.cochrane.org/epoc‐specific‐resources‐review‐authors.

EPOC 2015

Effective Practice, Organisation of Care (EPOC). Suggested risk of bias criteria for EPOC reviews. EPOC Resources for review authors; available at http://epoc.cochrane.org/epoc‐specific‐resources‐review‐authors2015.

Flodgren 2011

Flodgren G, Parmelli E, Doumit G, Gattellari M, O'Brien MA, Grimshaw J, et al. Local opinion leaders: effects on professional practice and health care outcomes. Cochrane Database of Systematic Reviews 2011, Issue 8. [DOI: 10.1002/14651858.CD000125.pub4]

Forrest 1989

Forrest JM, McKenna M, Stanley IM, Boaden NT, Woodcock GT. Continuing education: a survey among general practitioners. Family Practice 1989;6(2):98‐107.

French 2010

French SD, Green S, Buchbinder R, Barnes H. Interventions for improving the appropriate use of imaging in people with musculoskeletal conditions. Cochrane Database of Systematic Reviews 2010, Issue 1. [DOI: 10.1002/14651858.CD006094.pub2]

Giguere 2012

Giguère A, Légaré F, Grimshaw J, Turcotte S, Fiander M, Grudniewicz A, et al. Printed educational materials: effects on professional practice and healthcare outcomes. Cochrane Database of Systematic Reviews 2012, Issue 10. [DOI: 10.1002/14651858.CD004398.pub3]

Grimshaw 2004

Grimshaw JM, Thomas RE, MacLennan G, Fraser C, Ramsay CR, Vale L, et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technology Assessment 2004;8(6):1‐72.

Guyatt 2008

Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck‐Ytter Y, Schünemann HJ, GRADE Working Group. Rating quality of evidence and strength of recommendations: what is "quality of evidence" and why is it important to clinicians?. BMJ 2008;336(7651):995‐8..

Higgins 2003

Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta‐analyses. BMJ 2003;327(7414):557‐60.

Higgins 2011a

Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.

Higgins 2011b

Higgins JPT, Altman DG, Sterne JAC. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011].The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. The Cochrane Collaboration.

Ivers 2012

Ivers N, Jamtvedt G, Flottorp S, Young JM, Odgaard‐Jensen J, French SD, et al. Audit and feedback: effects on professional practice and healthcare outcomes. Cochrane Database of Systematic Reviews 2012, Issue 6. [DOI: 10.1002/14651858.CD000259.pub3]

Jones 1998

Jones JR, Hodgson JT, Clegg TA, Elliott RC. Self‐reported Work‐Related Illness in 1995. Results from a Household Survey. www.hse.gov.uk/statistics/2002/swi95.pdf. London: Health and Safety Executive, 1998.

Jordan 2007

Jordan K, Clarke AM, Symmons DP, Fleming D, Porcheret M, Kadam UT, et al. Measuring disease prevalence: a comparison of musculoskeletal disease using four general practice consultation databases.. British Journal of General Practice 2007;57(534):7‐14.

Klinkman 1997

Klinkman MS. Competing demands in psychosocial care: a model for the identification and treatment of depressive disorders in primary care. General Hospital Psychiatry 1997;19(2):98‐111.

Kroenke 2000

Kroenke K, Taylor‐Vaisey A, Dietrich AJ, Oxman TE. Interventions to improve provider diagnosis and treatment of mental disorders in primary care: a critical review of the literature. Psychosomatics 2000;41(1):39‐52.

Lally 2010

Lally P, Van Jaarsveld C, Potts H, Wardle J. How are habits formed: Modelling habit formation in the real world. European Journal of Social Psychology October 2010;40(6):998‐1009.

Lefebvre 2011

Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.

Majumdar 2007

Majumdar SR, Johnson JA, Lier DA, Russell AS, Hanley DA, Blitz S, et al. Persistence, reproducibility and cost‐effectiveness of an intervention to improve the quality of osteoporosis care after a fracture of the wrist: results of a controlled trial.. Osteoporos International 2007;18(3):261‐70.

McCormick 1995

McCormick A, Fleming D, Charlton J. Morbidity Statistics from General Practice Fourth National Morbidity Survey 1991‐1992. London: HMSO, 1995.

McKenna 2009

McKenna C, Bojke L, Manca A, Adebajo A, Dickson J, Helliwell P, Morton V, Russell I, Torgerson D, Watson J. Shoulder acute pain in primary health care: is retraining GPs effective? The SAPPHIRE randomized trial: a cost‐effectiveness analysis. Rheumatology (Oxford) May 2009;48(5):558‐563.

Michie 2011

Michie S, Van Stralen MM, West R. The behaviour change wheel: A new method for characterising and designing behaviour change interventions. Implementation Science 2011;6:42.

National Center for Health Statistics 1995

National Health Interview Survey. National Center for Health Statistics. US Department of Health and Human Services, Hyattsville, MD1995.

Ramsey 2003

Ramsay CR, Eccles M, Grimshaw JM, Steen N. Assessing the long‐term effect of educational reminder messages on primary care radiology referrals. Clinical Radiology 2003;58:319‐321.

RCGP 1995

Royal College of General Practitioners, Office of Population Censuses and Surveys, Department of Health. Morbidity Statistics from General Practice: fourth national study, 1991/92. London: HMSO, 1995.

RCGP Curriculum 2006

Wise E, Leach J, Fraser A, Field S. Rheumatology and conditions of the musculoskeletal system (including trauma). Royal College of General Practitioners Curriculum Statement 15.9January 2006.

Schünemann 2011

Schünemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, et al. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions.Version 5.1.0 [updated March 2011].The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. The Cochrane Collaboration.

Shemilt 2011

Shemilt I, Mugford M, Byford S, Drummond M, Eisenstein E, Knapp M, et al. Chapter 15: Incorporating economics evidence. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011].The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. The Cochrane Collaboration, 2011.

Smith 2009

Smith H, Brown H, Khanna J. Continuing education meetings and workshops: effects on professional practice and health‐care outcomes: RHL commentary. The WHO Reproductive Health Library; Geneva: World Health OrganizationOctober 2009.

Smith 2016

Smith SM, Wallace E, O`Dowd T, Fortin M. Interventions for improving outcomes in patients with multimorbidity in primary care and community settings. Cochrane Database of Systematic Reviews 2016 2016;Issue 3:Art. No.: CD006560.

Ukoumunne 1999

Ukoumunne O C, Gulliford M C, Chinn S, Sterne J A, Burney P G. Methods for evaluating area‐wide andorganisation‐based interventions in health and health care: a systematic review.. Health Technology Assessment 1999;3(5):iii‐92.

Van Bokhoven 2003

Van Bokhoven MA, Kok G, Van der Weijden T. Designing a quality improvement intervention: a systematic approach. Quality & Safety in Health Care Jun 2003;12(3):215‐20.

WHO 2003

Akesson K, Dreinhofer KE, Woolf AD. Improved education in musculoskeletal conditions is necessary for all doctors . Bulletin of the World Health Organization 2003;81(9):677‐83.

Worker Health Chartbook 2004

Department of Health and Human Sciences. Worker Health Chartbook 2004; Chapter 2, Musculoskeletal Disorders. www.cdc.gov/niosh/docs/2004‐146/pdfs/2004‐146.pdfSeptember 2004; Vol. NIOSH Publication No. 2004‐146.

Tzortziou 2008

Tzortziou V, Morrissey D, Underwood M. Professional interventions for general practitioners on the management of musculoskeletal conditions. Cochrane Database of Systematic Reviews 2008, Issue 4. [DOI: 10.1002/14651858.CD007495]

Characteristics of studies

Characteristics of included studies [ordered by study ID]

Becker 2008

Methods

Study Design: Cluster‐RCT

Participants

Setting: Primary care

Country: Germany.

Participants: All 883 family physicians in 2 German regions were invited to participate

118 practices (126 GPs) agreed to participate and were randomised at practice level. 1 practice withdrew and 1 was excluded because it did not recruit any participants. Total participants recruited: 1378

Condition: Low back pain    

Inclusion criteria for patients were LBP as presenting symptom on the day of recruitment, written consent to participate in the study, and age above 19 years. Exclusion
criteria were insufficient German language skills, pregnancy, and isolated thoracic pain.

Interventions

Practices were randomised into 2 intervention and 1 "control" group.

1. Intervention: Distribution of guidelines on low back pain, 3 interactive seminars, 2 individual academic‐detailing sessions, patient leaflets (educational material + outreach visits +educational meetings)

2. Intervention: Distribution of guidelines on low back pain, 3 interactive seminars, 2 individual academic‐detailing sessions, patient leaflets. Also, motivational counselling session for GPs and 20‐hour training for 2 nurses per practice. Patients recruited received 3 counselling sessions by the nurses (patient‐directed component).

3."Control": Distribution of guidelines on low back pain (educational material)                          

Outcomes

GP outcomes: None

Patient outcomes: Functional capacity (measured by Hannover Functional Ability Questionnaire), days in pain, days of sick leave physical activity, quality of life (measured with EuroQol), and Fear Avoidance Beliefs questionnaire

Notes

We were unable to confirm the results and calculate the standardised mean differences (SMD) due to non‐reported standard deviations

Sources of funding: The study was funded by the German Ministry for Education and Research (BMBF, FKZ 01 EM 0113).

Conflicts of interest as declared by the authors: Federal funds were received in support of this work. No benefits in any form have been or will be received from a commercial party related
directly or indirectly to the subject of this manuscript.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

“Practices were assigned to the 3 study arms by central permuted block randomisation with allocation concealment.”

Allocation concealment (selection bias)

Low risk

“Practices were assigned to the 3 study arms by central permuted block randomisation with allocation  concealment.”

Protection against contamination

Unclear risk

Allocation was by practice but it is unclear if communication between intervention and control practices could have occurred

Baseline outcomes similar

Low risk

No important differences present across study groups.

Baseline characteristics similar

Low risk

Baseline characteristics were reported and were similar between the 2 groups

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

"Outcome measure was objective and recorded by interviewers and trained nurses."

Incomplete outcome data (attrition bias)
All outcomes

Low risk

All outcomes were reported

Selective reporting (reporting bias)

Unclear risk

No study protocol was published in order to be able to verify this.

Other bias

Unclear risk

Possibility of bias during participant recruitment but GPs were asked to recruit consecutive patients

Bessette 2011

Methods

Study design: RCT

Participants

Country: Canada (Quebec)

Condition: osteoporosis

Participants: 1314 women without osteoporosis treatment were randomised.

Inclusion Criteria:

Women, aged 50 years and over

Not residing in a long‐term care hospital before the fracture

Able to understand the programme information and consent form

Must voluntarily accept to participate in this programme and sign the consent form

Participants must have a fragility or traumatic fracture of one of the following sites: wrist, forearm, humerus, scapula, clavicle, sternum, thoracic or lumbar vertebrae, pelvis, sacrum, hip, femur, proximal and distal tibia, fibula (including ankle), and foot

Participants must be able to answer the questionnaires via phone interviews

Exclusion Criteria:

Unable to understand the purpose of the programme

Participants with a traumatic fracture of one of the following sites: cervical, skull and face, hand and finger, toe, metatarsus, and patella

Pathological fracture

Women currently participating in a clinical trial requiring them to take a medication for osteoporosis

Interventions

Experimental group 1: Written educational material on osteoporosis for the physician (distribution of educational material) plus education of patients with advice to see their GP and give them written material (patient‐directed component)

Experimental group 2: 15‐minute educational video on osteoporosis as well as written documentation on osteoporosis for the physician (distribution of educational material) plus education of participants with written material and video and advice to see their GP and give them written material (patient‐directed component)

Control group: No intervention. However the control group completed a questionnaire on osteoporosis which may have increased their awareness

Outcomes

Treatment for osteoporosis (using bisphonates, raloxifene, nasal calcitonin or teriparatide)

Notes

The analysis of the delivery of the reading material to physicians was completed as post hoc observation

Conflicts of interest and funding sources as declared by the authors: Conflicts of interest Dr. Bessette has received research grants from
Abbott, Amgen, Bristol‐Myers‐Squibb, Eli Lilly, Merck, Pfizer, and Roche, has received consulting fees or other remuneration from Abbott,
Amgen, Merck, Novartis, Pfizer, and Roche and has participated on the speakers bureau for Amgen, Novartis, Merck, Pfizer, Roche, andWarner
Chilcott. Dr. Brown has received research grants from Abbott, Amgen, Bristol‐Myers‐Squibb, Eli Lilly, Pfizer, and Roche, has received consulting fees
or other remuneration from Abbott, Amgen, Eli Lilly, Novartis, Merck, and Warner Chilcott and has participated on the speakers bureau for Eli
Lilly, Amgen, Novartis, Merck, and Warner Chilcott. Dr. Davison has received consulting fees or other remuneration
from Amgen and Servier and has participated on the Speakers’ Bureau for Amgen, Merck Frosst Warner Chilcott and Servier.
Dr. Ste‐Marie has received research grants from the Alliance for Better Bone Health and Novartis, has received consulting fees or other
remuneration fromtheAlliance for Better Bone Health,Amgen,Novartis, Eli Lilly, and Servier and has participated on the Speakers’ Bureau for the
Alliance for Better Bone Health, Amgen, Novartis, Eli Lilly, Servier, and Merck. No other authors have a conflict or interest to disclose
The ROCQ program was funded by Merck Frosst Canada, Inc., Warner Chilcott, Sanofi‐Aventis group, Amgen Canada Inc., Eli Lilly
Canada, Inc., and Novartis Pharmaceuticals Canada, Inc. None of the funding sources had a role in the collection, analysis, or interpretation
of the data or in the decision to publish this article.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

The manner of randomisation has not been reported

Allocation concealment (selection bias)

Unclear risk

Not reported

Protection against contamination

Low risk

There were 4452 physicians available to treat 1174 included patients and we therefore felt the risk of contamination to be small

Baseline outcomes similar

Low risk

There were no statistically significant baseline differences among the groups for any investigated variable

Baseline characteristics similar

Low risk

The distribution of baseline characteristics was similar among the groups

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

There was no reported blinding of outcome assessment

Incomplete outcome data (attrition bias)
All outcomes

High risk

The main outcomes (treatment rates) were reported as percentages. The analysis of the delivery of the reading material to physicians was completed as post hoc observation

Selective reporting (reporting bias)

Low risk

The main outcomes were treatment rates. The protocol of the study was published.

Other bias

Unclear risk

The analysis of the delivery of the reading material to physicians was completed as post hoc observation

Bishop 2006

Methods

Study design: RCT

Participants

Setting: Primary care

Country: Canada

462 providers, 428 patients

Condition: Acute low back pain.

Inclusion criteria: The patients included in this study were all residents of British Columbia, Canada, aged between 19 and 65 years.
They had as their chief complaint, acute low back pain and an accepted claim with the Workers’ Compensation
Board of British Columbia relating to an injury that was thought to be causative. All patients included in the study
satisfied the Quebec Task Force Classification of Spinal Disorders criteria for categories 1 or 2 and had symptoms
for more than 2 weeks and less than 4 weeks.

Interventions

1.Distribution of educational materials to GP only + 3 reminders at 0 ‐ 4 weeks (via letters), 5 ‐ 12 weeks and after 12 weeks

2.Distribution of educational materials to participant and GP + 3 reminders (both to participant and GP) at 0 ‐ 4 weeks, 5 ‐ 12 weeks and after 12 weeks (distribution of educational material, reminders and patient‐directed component)

3. Control: no educational material, usual care 

Outcomes

GP outcomes: Concordance with specific clinical guideline‐derived history‐taking items, physical examination procedures and treatment recommendations

Patient outcome: None

Conflicts of interest and sources of funding as declared by the authors: FDA device/drug status: not applicable.
This research was supported by the Workers’ Compensation Board of British Columbia, Canada. No funds were received from a commercial
entity related to this manuscript.

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

“Random number generator” used                                

Allocation concealment (selection bias)

High risk

 In group 2 GPs received “ a letter from a study physician regarding a specific named patient.”                                                                                                          

Protection against contamination

High risk

Randomisation happened at participant level and it is not clear if the same physician was part of both the intervention and the control group

Also, there is a risk of contamination if communication occurred between physicians allocated in different groups who worked in the same practice

Baseline outcomes similar

Unclear risk

Not specified

Baseline characteristics similar

Unclear risk

Not specified

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Not reported

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No missing outcome data

Selective reporting (reporting bias)

Unclear risk

No study protocol published and therefore this could not be verified

Other bias

Unclear risk

It is unclear if either participants or GPs were blinded (possibility of performance bias)

Boyd 2002

Methods

Study design: Randomised trial, no control

Participants

Setting: Primary care

Country: USA
149 GPs were sent letters, 258 patients were recruited, 200 patients were contacted by GPs
Condition: osteoporosis detected by heel ultrasound

Fifty‐nine men (mean age 62.8) and 199 women (mean age 58.7) were involved in the survey; thirty‐seven men and 163 women were able to be questioned.

Of Caucasian patients 169 of 223 were reached and of African American patients 30 of 35 were reached.

Interventions

1. Patient‐mediated: extended letter to physician about patient’s risk of osteoporosis after USS screening result including advice on management (educational material)
2. Patient‐mediated: short letter about patient’s risk of osteoporosis

Outcomes

Number of participants contacted by GPs following distribution of reminders

Ordering BMD scan within 6 months

Prescription of osteoporosis medication

Notes

There was no control group

Conflicts of interest and sources of funding as declared by the authors: Merck, Procter and Gamble, and Aventis pharmaceuticals

for unrestricted grants for purchase of supplies and to support student activities related to the health fairs.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

“Randomly assigned” is the only information provided

Allocation concealment (selection bias)

Unclear risk

Not reported

Protection against contamination

Unclear risk

Randomisation happened at physician level but it is not clear if physicians within the same practice were allocated in different groups

Baseline outcomes similar

Unclear risk

Not specified

Baseline characteristics similar

Unclear risk

Not specified

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Not reported

Incomplete outcome data (attrition bias)
All outcomes

High risk

Outcomes for only 63% of participants followed up

Selective reporting (reporting bias)

Unclear risk

No published protocol and therefore unable to verify this

Other bias

Unclear risk

Potential bias when recruiting participants: 149 GPs were sent letters, 258 patients were recruited, 200 patients were contacted by GPs

Also, not clear if participants were blinded or if they were aware that they were taking part in the study (potential performance bias)

Broadhurst 2007

Methods

Study design: CBA

2 intervention and 2 control sites (2 divisions of general practice in Adelaide)

Participants

Setting: Primary care

Country: Australia

87 GPs were recruited in the intervention group. 90 in the control group. GPs were eligible to participate if they were members in one of these
Divisions and were working ≥ 0.5 full time equivalent (FTE). All GPs in the two Divisions who met the selection criteria were invited to participate. 

Condition: Shoulder pain

Interventions

1. Two sessions of academic detailing (outreach session) on shoulder assessment + educational material (DVD) + guideline + follow‐up session 3 months afterwards (distribution of educational material)

2. Control group: 90 randomly‐selected GPs who received no extra training

Outcomes

GP outcomes: Knowledge score before, immediately after and 3 months after academic detailing + requests for ultrasound and Xray imaging

Notes

Conflicts of interest and funding resources as declared by the authors: Funded by the Diagnostic Imaging Reform Implementation Package, Diagnostic
Imaging Section, the Australian Department of Health and Ageing.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

High risk

Not a randomised study

Allocation concealment (selection bias)

High risk

Not done

Protection against contamination

Unclear risk

There is a possibility of contamination if communication occurred between physicians allocated in different groups but working in the same practice

Baseline outcomes similar

Unclear risk

Not specified

Baseline characteristics similar

Low risk

Baseline characteristics of the intervention and control providers are reported as similar

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Not reported

Incomplete outcome data (attrition bias)
All outcomes

Low risk

All outcomes reported

Selective reporting (reporting bias)

Unclear risk

No study protocol published and therefore unable to verify this

Other bias

High risk

Possible recruitment (self selection) bias of participants                                                               

Chassany 2006

Methods

Study design: RCT

Participants

Setting: Primary care

Country: France

180 GPs, randomisation at GP level.

842 patient participants were recruited by the GPs. Patients over 49 years of age could enter the study if they had radiographic confirmation of OA

of the knee or hip for at least 6 months, had pain intensity on motion > or equal to 40 mm on a 100 mm visual analogue scale (VAS) the day before inclusion

; and were suitable for treatment with acetaminophen.

Condition: Osteoarthritis pain management

Interventions

1. Course on chronic pain management (3 x 4‐hourly group sessions), 8 postal letters emphasising recommendations, patient leaflet with 5 statements about pain relief (educational meeting/workshop plus distribution of educational material)

2. Control, unrelated presentation received

Outcomes

Outcomes: Change in the intensity of pain on motion as measure on a 100 mm VAS + Lequesne index score + Womac scores + Global perception of change + Acetaminophen use

Notes

Conflicts of interest ad sources of funding as declared by the authors: Supported and sponsored by Sanofi‐Aventis OTC, Direction Medicale, Gentilly, France.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

“Randomization stratified according to practice location and date of qualification."

Allocation concealment (selection bias)

High risk

Not done

Protection against contamination

Unclear risk

There is a possibility of contamination if communication occurred between GPs allocated to different groups but working in the same practice

Baseline outcomes similar

Low risk

No important differences present across study groups

Baseline characteristics similar

Low risk

Baseline characteristics are reported as similar

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Not reported

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Missing data balanced in numbers across groups. Similar reasons for missing data across groups

Selective reporting (reporting bias)

Unclear risk

No evidence of published protocol

Other bias

Unclear risk

Possibility of bias during recruitment of patients by GPs. Unclear if participants were blinded

Ciaschini 2010

Methods

Study design: RCT

Participants

Country: Canada, Ontario

Participants: patients over the age of 55, able to give consent and identified to be at risk of future fracture

Patients were eligible for inclusion in the study if they were community‐dwelling, aged 55 years or older, able
to give informed consent, and were identified to be at risk for future fracture according to one of the following
criteria:
1. attended the hospital Fracture Clinic for a non‐pathological fracture of the vertebrae, hip or wrist or
had a BMD in the past year with a T‐score of ≤‐2.0

2. attended the hospital Emergency Department with a fall and found to be at high risk for falls as defined
by a Timed Up and Go [25] result of greater than 14 seconds; or,
3. were self‐referred or referred by a health care provider because of perceived high risk of fracture and
identified as a high risk for falls defined by a Timed Up and Go result of greater than 14 seconds.
Patients already receiving appropriate pharmacological therapy for osteoporosis as outlined in the Osteoporosis
Canada guidelines were excluded from the study.

Interventions

Intervention group: The results of the patient's recent BMD test (patient‐mediated) and patient‐specific advice on prescribing according to the Osteoporosis Canada guidelines (reminders and educational material) were sent to the participant's physician. The participant received personalised counselling on osteoporosis from a research nurse, a written summary of the proposed management plan and educational material (patient‐directed component)

Control group: usual care

Outcomes

The main outcome was prescribing of osteoporosis medication (alendronate, risedronate, raloxifene) 6 months after the intervention

Notes

The control participants received the intervention 6 months after randomisation (delayed protocol group)

Conflicts of interest and sources of funding as declared by the authors: Financial support for completion of the study was given by Merck Frosst
Canada Ltd., Sanofi‐Aventis Pharma Inc., Proctor & Gamble Pharmaceuticals Canada Inc., Eli Lilly Canada Inc., and the Greenshield Foundation.
Equipment (e.g. office space, computers, telephones) was contributed in kind by the Group Health Centre, Algoma Public Health, Sault Area Hospital,
Algoma Community Care Access Centre, and the Slips, Trips and Falls Committee of Sault Ste. Marie Safe Communities Partnership, all located in
Sault Ste. Marie, Ontario. The Ontario Ministry of Health and Long‐term Care provided additional support.
PMC is supported by the Algoma District Medical Group in Sault Ste. Marie, Ontario. SES was supported by a salary award from the Alberta Heritage
Foundation for Medical Research (Health Scholar) when this study was completed and holds a Canada Research Chair in Knowledge Translation
and Quality of Care. LRD is supported by a Canadian Institutes of Health Research Rx&D Health Research Foundation Research Career Award. SRM is
supported by salary awards from the Alberta Heritage Foundation for Medical Research (Health Scholar) and the Canadian Institutes for Health
Research (New Investigator).

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

A computer‐generated randomisation scheme was used

Allocation concealment (selection bias)

High risk

Participants and treating physicians were not blinded

Protection against contamination

Unclear risk

Not reported

Baseline outcomes similar

Low risk

No statistically significant baseline differences were detected among the groups

Baseline characteristics similar

Low risk

Baseline characteristics were similar among the groups

Blinding of outcome assessment (detection bias)
All outcomes

High risk

Outcome assessors could not be blinded; however the primary source of data was obtained from the Group Health Centre Electronic Medical record

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Selective reporting (reporting bias)

Low risk

All outcomes were reported. The protocol of the study was published

Other bias

Low risk

No other bias identified

Cranney 2008

Methods

Study design: Cluster‐RCT

56 cluster practices were in the intervention group and 63 in the control group

Participants

Setting: Primary care

Country: Canada 

119 GP practices (these were randomised), 270 patients (the unit of analysis).

Condition: Osteoporosis

Participants patients inclusion criteria: Participants included postmenopausal women who had sustained a wrist fracture (confirmed by
x‐ray). Women currently taking osteoporosis therapies (e.g., risedronate, raloxifene, alendronate, teriparatide) were
excluded, but we did not exclude women on hormone therapy (HT), since they may have been taking HT for
menopausal symptoms. Women who had a traumatic wrist fracture (based on description of fracture), or were unable
to communicate in English or give consent were also excluded. Women who had a previous BMD test were not
excluded, since a previous test could be a predictor of receiving osteoporosis therapy.

Interventions

1. Personalised letter to GP from research co‐ordinator 2 weeks and 2 months post‐fracture (patient‐mediated and reminders) incorporating advice on management, recommended therapies and a treatment algorithm (distribution of educational material). Participants also received a letter 2 weeks and 2 months post‐fracture with advice to see their GP and an educational booklet (patient‐directed component)

2. Control: no information, usual care

Outcomes

Outcomes: Proportion of women who stated that their primary care physician had: Discussed osteoporosis with them + started them on osteoporosis therapy within 6 months of fracture + BMD testing within 6 months + changes in the participant’s knowledge of osteoporosis using the Osteoporosis Knowledge Questionnaire (OPQ). Outcomes were assessed by telephone interviews

Notes

Conflicts of interest and sources of funding as declared by the authors: This trial was funded by a peer‐reviewed grant from the
Canadian Institutes of Health Research (KTS 62358).

The study did not provide sufficient information to allow the re‐calculation of adjusted for clustering effect sizes.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

“Computer generated list of random numbers in a blinded fashion”

Allocation concealment (selection bias)

Low risk

As above

Protection against contamination

Unclear risk

Although the practices were randomised using a cluster design, it is still unclear if communication between physicians or patients of different groups was possible

Baseline outcomes similar

Low risk

No important differences present between the groups

Baseline characteristics similar

Low risk

Baseline characteristics were reported as similar

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Not clear if telephone interviews were conducted blindly

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Similar reasons and rates of dropouts between both groups

Selective reporting (reporting bias)

Unclear risk

No evidence of published protocol

Other bias

Low risk

No other bias identified

Dey 2004

Methods

Study design: cluster‐RCT

Participants

Setting: primary care

Country: UK
24 practices (practice was the unit of randomisation, stratified by primary care group; 3 primary care groups), 2187 patients
Condition: acute LBP

Patients were eligible for this study if they were aged between 18 and 64 years, registered with a GP in
Birkenhead, Wallasey or West Wirral Primary Care Groups (PCGs), and had consulted their GP about an episode of
acute low back pain for which they had not already sought advice during the preceding 6 months.

Interventions

1. Educational outreach visit + guidelines (educational material)+ poster of guidelines + referral forms with guidelines + access to fast‐track physiotherapy and a back clinic                      

2. Control: standard practice

Outcomes

Rate of referral for lumbar spine x‐ray within 3 months

Number of sickness certificates issued

Number of prescribed opioids or muscle relaxants

Number referred to secondary care

Number referred to physio or educational programme

Notes

Conflicts of interest and sources of funding as declared by the authors: None reported

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Random allocation, each centre was given a unique identifier, stratification by primary care group

Allocation concealment (selection bias)

Low risk

Central allocation

Protection against contamination

Unclear risk

Although the practice was the unit of randomisation, it is not clear if communication between practices could affect the results

Baseline outcomes similar

Unclear risk

Not specified

Baseline characteristics similar

Low risk

Baseline characteristics are reported as similar

Blinding of outcome assessment (detection bias)
All outcomes

High risk

“Only one research assistant was employed and blind outcome assessment was not possible.”

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No missing outcome data

Selective reporting (reporting bias)

Unclear risk

Insufficient information as no published protocol

Other bias

Low risk

No other bias identified

Eccles 2001

Methods

Study design: cluster‐RCT

Participants

Setting: Primary care

Country: UK
247 practices randomised; practice was unit of randomisation and analysis‐stratified randomisation by radiology department (3 radiology departments) and practice size.

The audit and
feedback intervention was delivered to all eligible GPs
according to study design.
Condition: acute LBP or knee pain

Interventions

2 x 2 factorial design

1. Distribution of educational materials + audit and feedback (number of practice referrals compared with peers)
 2. Distribution of educational materials + reminders (messages on x‐ray results)
 3. Distribution of educational materials + audit and feedback + reminders
 4. Distribution of educational materials (guideline) (control group)

Outcomes

Number of lumbar or knee radiographs requested per 1000 patients for 2 years

Notes

Intervention fidelity: Measured attachment rate of educational reminder messages to x‐ray reports

Conflicts of interest and sources of funding as reported by the authors: The study was funded by the UK National Health Service Research and
Development Primary Secondary Interface Programme. The Health Service Research Unit, University of Aberdeen, is funded by the Chief
Scientist Office of the Scottish Office Department of Health. The Centre for Health Services Research, University of Newcastle upon Tyne, and the
Health Services Research Unit, University of Aberdeen are members of the Medical Research Council Health Services Research Collaboration.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Computer‐generated random number tables. 

Allocation concealment (selection bias)

Low risk

 Performed centrally by statistician

Protection against contamination

Low risk

The intervention was individualised messages and feedback to practices and therefore the risk of it being disseminated to other practices is low

Baseline outcomes similar

High risk

There was baseline imbalance between the groups

Baseline characteristics similar

Unclear risk

Not specified

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Outcomes were measured objectively by radiology departments

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No missing outcome data

Selective reporting (reporting bias)

Unclear risk

No published protocol

Other bias

Unclear risk

The intervention of attaching messages to radiology reports was not consistently applied across sites. The site where the messages were attached by an operator pressing a key had an attachment rate of 40% while the other 2 sites had a rate of close to 100%                                                          

Engers 2005

Methods

Study design: Cluster‐RCT

Participants

Setting: Primary care

Country: Netherlands

67 GPs eligible to participate, 41 of these completed outcome reports, 531 participants

Condition: Low back pain

The participating GPs were asked to recruit consecutive patients with a new episode of low back pain as the main reason
for consultation. Low back pain was defined as pain, discomfort, stiffness, or fatigue between the lower edge of the shoulder
blades and the gluteal fold either with or without radiation to the legs. Patients who were pregnant, younger than 16 years of
age, or not familiar with the Dutch language were excluded. Only patients who were diagnosed with “nonspecific low back
pain” and no “red flags” present were included in the analyses.

Interventions

1. Two‐hour workshop (negotiation skills) , guideline on low back pain and guidance on low back pain for occupational physicians, 2 scientific articles, a patient education tool and a management decision tool (distribution of educational materials)

2. Control: no intervention, usual care

Outcomes

Number of referrals to a therapist (physical, exercise, or manual therapist)

Prescription of pain medication on a time‐contingent basis

Prescription of paracetamol versus NSAIDs

Adequacy of patient education.

Notes

Conflicts of interest and sources of funding as declared by the authors: The manuscript submitted does not contain information about medical
device(s)/drug(s).
No funds were received in support of this work. No benefits in any form have been or will be received from a commercial party related
directly or indirectly to the subject of this manuscript.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

"Computer‐generated random‐ list of numbers” used

Allocation concealment (selection bias)

High risk

“Research team knew which practices received which intervention."

Protection against contamination

Unclear risk

The unit of allocation was the GP so there is a risk of communication between GPs allocated to different groups but working in the same practice

Baseline outcomes similar

Unclear risk

Not specified

Baseline characteristics similar

Unclear risk

Baseline characteristics were reported as similar

Blinding of outcome assessment (detection bias)
All outcomes

High risk

“Research team knew which practices received which intervention."

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Intention‐to‐treat analysis performed                                                                                                                                 

Selective reporting (reporting bias)

Unclear risk

No protocol was published (although the protocol is mentioned in the study)

Other bias

High risk

Possible bias as GPs recruited participants. Possible recollection or report bias due to self‐reported outcomes                                                                                                                               

Feldstein 2006

Methods

Study design: RCT            

Participants

Setting: Primary care

Country: USA 
15 practices, 159 providers, 327 participants (randomisation at patient level)
Condition: women aged 50 to 89 who had suffered a fracture (any type) and therefore high likelihood of osteoporosis

The goal in participant selection was to identify older patients who had fractures indicating an increased
risk of osteoporosis, had not received a BMD measurement or a medication for osteoporosis, and did not have
medical conditions or other factors that would contraindicate the interventions.

Interventions

1. Reminders: electronic medical record message about participant’s risk of osteoporosis + distribution of education materials (with guidelines)
2. Reminders + distribution of education materials + patient‐directed component (educational material and reminder to see the GP)
3. Control: standard practice

Outcomes

GP outcomes: proportion of study population who received medication for osteoporosis or a BMD test within 6 months after the intervention

Participant outcomes: regular physical activity, total caloric expenditure, total calcium intake and patient satisfaction

Notes

Conflicts of interest and sources of funding as declared by the authors: This study was supported by a research
contract through Merck & Co. Inc. The funding organization was not involved in the design or conduct of the study;
the collection, management, analysis, or interpretation of the data; or in the preparation or approval of this manuscript.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Computerised random number generator used                                                                                                                            

Allocation concealment (selection bias)

Low risk

 "The study statistician randomised and assigned participants to the study groups"

Protection against contamination

Unclear risk

Possible contamination as the participant was the unit of randomisation

Baseline outcomes similar

Unclear risk

Not specified

Baseline characteristics similar

Low risk

Baseline characteristics were reported as similar

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Study analyst “was blinded to the treatment groups.”

 

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No missing outcome data

Selective reporting (reporting bias)

Unclear risk

Protocol mentioned in the study but not published

Other bias

Unclear risk

Unclear if participants were blinded                                                                             

 

French 2013

Methods

Study design: Cluster‐RCT

Participants

Setting: Primary care

Country: Australia
78 practices, 92 GPs were randomised and participated in the study (randomisation at practice level)
Condition: Low back pain

Patient participant inclusion criteria were people presenting with acute (less than three months duration) non‐specific LBP and
aged 18 years or older.

Interventions

Intervention group: 2 facilitated, interactive, educational workshops aiming to facilitate behaviour change plus distribution of educational DVDs to all physicians

Control group: usual care

Outcomes

Primary outcomes were patient outcomes but due to low numbers of patients recruited, these were not measured.

Secondary outcomes included self‐reported behavioural change and number of x‐ray and CT requests

Notes

Not all physicians participated in the full intervention. Only 36 (61%) attended the workshops and an additional 6 watched the DVDs. However the analysis included all physicians

Conflicts of interest and sources of funding as declared by the authors: The authors have declared that no competing interests exist. The IMPLEMENT trial was funded by the Australian National Health and Medical Research Council (NHMRC) by way of a Primary Health Care Project
Grant (334060). SDF and DAO are supported by NHMRC Early Career Fellowships. RB is supported in part by a NHMRC Practitioner Fellowship. The funders had no
role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

An independent and blinded statistician implemented the randomisation (computer‐generated random numbers) after stratifying practices based on the number of GPs and whether the practice was rural or not

Allocation concealment (selection bias)

Low risk

Allocation was concealed from the investigators until baseline data had been collected from GPs

Protection against contamination

Low risk

The whole practice was randomised to reduce risk of contamination

Baseline outcomes similar

Unclear risk

There is no information on baseline outcomes (on x‐ray and CT numbers)

Baseline characteristics similar

High risk

There was some baseline imbalance, with control GPs more likely to identify themselves as having an interest in low back pain (24% versus 9%) and more GPs in the intervention group undertaking low back pain continuing education in the past year (16% versus 5%)

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Investigators not involved in the intervention who entered the data and the statistician were blinded to group allocation until the statistical analysis was completed

Incomplete outcome data (attrition bias)
All outcomes

High risk

The primary outcomes were not measured due to low numbers of participants recruited

Selective reporting (reporting bias)

High risk

As above. Also, subgroup analysis to investigate the effect on GPs who attended the workshop (as per protocol) was not done

Other bias

High risk

Not all physicians participated in the full intervention. Only 36 (61%) attended the workshops and an additional 6 watched the DVDs. However the analysis included all physicians

Participants could not be blinded. Primary outcomes not measured. Reported outcomes were self reported

Gormley 2003

Methods

Study design: RCT

Participants

Setting: Primary care

Country: Northern Ireland

40 GP principals randomised

Condition: Shoulder pain

Interventions

1. Educational meeting/workshop on shoulder management and injection technique training on mannequins

2. As above plus injection training on real patients

Outcomes

Number of shoulder injections

Referrals to physiotherapy and injection clinics over last 6 months

Level of confidence (10 cm VAS)

Notes

Conflicts of interest and sources of funding as declared by the authors: None reported.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Not reported in the study

Allocation concealment (selection bias)

Unclear risk

Not reported in the study

Protection against contamination

Low risk

The randomisation was at physician level. The intervention required the physician to be present to practise their skills and therefore contamination is unlikely

Baseline outcomes similar

Low risk

No important differences between the groups

Baseline characteristics similar

Low risk

No important differences between the groups

Blinding of outcome assessment (detection bias)
All outcomes

High risk

Not done, this was self reported

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

"One GP's assessment return after training was incomplete and another failed to make a return. Both of these were in the "mannequin only" training group". It is unclear what the exact proportion of missing data was and if this could bias the results

Selective reporting (reporting bias)

Unclear risk

No published protocol of the study

Other bias

High risk

Results were based on self reporting by GPs. GPs were not blinded

Hazard 1997

Methods

Study design: RCT

Participants

Setting: Primary care

Country: USA

59 GPs

59 patients: workers 18‐60 years old with VDPQ scores suggesting a high risk of prolonged work disability (i.e. VDPQ score of at least 0.37 (scale = 0‐1))

Condition: Low back injury

Interventions

1.Distribution of educational materials + reminders to GPs (letters regarding the specific patient with advice on how to limit work loss)               

2. Control

Outcomes

3‐month work absence rate

VDPQ (disability) score

Satisfaction with health care

Impact of health care on return to work

Days of work loss

Days until first return to work

Notes

Conflicts of interest and sources of funding as reported by the authors: Supported, in part, by The National Institute on Disability
and Rehabilitation Research, Washington, D.C. (grant H133E30014‐95).

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

"Each high risk worker was assigned to the physician intervention group or to the control group, according to a predetermined allotment list developed from a table of random digits balancing the assignments with every six workers".

Allocation concealment (selection bias)

High risk

“Physician was sent a letter identifying the patient and the patient's high risk for work absence 3 months after injury."

"The workers themselves knew whether they were in the intervention or control groups".

Protection against contamination

Unclear risk

Physicians could be working in the same practice.

Baseline outcomes similar

Unclear risk

Not specified

Baseline characteristics similar

Unclear risk

Not specified

Blinding of outcome assessment (detection bias)
All outcomes

High risk

"The follow up interviewer was not blinded to the VDPQ scores or groups assignments".

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No missing outcome data

Selective reporting (reporting bias)

Unclear risk

No published protocol of the study

Was knowledge of the allocated interventions adequately prevented during the study?

High risk

Other bias

Unclear risk

Participants were not blinded

Hollingworth 2002

Methods

Study: ITS

Participants

Setting: Primary care

Country: UK

Number of practices and GPs not reported. Analysed 2100 x‐ray referrals

The mean age of the 2100 patients whose radiography reports were selected for review was 53.6 years (range = 7 to 94 years), 57.9% were female.

Interventions

Distribution of guidelines (by Royal College of General Practitioners and Royal College of Radiologists)

Outcomes

Number of primary care referrals for radiography of the lumbar spine

Notes

Conflicts of interest and sources of funding as declared by the authors: The lead author is sponsored by a MRC training fellowship in Health
Services Research. This study was funded in part by task‐linked NHS R&D support funding.
The work was undertaken at University of Cambridge, which received funding from the NHS Executive eastern region. The views expressed in
this publication are those of the authors and not necessarily those of the NHS Executive eastern region.

Risk of bias

Bias

Authors' judgement

Support for judgement

Was the intervention independent of other changes?

Unclear risk

No other changes were reported at the time of the guideline dissemination. However, such changes (such as waiting times, funding arrangement changes or changes in the prevalence of low back pain were possible)

Was the shape of the intervention effect pre‐specified?

Unclear risk

This was not specified in the study

Was the intervention unlikely to affect data collection?

Low risk

The intervention was independent of the data collection method

Was knowledge of the allocated interventions adequately prevented during the study?

Low risk

Participants were not aware of the study

Were incomplete outcome data adequately addressed?

Unclear risk

The study does not give sufficient information on this

Other bias

Low risk

No other risks identified

Huas 2006

Methods

Study design: Cluster‐RCT

Participants

Setting: Primary care

Country: France

155 GPs (randomisation was stratified by University; 20 different Universities), 772 participants

Condition: Chronic musculoskeletal pain

All included patients were over 18 years of age, had been suffering for at least 3 months from sustained daily chronic pain, of musculoskeletal origin

affecting the locomotor system, and were regularly taking painkillers.

Interventions

1.Training in the use of VAS and HAD scales for pain (educational meeting + patient‐mediated intervention)    

2. Control: usual care                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

Outcomes

GP outcomes: changes in prescription of painkilling modalities

Patient outcomes: Level of relief obtained (numerical relief scale) (self reported by participant)

Notes

Conflicts of interest and sources of funding as declared by the authors: The Fondation de la Caisse Nationale de Prevoyance funded the study and the Nukleus company provided material support.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

“Randomisation was stratified by University.” No further information provided

 

Allocation concealment (selection bias)

Unclear risk

No information provided

Protection against contamination

Low risk

"In order to avoid contamination bias, physicians from both groups never met during the course of the study".

Baseline outcomes similar

Low risk

"Painkilling treatment prescribed at inclusion was comparable in both groups ‐ the main difference being that a larger number of patients in the scale group were taking level 3 analgesics, although the number of patients concerned was very small".

Baseline characteristics similar

Low risk

"The characteristics of the physicians were comparable for both groups", "The patient groups in the treatment and control groups were of similar nature", "pain location was comparable in the 2 groups except for back pain"

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Participants probably unaware of GPs' training. Not clear how secondary outcomes were assessed and by whom

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

Not reported

Selective reporting (reporting bias)

Unclear risk

No published protocol of the study

Other bias

Low risk

No other risks identified

Kerry 2000

Methods

Study design: cluster‐RCT

Participants

Setting: Primary care

Country: UK
69 practices (practice is the level of randomisation), 175 GPs, 43,778 radiological requests
Condition: People potentially requiring an x‐ray of chest, spine or limbs and joints

Interventions

1. Distribution of guidelines + individual feedback on referral rates + graph of the average radiation dose for different examinations (educational material and audit/feedback)
2. Control: standard care

Outcomes

Professional practice: number of x‐rays requested (chest, limbs and joints, spine) within 12 months

Notes

Conflict of interests and sources of funding as declared by the authors: This study was funded by The South Thames Project
Grant Scheme.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

“Practices were randomly allocated to an intervention or a control group using a stratified randomisation.”

Allocation concealment (selection bias)

Unclear risk

Not reported

Protection against contamination

Unclear risk

Randomisation was at practice level but unclear if practices of different groups could communicate

Baseline outcomes similar

Unclear risk

Not reported

Baseline characteristics similar

Unclear risk

Not reported. Although randomisation happened using 10 strata depending on "numbers of partners, referral rates, fund‐holding status, and having received guidelines in a previous study".

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Outcome objectively collected (routine data, collected electronically)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

All outcomes were reported

Selective reporting (reporting bias)

High risk

Results (referrals for x‐rays) not reported per 1000 patients. Protocol of the study not published

Other bias

Low risk

No other risks identified

Lafata 2007

Methods

Study design: cluster‐RCT

Participants

Setting: Primary care

Country: USA

15 practices randomised after stratification (randomisation at practice level), 123 primary care physicians, 10,354 patients

Condition: women 65 to 89 years of age on 3/31/2003 and high likelihood of osteoporosis with a visit between 4/1/2001 and 3/31/2003 to
a primary care physician.

Interventions

1. Patient‐directed component (educational material on osteoporosis)

2. Patient‐directed (educational material on osteoporosis) + physician prompt/reminder (reminder on electronic medical record and biweekly letter to physician listing patients needing treatment)

3. Control: standard care

Outcomes

Professional practice: proportion of patients receiving BMD testing within 12 months; prescription of osteoporosis medication

Notes

Possible risk of contamination

Conflicts of interest and sources of funding as declared by the authors: Dr. Weiss and Dr. Chen are employees of Merck & Co.

The study did not provide sufficient information to allow the re‐calculation of adjusted for clustering effect sizes.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

"Within stratum, clinics were allocated to the three arms using a random numbers table"

Allocation concealment (selection bias)

Unclear risk

Not reported

Protection against contamination

Unclear risk

Randomisation was at practice level but unclear if practices of different groups could communicate

Baseline outcomes similar

Low risk

Women with previous BMD screening or on osteoporosis medication were excluded from the evaluation

Baseline characteristics similar

Unclear risk

"Although statistically significant baseline differences were found for most of the patient characteristics assessed, only a handful meaningful differences existed".

"Women in the patient mailed reminder arm were less likely to be African American",

"there was variation in health plan enrolment".

There was no assessment of GP baseline characteristics

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Used "automated clinical and pharmacy data"

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Missing outcome data balanced in numbers across intervention groups

Selective reporting (reporting bias)

Unclear risk

Insufficient information provided. No published protocol of the study

Other bias

Low risk

Leslie 2012

Methods

Study design: RCT

Participants

Setting: Primary care

Country: Canada
4264 patients were randomised; patients included men and women 50 years of age and older who had suffered a previous fracture and had not received a BMD or osteoporosis medication
Condition: osteoporosis

Interventions

1. Notification letter to primary care physician (reminder) about the patient's fracture accompanied by educational material

2. Notification letter to primary care physician accompanied by educational material as above plus patient‐directed intervention (educational material and reminder)

3. Control group: usual care

Outcomes

BMD and osteoporosis medication

Notes

Conflicts of interest and sources of funding as declared by the authors: Wiliam Leslie has received speaker fees from Merck Frosst and Amgen;

he has unrestricted research grants from Merck Frosst, Sanofi‐Aventis, Procter and Gamble, Novartis, Amgen and Genzyme; he is on the advisory boards

for Genzyme, Novartis, and Amgen. Patricia A Caetano has received unrestricted research grant from Amgen. No other competing interests were declared.

The article was funded by the Manitoba Patient Access Network whose mandate is to identify, advocate, support and guide health system change and process improvement

initiatives. The network is financially supported by the Wait Times Reduction Fund and receives secretariat services from Manitoba Health`s Wait Times Task Force.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

"The randomisation was done using a centralised computer‐based algorithm"

Allocation concealment (selection bias)

Low risk

"The computer‐based algorithm concealed the allocation process from the clinical investigators"

Protection against contamination

Unclear risk

It is not clear if primary care physicians in the control group were also physicians of patients under the intervention groups

Baseline outcomes similar

Low risk

"The groups were well balanced in terms of age, sex and site of fracture"

Baseline characteristics similar

Low risk

As above. The patients included had not received previous BMD test or osteoporosis medication

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

The outcomes were taken from a centralised database

Incomplete outcome data (attrition bias)
All outcomes

Low risk

The analysis followed an intention‐to‐treat methodology and all participants were included

Selective reporting (reporting bias)

Low risk

All outcomes as per study protocol were reported

Other bias

Low risk

No other risks identified

Majumdar 2008

Methods

Study design: RCT

Participants

Setting: Primary care

Country: Canada
266 GPs, 272 patients (unit of randomisation the patients)

Condition: 50 years or older and distal forearm fracture (high likelihood of osteoporosis) 

Patients were excluded if they were already receiving treatment for osteoporosis with a bisphosphonate,
were unable or unwilling to provide informed consent, had no fixed address, were residing outside the Capital Health region
or were residing in a long‐term care facility.

Interventions

1. Distribution of guidelines endorsed by five local leaders (educational material) + physician reminder (patient‐specific letter to GP) + patient‐directed component (education and counselling via telephone)
2. Control group, usual care

Outcomes

Proportion of participants who had received BMD test

Prescription of osteoporosis medication

Composite measure of quality of guideline‐concordant or “appropriate” care

Patient Outcomes:  Health status (SF‐12)

Osteoporosis‐related quality of life

Wrist‐related functional outcomes

Osteoporosis‐related knowledge

Satisfaction with care

Costs: intervention cost per patient (this outcome was reported in a different publication, Majumdar 2007)

Notes

Conflicts of interest and sources of funding as declared by the authors: None declared for Sumit Majumdar, Jeffrey Johnson,
Finlay McAlister, Debbie Bellerose, Anthony Russell, Don Morrish, Walter Maksymowych or Brian Rowe. David Hanley has been a clinical investigator
in phase III clinical trials of bisphosphonates manufactured by Proctor & Gamble, Merck and Novartis; in addition, he has received speaker fees from
and has been a paid consultant on advisory boards of these companies.Sumit Majumdar, Jeffrey Johnson, Finlay McAlister and
Walter Maksymowych receive salary support awards from the Alberta Heritage Foundation for Medical Research; Sumit Majumdar and Finlay McAlister
receive salary support awards from the Canadian Institutes of Health Research; Jeffrey Johnson and Brian Rowe hold Canada Research Chairs; and
Finley McAlister holds the Aventis/Merck‐Frosst Chair in Patient Health Management. The study was supported by peer‐reviewed grants from the Canadian
Institutes of Health Research.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

 “Allocation was concealed by application of various block sizes and by use of a secure,centralised, Internet based computer‐generated randomisation system.”

Allocation concealment (selection bias)

Low risk

As above

Protection against contamination

High risk

The randomisation unit was the patient and therefore there could be contamination at physician level

Baseline outcomes similar

Unclear risk

Not reported

Baseline characteristics similar

Unclear risk

"Intervention and control patients were comparable" and "all multivariable analysis adjusted" for any differences. There was no assessment of physician characteristics

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

"Research nurses collected outcome data without knowledge of allocation status".

Incomplete outcome data (attrition bias)
All outcomes

Low risk

All participants were accounted for

Selective reporting (reporting bias)

Unclear risk

All outcomes listed in Methods were reported. However, there was no published study protocol

Was knowledge of the allocated interventions adequately prevented during the study?

Low risk

Other bias

Low risk

"Neither physicians nor patients were aware of the study outcomes"

Rahme 2005

Methods

Study design: Cluster‐RCT

Participants

Setting: Primary care

Country: Canada

249 providers, patients; before intervention = 3280, and post intervention = 2883

Condition: Osteoarthritis

All NSAID, COX‐2 inhibitor, or acetaminophen prescriptions dispensed to patients with osteoarthritis were identified.
Patients with osteoarthritis were those who had at least one diagnosis for osteoarthritis (ICD‐9 code 715) in the
previous 1215 days.

Interventions

1. Distribution of educational material (decision‐tree laminated sheet) without face‐to‐face discussion

2. 90‐minute workshops on osteoarthritis without distribution of the decision‐tree laminated sheet

3. 90‐minute workshop on osteoarthritis + distribution of the decision‐tree laminated sheet      

4. Controls: standard care, no educational intervention

Outcomes

Professional practice: prescription of medications for elderly patients suffering from osteoarthritis

Notes

Conflicts of interest and sources of funding as declared by the authors: Drs. LeLorier, Choquette, Bessette and Rahme have served as consultants
and paid speakers for Merck & Co. Inc. and for Pfizer Inc. Ms. Beaulieu is an employee at Merck Frosst Canada Ltd. Dr. Rahme is a
research scholar funded by The Arthritis Society.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

“Each town was randomly allocated 1 of 4 intervention options”. No further details of the randomisation method are given

Allocation concealment (selection bias)

Unclear risk

Not reported

Protection against contamination

Low risk

"The towns were geographically distant to minimise cross‐contamination"

Baseline outcomes similar

Unclear risk

Not reported

Baseline characteristics similar

Low risk

"Patient and physician characteristics were on average similar among the four groups"

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Outcomes data were obtained from electronic databases (Provincial Health Care Fund database)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Intention‐to‐treat analysis performed.

Selective reporting (reporting bias)

Unclear risk

No study protocol was published

Other bias

Unclear risk

Not clear if participants were blinded with regards to the study outcomes

Robling 2002

Methods

Study design: cluster‐RCT

Participants

Setting: Primary care

Country: UK
30 practices, 182 MRI requests
Condition: people who potentially require MRI for knee or lumbar problems

Interventions

1. Distribution of local guidelines + practice‐based seminar during which a 15‐minute video was shown (outreach visit)
2. Distribution of local guidelines + feedback on practice‐specific MRI use and comparative data on orthopaedic and neurosurgical referrals (audit and feedback)
3. (1 + 2) Distribution of educational material plus outreach visits plus audit and feedback
4. Control group: distribution of local guidelines by post

Outcomes

Professional practice: proportion of MRI requests that are in concordance with guideline (length of follow‐up not clear)
Cost outcome: intervention cost

Notes

Conflicts of interest and sources of funding: The study was funded by the NHS Research and Development Programme on the

Primary Secondary Care Interface.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

“Randomisation was performed using a random numbers table.”

Allocation concealment (selection bias)

Unclear risk

 Not reported

Protection against contamination

Unclear risk

Randomisation was at practice level but it is unclear if practices of different groups could communicate

Baseline outcomes similar

Unclear risk

Not reported

Baseline characteristics similar

Unclear risk

Not reported

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

 "Anonymised interview data were assessed by a study panel"

"Panel members were blinded to study randomisation"

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

Not reported

Selective reporting (reporting bias)

Unclear risk

Insufficient information, no study protocol was published.

Other bias

Unclear risk

It is unclear if participants were blinded on the outcome measures

Rosemann 2007

Methods

Study design: Cluster‐RCT

Participants

Setting: Primary care

Country: Germany

75 practices, 75 GPs, 1021 patients. The GPs were the unit of randomisation.

Condition: Osteoarthritis  

To be eligible for inclusion, patients had to be age 18 years and diagnosed with OA in
the knee or the hip according to the American College of Rheumatology criteria   

Interventions

1. Educational meeting/workshop (2 interactive quality circle meetings of 8 hours each on management of osteoarthritis and motivational skills) plus educational material (written educational material + patient educational material including leaflets, booklets and audio CDs)

2. 1 + practice nurse training to call participants and complete questionnaire on osteoarthritis management

3. Control

Outcomes

Patient outcomes: Change in quality of life, assessed by the German version of the Arthritis Impact Measurement Scales Short Form (AIMS2‐SF),

Health service utilisation

Prescriptions

Physical activity.

Notes

Conflicts of interest and sources of funding as declared by the authors: None reported

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

GPs randomised by SPSS

Allocation concealment (selection bias)

Unclear risk

Not reported

Protection against contamination

High risk

As the randomisation was at GP level, it may have been possible that communication between intervention and control professionals could have occurred.

Baseline outcomes similar

Low risk

No significant differences between participant groups were identified

Baseline characteristics similar

Low risk

"No statistically significant differences in the outcome measures" at baseline were found

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Participant answers were cross‐checked by a research assistant but it is not clear if the assistants were blinded

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No missing outcome data."No practice dropped out during the study"

Selective reporting (reporting bias)

Low risk

Published study protocol

Other bias

Unclear risk

The participants were not blinded and this may have affected the results

Roux 2013

Methods

Study design: RCT

Participants

Setting: Primary care
Country: Canada (Quebec, Sherbrooke)
Women and men aged 50 years or older with a fracture confirmed on radiograph were screened by the study co‐ordinators for circumstances suggestive of a fragility fracture when they attended the orthopedic outpatient clinics.

Patients unable to speak French or English fluently, as well as those with known severe psychiatric problems, delirium, or dementia were not approached because of their inability to provide valid informed consent. 881 patients were randomised

Interventions

Group 1: Verbal and written information on osteoporosis to patient (patient‐directed component) and letter with specific management plan sent to their treating physician (GP reminder). Patient reminders at 6 and 12 months. Reminder to physician if patient untreated at 6 months

Group 2: Verbal and written information on osteoporosis to patient (patient‐directed component) and letter with specific management plan sent to their treating physician (GP reminder). Blood tests and BMD test ordered for patient and results sent to the physician (patient‐mediated intervention). Patient reminders at 4,8 and 12 months and physician reminders at 4 and 8 months if patient remained untreated

Control group: Telephone interviews at 6 and 12 months to assess treatment scores.

Outcomes

Osteoporosis‐related drug treatment at 12 months was the main outcome.

Notes

Conflicts of interest and sources of funding as reported by the authors: Supported by unrestricted research grants from Merck Canada, The
Alliance for Better Bone Health at Procter & Gamble (now Warner Chilcott) and Sanofi‐Aventis, Amgen Canada, Novartis Pharmaceuticals
Canada Inc., and Servier Canada; and by the Centre de Recherche Clinique Étienne‐LeBel (CRC), Centre Hospitalier Universitaire de
Sherbrooke (CHUS), which received a team grant from the Fonds de la Recherche en Santé du Québec.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Patients were recruited concurrently by a research co‐ordinate from consecutive fracture clinics. Attending surgeons did not play an active role in recruitment

Recruitment to the control group was random but not randomised relative to recruitment to the intervention groups in order to avoid contamination between participants

Allocation concealment (selection bias)

Low risk

The consent form outlined all 3 interventions but did not suggest that any of the 3 was more effective. Primary care physicians were blinded to which group their patients were assigned to

Protection against contamination

Unclear risk

Participants were protected from contamination by separating the control and intervention groups but the possibility of physician contamination was not explored

Baseline outcomes similar

Low risk

There were no significant differences between groups

Baseline characteristics similar

High risk

The participants in the first intervention group were older (median age 67 while for the control group this was 64 and for the second intervention group was 63)

Blinding of outcome assessment (detection bias)
All outcomes

High risk

The assessors were not blinded

Incomplete outcome data (attrition bias)
All outcomes

Low risk

The data were analysed by intention‐to‐treat methodology

Selective reporting (reporting bias)

Unclear risk

The main outcome was reported but we could not find a published study protocol

Other bias

Unclear risk

Unclear if the participants were blinded

Rozental 2008

Methods

Study design: RT (no control group)

Participants

Setting: Primary care

Country: USA

Aim 1: 240/298 patients: retrospective review

Aim 2: RT 50 patients were randomised to 1 of 2 interventions

Condition: Osteoporosis

The inclusion criteria included an age of over fifty years (for women) or over sixty‐five years (for men), a fragility fracture
of the distal part of the radius, no evaluation with a bone mineral density examination within two years before the fracture,
and no current treatment with antiresorptive medication or hormone replacement therapy.

Interventions

1. Orthopaedic surgeon orders BMD and BMD results are forwarded to primary care physician (patient‐mediated)

2. Letter from orthopaedic surgeon to primary care physician outlining guidelines for osteoporosis screening (educational material and reminder)

No control group

Outcomes

Professional practice: the rates of evaluation (BMD testing) within 6 months and treatment (discussion and initiation) for osteoporosis

Notes

Conflicts of interest and sources of funding as declared by the authors: In support of their research for or preparation of this work, one or more of the authors received, in any one year, outside funding or grants of
less than $10,000 (a Procter and Gamble Development Grant). Neither they nor a member of their immediate families received payments or other
benefits or a commitment or agreement to provide such benefits from a commercial entity. No commercial entity paid or directed, or agreed to pay or
direct, any benefits to any research fund, foundation, division, center, clinical practice, or other charitable or nonprofit organization with which the
authors, or a member of their immediate families, are affiliated or associated.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

No information on how the randomisation took place

Allocation concealment (selection bias)

Unclear risk

No information is provided on allocation concealment

Protection against contamination

High risk

Randomisation happened at patient level

Baseline outcomes similar

Unclear risk

These were not assessed at baseline

Baseline characteristics similar

Low risk

Baseline characteristics between participant groups seemed similar

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Not specified in the paper.Not clear if the assessor was blinded

Incomplete outcome data (attrition bias)
All outcomes

Low risk

All participants were accounted for

Selective reporting (reporting bias)

Unclear risk

No study protocol was published

Other bias

Unclear risk

It is unclear if participants were blinded with regards to the outcomes

Schectman 2003

Methods

Study design: Cluster‐RCT

Participants

Setting: Primary care

Country: USA

85 physicians, 2020 patients, 14 group practice sites, randomisation at practice level

Condition: Acute low back pain 

Patients were eligible for study inclusion if they met all three of the following criteria: (1) presence of low back pain; (2) duration
of current symptoms less than 6 weeks; and (3) no episodes of pain reported or office visits for low back pain in the preceding year.

Interventions

1. Distribution of guideline on the management of acute low back pain + educational meeting + feedback on back pain encounters + individual follow‐up visit by investigator 6 months afterwards and another feedback on back encounters + educational material for patients including a videotape (educational material + meeting + audit + outreach)
2. Education materials for patients: pamphlet and video and 2 reminders within the first 3 months to clinicians to use these materials (educational material)
3. 1 + 2
4. Control group

Outcomes

Professional practice: 

Proportion of lumbar plain x‐rays

CT or MRI consistent with guideline within 12 months

Subspecialty referral

Physiotherapy referral
Patient outcomes:

Beliefs about care

Satisfaction with care

Clinical outcome measures using validated instruments

Notes

Conflicts of interest and sources of funding as reported by the authors: Agency for Health Care Policy and Research,
Public Health Service, Department of Health and Human Services, Grant #: RO1 HS07069.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

“Clinician practices were stratified by affiliation and then, using sealed envelopes, randomised by an investigator to 4 groups in a 2 × 2 factorial design.”

Allocation concealment (selection bias)

Low risk

Sealed envelopes used

Protection against contamination

Unclear risk

Randomisation was at practice level and also stratification by affiliation was used which can reduce the risk of contamination. However, there may have been contamination at patient level

Baseline outcomes similar

High risk

"The intervention group had substantially higher utilization of radiologic and specialty services during the baseline period".

"Similar baseline differences were found for utilization of services inconsistent with the guideline".

"These differences remained, though were diminished, after adjustment for patient characteristics that were strongly associated with utilisation".

Baseline characteristics similar

High risk

Patient and clinician characteristics between the groups were not similar

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Not reported if assessors were blinded

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

Not recorded if all charts audited

Selective reporting (reporting bias)

Unclear risk

Insufficient information provided; no study protocol was published

Was knowledge of the allocated interventions adequately prevented during the study?

Unclear risk

It is unclear if the participants were blinded with regards to the outcomes

Other bias

High risk

"The four intervention groups were collapsed into two for analysis and reporting purposes" after the patient education intervention revealed no effect. This was not in accordance with the study protocol. Potential unit of analysis error, potential contamination between groups.                                                                        

Solomon 2007a

Methods

Study design: cluster‐RCT

Participants

Setting: Primary care

Country: USA

828 providers, 13,455 patients
Condition: people with high likelihood of osteoporosis and high risk of future fracture

The at‐risk patients were women 65 years of age, men and women 65 years of age with a prior fracture, and men and women 65 yr of age who
used oral glucocorticoids.

Interventions

1. Physician education by trained pharmacists or nurses (academic‐detailing approach via outreach visits) + educational material and handouts for patients
2. Patient‐directed component: 3 mailed letters with educational material and questions to ask the physician
3. 1 + 2
4. Control: standard care

Outcomes

Professional practice (primary outcome): number of patients who began osteoporosis medication or had BMD test within 12 months

Patient outcomes (secondary outcomes): fracture of wrist, humerus or hip

Notes

Conflicts of interest and sources of funding: Dr Solomon possessed research grants in the past from Merck and Proctor & Gamble. Dr Gauthier is an employee of the Arthritis
Foundation, which partially funded this study. All other authors state that they have no conflicts of interest.This study was supported by NIH Grant AR48616 and
the Arthritis Foundation.

The study did not provide sufficient information to allow the re‐calculation of adjusted for clustering effect sizes.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Random‐number generator. The randomisation was at doctor level

Allocation concealment (selection bias)

Unclear risk

Not reported        

Protection against contamination

Low risk

"All patients in a given physician's practice were randomised as a group (cluster randomisation) to avoid contamination within a given physician's practice".

Baseline outcomes similar

Unclear risk

Not reported

Baseline characteristics similar

Low risk

The baseline characteristics of patients and physicians were similar across the groups

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

 

Data used were electronic from outside sources (from Medicare, PACE, inpatient and outpatient coding)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No missing outcome data; intention‐to‐treat analysis

Selective reporting (reporting bias)

Low risk

Primary and secondary outcomes reported. There is published study protocol.

Other bias

Unclear risk

Unclear if the participants were blinded

Stross 1985

Methods

Study: Cluster‐RCT

Participants

Setting: Primary care

Country: USA

Participants: 6 communities in the state of Michigan: 3 were randomly selected to be controls and 3 were designated as intervention communities. 6 educationally influential physicians (EIs) recruited (1 in each community)

Interventions

1. Local opinion leaders' education: self‐study programme including textbook, audiovisual materials and recent articles on osteoarthritis (distribution of educational material and local opinion leaders)

The aim was to improve the management of patients with OA by focusing on the role of intra‐articular corticosteroids, physical therapy and joint replacement

2. Standard care: no educational package

Outcomes

Total hip arthroplasties, use of intra‐articular corticosteroids, use of physical therapy

Notes

Conflicts of interest and sources of funding as declared by the authors: Supported by Multipurpose Arthritis Center grant 2P 60
AM20557 from the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Unclear how the randomisation took place

Allocation concealment (selection bias)

Unclear risk

Not reported

Protection against contamination

Low risk

Contamination is less likely due to the randomisation at large cluster level

Baseline outcomes similar

Low risk

There were no significant baseline differences between the groups

Baseline characteristics similar

Unclear risk

Not reported

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Not reported, although data were obtained from hospital records

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

Not reported

Selective reporting (reporting bias)

Unclear risk

No published protocol of the study

Other bias

Unclear risk

It is not clear if the participants were blinded with regards to the outcomes

Watson 2008

Methods

Study design: Cluster‐RCT

Participants

Setting: Primary care

Country: UK

160 providers, 91 practices were randomised to training or not training, 155 patients participated in the first part of the trial

Condition: Acute shoulder pain

Patients were eligible if:
1. they were presenting to GPs with pain in one or both shoulders for ≤12 months who would otherwise have received a steroid injection from primary care.
2. had a clinical diagnosis of rotator cuff tendonitis based on both history of pain in the deltoid area and pain during resisted active movement. Some mild restriction of passive
movement was acceptable.
3. were ≥ 16 yrs.
4. were able and willing to give informed consent.

Interventions

1. 60‐minute lecture on shoulder disorders, handouts, training in injection techniques (educational material + meeting)

2. Control (no educational intervention)

Outcomes

Patient Outcomes: Shoulder pain assessed by 4 instruments: score on the British Shoulder Disability Questionnaire (BSDQ), SF‐36, EuroQol and three VAS (night, rest, movement)

Notes

The study had a second part testing whether cortisone injections were better than anaesthetic injections for rotator cuff problems (patients were randomised into 2 groups).

The study included a cost‐effectiveness analysis

Conflicts of interest and sources of funding as declared by the authors: V.M. and J.W. received salary from the
MRC research grant. J.D. has received travel grants from Pfizer, Wyeth, Novartis and Napp and honoraria for tutorials from
Pfizer and Novartis. He has served on advisory boards for pharmaceutical companies including GlaxoSmithKline, Wyeth,
Novartis and IDEA. All other authors have declared no conflicts of interest.This trial was funded by the Medical Research Council
(grant number G0001147) and received support for the education seminars and training events from Merck, Sharp and Dohme. The
MRC established a trial steering committee to advise the grant holders and trial team on trial design, the collection, analysis,
interpretation and writing up of data and publication policy.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

“Computer generated sequence” used. Practices "were stratified by area"

Allocation concealment (selection bias)

High risk

“Patients were not informed of the allocation.”  But the researchers were not blinded.                        

Protection against contamination

Unclear risk

Randomisation was at practice level but it is not clear if practices of different groups could communicate between themselves

Baseline outcomes similar

Unclear risk

Not reported

Baseline characteristics similar

Low risk

The participant baseline characteristics were reported and were similar

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Not reported; participants completed the pain‐assessment questionnaires

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Intention‐to‐treat analysis was performed          

Selective reporting (reporting bias)

Unclear risk

Not enough information is provided. The study protocol has not been published

Other bias

Unclear risk

  Unclear if participants were blinded with regards to the outcomes.                                                                        

CBA: controlled before‐and‐after
BMD: bone mineral density
HAD: Hamilton anxiety and depression
ITS: interrupted time series
LBP: low back pain
RCT: randomised controlled trial
USS: ultrasound scan
VAS: visual analogue scale
VDPQ: Vermont Disability Prediction Questionnaire

Characteristics of excluded studies [ordered by study ID]

Study

Reason for exclusion

Ashe 2004

This was a small controlled trial; not all outcomes were reported and the measurement of the main outcome (investigations for osteoporosis) was not well defined and not objectively measured or reported

Corson 2011

This was an organisational intervention and not a professional one according to the EPOC taxonomy

Fabiani 2004

Before‐and‐after study. 3 groups. There were no 2‐intervention and 2‐control groups

Feldstein 2007

Retrospective cohort study. No 2‐intervention and 2‐control groups

Garala 1999

CBA with no 2‐intervention and 2‐control groups

Gardner 2002

Retrospective cohort study in a hospital setting

Gardner 2005

The intervention was directed at patients and not their physicians

Glazier 2005

GPs not more than 50% of participants

Goldberg 2001

GPs not more than 50% of participants

Ioannidis 2008

Before‐and‐after study with no controls        

Ioannidis 2009

2‐year cohort study with no controls

McDonald 2003

Quasi‐experimental with no controls

Nazareth 2002

Observational study, no control group

Rolfe 2001

Pilot study, irrelevant topic (leg ulcer, persistent wheeze and stable angina)

Ruiz 2001

No objective measurement of primary outcomes       

Solomon 2007b

Only 1/3 of participants trained in family medicine 

Vernacchio 2013

This was an ITS study addressed to paediatric physicians as opposed to general primary care physicians

CBA: controlled before‐and‐after

Data and analyses

Open in table viewer
Comparison 1. Meta‐analysis of osteoporosis studies evaluating physician and patient interventions versus usual care

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Bone Mineral Density Show forest plot

3

3386

Risk Ratio (M‐H, Fixed, 95% CI)

4.44 [3.54, 5.55]

Analysis 1.1

Comparison 1 Meta‐analysis of osteoporosis studies evaluating physician and patient interventions versus usual care, Outcome 1 Bone Mineral Density.

Comparison 1 Meta‐analysis of osteoporosis studies evaluating physician and patient interventions versus usual care, Outcome 1 Bone Mineral Density.

2 Osteoporosis medication Show forest plot

5

4223

Risk Ratio (M‐H, Fixed, 95% CI)

1.71 [1.50, 1.94]

Analysis 1.2

Comparison 1 Meta‐analysis of osteoporosis studies evaluating physician and patient interventions versus usual care, Outcome 2 Osteoporosis medication.

Comparison 1 Meta‐analysis of osteoporosis studies evaluating physician and patient interventions versus usual care, Outcome 2 Osteoporosis medication.

Open in table viewer
Comparison 2. Meta‐analysis of osteoporosis studies evaluating physician‐only interventions versus usual care

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Bone mineral density Show forest plot

2

3047

Risk Ratio (M‐H, Fixed, 95% CI)

4.75 [3.62, 6.24]

Analysis 2.1

Comparison 2 Meta‐analysis of osteoporosis studies evaluating physician‐only interventions versus usual care, Outcome 1 Bone mineral density.

Comparison 2 Meta‐analysis of osteoporosis studies evaluating physician‐only interventions versus usual care, Outcome 1 Bone mineral density.

2 Osteoporosis medication Show forest plot

2

3047

Risk Ratio (M‐H, Fixed, 95% CI)

1.52 [1.26, 1.84]

Analysis 2.2

Comparison 2 Meta‐analysis of osteoporosis studies evaluating physician‐only interventions versus usual care, Outcome 2 Osteoporosis medication.

Comparison 2 Meta‐analysis of osteoporosis studies evaluating physician‐only interventions versus usual care, Outcome 2 Osteoporosis medication.

Open in table viewer
Comparison 3. Meta‐analysis of osteoporosis studies evaluating physician only interventions versus physician and patient interventions

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Bone mineral density Show forest plot

2

2995

Odds Ratio (M‐H, Fixed, 95% CI)

0.93 [0.77, 1.12]

Analysis 3.1

Comparison 3 Meta‐analysis of osteoporosis studies evaluating physician only interventions versus physician and patient interventions, Outcome 1 Bone mineral density.

Comparison 3 Meta‐analysis of osteoporosis studies evaluating physician only interventions versus physician and patient interventions, Outcome 1 Bone mineral density.

2 Medication Show forest plot

2

2995

Risk Ratio (M‐H, Fixed, 95% CI)

0.93 [0.79, 1.10]

Analysis 3.2

Comparison 3 Meta‐analysis of osteoporosis studies evaluating physician only interventions versus physician and patient interventions, Outcome 2 Medication.

Comparison 3 Meta‐analysis of osteoporosis studies evaluating physician only interventions versus physician and patient interventions, Outcome 2 Medication.

Prisma study flow diagram.
Figuras y tablas -
Figure 1

Prisma study flow diagram.

Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
Figuras y tablas -
Figure 2

Risk of bias summary: review authors' judgements about each risk of bias item for each included study.

Risk of bias summary for ITS study design: review authors' judgements about each risk of bias item for each included study.
Figuras y tablas -
Figure 3

Risk of bias summary for ITS study design: review authors' judgements about each risk of bias item for each included study.

Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
Figuras y tablas -
Figure 4

Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.

Risk of bias graph for ITS study design: review authors' judgements about each risk of bias item presented as percentages across all included studies.
Figuras y tablas -
Figure 5

Risk of bias graph for ITS study design: review authors' judgements about each risk of bias item presented as percentages across all included studies.

Comparison 1 Meta‐analysis of osteoporosis studies evaluating physician and patient interventions versus usual care, Outcome 1 Bone Mineral Density.
Figuras y tablas -
Analysis 1.1

Comparison 1 Meta‐analysis of osteoporosis studies evaluating physician and patient interventions versus usual care, Outcome 1 Bone Mineral Density.

Comparison 1 Meta‐analysis of osteoporosis studies evaluating physician and patient interventions versus usual care, Outcome 2 Osteoporosis medication.
Figuras y tablas -
Analysis 1.2

Comparison 1 Meta‐analysis of osteoporosis studies evaluating physician and patient interventions versus usual care, Outcome 2 Osteoporosis medication.

Comparison 2 Meta‐analysis of osteoporosis studies evaluating physician‐only interventions versus usual care, Outcome 1 Bone mineral density.
Figuras y tablas -
Analysis 2.1

Comparison 2 Meta‐analysis of osteoporosis studies evaluating physician‐only interventions versus usual care, Outcome 1 Bone mineral density.

Comparison 2 Meta‐analysis of osteoporosis studies evaluating physician‐only interventions versus usual care, Outcome 2 Osteoporosis medication.
Figuras y tablas -
Analysis 2.2

Comparison 2 Meta‐analysis of osteoporosis studies evaluating physician‐only interventions versus usual care, Outcome 2 Osteoporosis medication.

Comparison 3 Meta‐analysis of osteoporosis studies evaluating physician only interventions versus physician and patient interventions, Outcome 1 Bone mineral density.
Figuras y tablas -
Analysis 3.1

Comparison 3 Meta‐analysis of osteoporosis studies evaluating physician only interventions versus physician and patient interventions, Outcome 1 Bone mineral density.

Comparison 3 Meta‐analysis of osteoporosis studies evaluating physician only interventions versus physician and patient interventions, Outcome 2 Medication.
Figuras y tablas -
Analysis 3.2

Comparison 3 Meta‐analysis of osteoporosis studies evaluating physician only interventions versus physician and patient interventions, Outcome 2 Medication.

Summary of findings for the main comparison. Primary care physician alerting system and a patient‐directed intervention (education and reminder to see their primary care physician) compared to standard care for osteoporosis management

Primary care physician alerting system and a patient‐directed intervention (education and reminder to see their primary care physician) compared to usual care for osteoporosis management

Patient or population: General practitioners/family doctors involved in the management of patients with osteoporosis
Settings: Primary care
Intervention: Primary care physician alerting system and a patient‐directed intervention (education and reminder to see their primary care physician)
Comparison: Usual care

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of Participants
(studies)

Certainty of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

Usual care

A physician alerting system and a patient‐directed intervention (education and reminder to see their primary care physician)

Bone Mineral Density 1
Follow‐up: 6‐12 months

Study population

RR 4.44
(3.54 to 5.55)

3386
(3 studies)

⊕⊕⊕⊕
high3

49 per 1000

220 per 1000
(124 to 390)

Moderate

39 per 1000

176 per 1000
(99 to 311)

Osteoporosis medication 2
Follow‐up: 6‐12 months

Study population

RR 1.71
(1.50 to 1.94)

4223
(5 studies)

⊕⊕⊕⊕
high3

131 per 1000

241 per 1000 3
(193 to 301)

Moderate

106 per 1000

195 per 1000 3
(156 to 244)

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio;

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1 Bone mineral density (BMD) testing is an important outcome for osteoporosis because it leads to the diagnosis of the condition. This is one of the GP behaviour‐related outcomes (primary outcome)

2 Osteoporosis medication prescribing is an important outcome for osteoporosis management as it is the main aspect of treatment. This is one of the GP behaviour‐related outcomes (primary outcome)

3 One of the five studies (Roux 2013) had two intervention comparison groups which were combined to create a single pair‐wise comparison as recommended in chapter 16.5.4 of the Cochrane Handbook.

Figuras y tablas -
Summary of findings for the main comparison. Primary care physician alerting system and a patient‐directed intervention (education and reminder to see their primary care physician) compared to standard care for osteoporosis management
Summary of findings 2. Primary care physician alerting system compared to usual care for osteoporosis management

Primary care physician alerting system compared to usual care for osteoporosis management

Patient or population: General practitioners/family doctors involved in the management of patients with osteoporosis
Settings: Primary care
Intervention: Primary care physician alerting system
Comparison: Usual care

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of Participants
(studies)

Certainty of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

Usual care

Primary care physician alerting system

Bone mineral density1
Follow‐up: 6‐12 months

Study population

RR 4.75
(3.62 to 6.24)

3047
(2 studies)

⊕⊕⊕⊖
Moderate3

38 per 1000

302 per 1000
(64 to 1000)

Moderate

29 per 1000

231 per 1000
(49 to 1000)

Osteoporosis medication2
Follow‐up: 6‐12 months

Study population

RR 1.52
(1.26 to 1.84)

3047
(2 studies)

⊕⊕⊕⊖
Moderate3

102 per 1000

268 per 1000
(67 to 1000)

Moderate

77 per 1000

202 per 1000
(50 to 809)

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio;

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1 Bone mineral density (BMD) testing is an important outcome for osteoporosis because it leads to the diagnosis of the condition. This is one of the GP behaviour‐related outcomes (primary outcome)

2 Osteoporosis medication prescribing is an important outcome for osteoporosis management as it is the main aspect of treatment. This is one of the GP behaviour‐related outcomes (primary outcome)

3 The quality of evidence was downgraded because only two studies were included, one of which had a small number of participants and events, and in view of the considerable statistical heterogeneity observed.

Figuras y tablas -
Summary of findings 2. Primary care physician alerting system compared to usual care for osteoporosis management
Summary of findings 3. Primary care physician alerting system compared to primary care physician alerting system and a patient‐directed intervention (education and reminder to see their primary care physician) for osteoporosis management

Primary care physician alerting system compared to Primary care physician alerting system and a patient‐directed intervention (education and reminder to see their primary care physician) for osteoporosis management

Patient or population: General practitioners/family doctors involved in the management of patients with osteoporosis
Settings: Primary care
Intervention: Primary care physician alerting system
Comparison: Primary care physician alerting system and a patient‐directed intervention (education and reminder to see their primary care physician)

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of Participants
(studies)

Certainty of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

Primary care physician alerting system and a patient‐directed intervention (education and reminder to see their primary care physician)

Primary care physician alerting system

Bone mineral density1
Follow‐up: 6‐12 months

Study population

RR 0.94

(0.81 to 1.09)

2995
(2 studies)

⊕⊕⊕⊖
moderate3

192 per 1000

194 per 1000
(123 to 261)

Moderate

254 per 1000

257 per 1000
(163 to 345)

Medication2

Follow‐up: 6‐12 months

Study population

RR 0.93
(0.79 to 1.10)

2995
(2 studies)

⊕⊕⊕⊖

moderate3

167 per 1000

176 per 1000
(115 to 264)

Moderate

182 per 1000

191 per 1000
(126 to 288)

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio;

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1 Bone mineral density (BMD) testing is an important outcome for osteoporosis because it leads to the diagnosis of the condition. This is one of the GP behaviour‐related outcomes (primary outcome)

2 Osteoporosis medication prescribing is an important outcome for osteoporosis management as it is the main aspect of treatment. This is one of the GP behaviour‐related outcomes (primary outcome)

3 The quality of evidence was downgraded because only two studies were included, one of which had a small number of participants and events.

Figuras y tablas -
Summary of findings 3. Primary care physician alerting system compared to primary care physician alerting system and a patient‐directed intervention (education and reminder to see their primary care physician) for osteoporosis management
Summary of findings 4. Osteoporosis studies: Summary of findings

Professional interventions for GPs on the management of osteoporosis compared to usual care

Patient or population: General practitioners/family doctors involved in the management of patients with osteoporosis

Settings: Primary care

Intervention: Professional interventions (targeting physician‐only)

Comparison: Usual care

Outcomes

Impact (including effect sizes wherever available)

Number of Participants
(studies)

Certainty of the evidence
(GRADE)

Comments

Health professional (GP) behaviour‐related outcomes

  • Bone Mineral Density (BMD) testing

  • Osteoporosis medication (appropriate prescribing)

  • BMD RR 4.75 (95% CI 3.62 to 6.24)

  • Osteoporosis medication RR 1.52 (95% CI 1.26 to 1.84)

  • BMD 3047 (2 studies)

  • Osteoporosis medication 3047 (2 studies)

  • BMD ⊕⊕⊕⊖ moderate1

  • Osteoporosis ⊕⊕⊕⊖ moderate1

Patient outcomes

  • Fragility fractures

  • Hospitalisation

None of the included studies assessed these outcomes

Economic outcomes

  • Health service costs (including prescribing costs)

  • Cost effectiveness

Majumdar 2007, assessed the cost effectiveness of the study Majumdar 2008, and concluded that the intervention led to a per patient cost saving of CAD 13 (USD 9) and a gain of 0.012 quality‐adjusted life years.

272 participants (1 study)

⊕⊕⊖⊖ low2

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence Interval; RR: Risk Ratio

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1The quality of evidence was downgraded because only two studies were included, one of which had a small number of participants and events, and in view of the considerable statistical heterogeneity observed.

2 The quality of evidence was downgraded because only one study was included which had some risk of bias.

Figuras y tablas -
Summary of findings 4. Osteoporosis studies: Summary of findings
Summary of findings 5. Low back pain studies: Summary of findings

Professional interventions for GPs on the management of low back pain compared to usual care

Patient or population: General practitioners/family doctors involved in the management of patients with low back pain

Settings: Primary care

Intervention: Professional interventions (targeting physician‐only)

Comparison: Usual care

Outcomes

Impact (including effect sizes wherever available)

No of studies

Certainty of the evidence
(GRADE)

Comments

H ealth professional (GP) behaviour‐related outcomes

Guideline‐consistent advice during consultation

Bishop 2006 showed that the intervention may result in little or no improvements (RD < 10%) with regard to guideline‐consistent advice about exercise, return to work and education and reassurance.

Dey 2004 showed that the intervention probably results in a small reduction of sickness certification (RD 1.3).

Engers 2005 showed that the intervention may lead to no improvement of GP behaviour with regards to patient education and advice during the consultation (RD range (‐1.3 to 12.8), authors reported OR ranging between 0.4 and 2.9).

3

⊕⊕⊖⊖ low1

Guideline‐consistent prescribing of medication

Bishop 2006 showed that the intervention may lead to little improvements (RD < 10%) with regards to guideline‐consistent medication prescribing.

Dey 2004 showed that the intervention probably results in no difference on prescribing rates of opioids (RD ‐1.3).

Engers 2005 showed that the intervention may result in no improvement of GP behaviour with regard to prescribing (RD=2.8, OR=1, 95% CI (0.3 to 3), reported as not statistically significant).

3

⊕⊕⊖⊖ low1

Guideline‐consistent referrals for investigations (e.g.. x‐rays)

Schectman 2003 showed that the intervention may result in little or no change in GP behaviour with regards to the number of guideline‐consistent referrals for lumbar spine x‐rays and CT scans (RD <5%).

1

⊕⊕⊖⊖ low2

Guideline‐consistent referrals to other services

Bishop 2006 showed that the intervention may lead to little or no improvements (RD < 5%) with regards to guideline‐consistent referral to other services (such as physiotherapy).

Schectman 2003 showed that the intervention may result in little or no difference with regards to the number of guideline‐consistent specialist or physiotherapy referrals (RD <5%).

2

⊕⊕⊖⊖ low3

Number of investigations

Dey 2004 showed that the intervention probably results in a small increase in the ordering of x‐rays (RD 1.4).

French 2013 showed that the intervention may lead to little or no difference in the number of x‐ray and CT requests (RD ‐0.2% and 0.0% respectively).

Kerry 2000 showed that the intervention probably results in a cluster‐adjusted reduction of spinal x‐ray requests of 20% between the intervention and control groups (95% CI 4 to 36, P<0.05).

Schectman 2003 showed that the intervention may result in little or no change in GP behaviour with regards to referrals for lumbar spine x‐rays and CT scans (RD <5%).

4

⊕⊕⊖⊖low4

Number of referrals to other services

Dey 2004 showed that the intervention probably results in increased referrals to fast‐track physiotherapy and a back‐pain triage service (RD 12.6%).

Engers 2005 showed that the intervention may lead to little reduction of onward referrals to a therapist (RD 4.6, 23% in the intervention group versus 28% in the control group, clustered adjusted OR 0.8, 95% CI (0.5 to 1.4)).

Schectman 2003 showed that the intervention may result in little or no difference with regards to the number of specialist or physiotherapy referrals (RD <5%).

3

⊕⊕⊖⊖ low4

Patient outcomes

Functional capacity/activity scores

0

None of the included studies assessed this outcome

Pain control

0

None of the included studies assessed this outcome

Work absence

Hazard 1997 showed that the intervention may result in no improvement with respect to days of sick leave compared to the control group (RD ‐4.6%).

1

⊕⊕⊖⊖ low2

The study by Hazard 1997 was very small (just 53 participants)

Quality of life

0

None of the included studies assessed this outcome

Economic outcomes

  • Health service costs (including prescribing costs)

  • Cost effectiveness

0

None of the included studies assessed these outcomes

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
RD: Risk Difference SMD: Standardised Mean Difference CI: Confidence Interval; RR: Risk Ratio

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1 The quality of evidence was downgraded because the studies have a high risk of bias and high heterogeneity in terms of the types of interventions evaluated. Additionally the effect sizes are small.

2 The quality of evidence was downgraded because the results are based only on one study with high risk of bias.

3 The quality of evidence was downgraded because the results are based on just two studies with high risk of bias.

4 The quality of evidence was downgraded because the studies have a high risk of bias and high heterogeneity in terms of the types of interventions evaluated. Additionally there is high inconsistency in the direction of effects across the studies.

Figuras y tablas -
Summary of findings 5. Low back pain studies: Summary of findings
Summary of findings 6. Osteoarthritis studies: Summary of findings

Professional interventions for GPs on the management of osteoarthritis compared to usual care

Patient or population: General practitioners/family doctors involved in the management of patients with osteoarthritis

Settings: Primary care

Intervention: Professional interventions (targeting physician‐only)

Comparison: Usual care

Outcomes

Impact (including effect sizes wherever available)

No of studies

Certainty of the evidence
(GRADE)

Comments

Health professional (GP) behaviour‐related outcomes

Guideline‐consistent advice during consultation

Stross 1985 showed that the intervention may increase the use of intra‐articular corticosteroids (RD large at 29%).

⊕⊕⊖⊖ low1

Guideline‐consistent prescribing of medication

Rahme 2005 showed that the intervention may result in a slight improvement in osteoarthritis guideline‐consistent GP prescribing of medication (acetaminophen, NSAIDs and COX‐2 inhibitors) 5 months afterwards (RD 5% after dissemination of educational material, RD 7% after a workshop and RD 13% for the combined intervention)

Rosemann 2007 showed that prescriptions for painkillers may slightly increase following the intervention (RDs between ‐2.2% and 11.1%).

Stross 1985 showed that the intervention may reduce the use of systemic corticosteroids according to the guidelines (RD moderate at 19%).

⊕⊕⊖⊖ low1

Guideline‐consistent referrals for investigations (e.g.. x‐rays)

None of the included studies assessed this outcome

Guideline‐consistent referrals to other services

Stross 1985 showed that the intervention may increase the utilisation of physical therapy pre‐operatively (RD large at 57%).

⊕⊕⊖⊖ low1

Number of investigations

Rosemann 2007 showed that the intervention may result in some small reduction in the number of GP referrals for radiographs (SMD 0.2‐0.4).

⊕⊕⊖⊖low3

Number of referrals to other services

Rosemann 2007 showed that the intervention may result in a reduction in the number of GP referrals to orthopaedics (SMD 0.8 for the educational intervention and 0.2 for the combined intervention after adding nurse case management).

⊕⊕⊖⊖ low4

Patient outcomes

Functional capacity/activity scores

Chassany 2006 showed that the intervention may result in small improvements with regard to physical function scores (WOMAC index physical function score) (SMD 0.3, P<0.05).

⊕⊕⊖⊖ low5

Results were assessed within two weeks of the Chassany 2006 trial, so it is unclear whether the positive patient outcomes persisted.

Pain control

Chassany 2006 showed that the intervention may result in small improvements with regard to pain scores (VAS score, Pain relief (SPID), WOMAC index pain score) (SMD 0.2, P<0.05 across all outcomes).

⊕⊕⊖⊖ low5

Results were assessed within two weeks of the Chassany 2006 trial, so it is unclear whether the positive patient outcomes persisted.

Work absence

None of the included studies assessed this outcome

Quality of life

Rosemann 2007 showed that the intervention may result in small or no improvement with regard to patient related outcomes (SMD <0.40).

⊕⊕⊖⊖ low3

Economic outcomes

  • Health service costs (including prescribing costs)

  • Cost effectiveness

None of the included studies assessed these outcomes

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
RD: Risk Difference SMD: Standardised Mean Difference CI: Confidence Interval; RR: Risk Ratio

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1 The quality of evidence was downgraded because the results are based on one study only with high risk of bias and a small number of participants (114).

2 The quality of evidence was downgraded because the studies have high heterogeneity in terms of the types of interventions and the types of medications prescribed.

3 The quality of evidence was downgraded because the results are based on just one study and the effect size was small.

4 The quality of evidence was downgraded because the results are based on just one study and the effect size varies considerably between the two intervention groups.

5 The quality of evidence was downgraded because the results are based on just one study and were assessed just 2 weeks following the intervention.

NSAIDs: Non steroidal anti‐inflammatory drugs, COX‐2 inhibitors: Cyclo‐oxygenase 2 inhibitors, WOMAC: Western Ontario and McMaster Universities Osteoarthritis Index, VAS: Visual analogue scale, SPID: sum of pain intensity differences.

Figuras y tablas -
Summary of findings 6. Osteoarthritis studies: Summary of findings
Summary of findings 7. Shoulder pain studies: Summary of findings

Professional interventions for GPs on the management of shoulder pain compared to usual care

Patient or population: General practitioners/family doctors involved in the management of patients with shoulder pain

Settings: Primary care

Intervention: Professional interventions (targeting physician‐only)

Comparison: Usual care

Outcomes

Impact (including effect sizes wherever available)

Number of studies

Certainty of the evidence
(GRADE)

Comments

Health professional (GP) behaviour‐related outcomes

Guideline‐consistent advice during consultation

None of the included studies assessed this outcome

Guideline‐consistent prescribing of medication

None of the included studies assessed this outcome

Guideline‐consistent referrals for investigations (e.g.. x‐rays)

None of the included studies assessed this outcome

Guideline‐consistent referrals to other services

None of the included studies assessed this outcome

Number of investigations

Broadhurst 2007 showed that the intervention may result in a temporary, slight reduction in ultrasound requests, but little or no change in the x‐ray requests.

⊕⊕⊖⊖ low1

Number of referrals to other services

None of the included studies assessed this outcome

Patient outcomes

Functional capacity/activity scores

Watson 2008 showed that the intervention may result in little or no improvement in function a year later (BSDQ SMD 0.2, SF‐36 for physical component SMD 0 and SF‐36 mental component SMD 0.1)

⊕⊕⊖⊖ low2

Pain control

None of the included studies assessed this outcome

Work absence

None of the included studies assessed this outcome

Quality of life

None of the included studies assessed this outcome

Economic outcomes

  • Health service costs (including prescribing costs)

  • Cost effectiveness

McKenna 2009 assessed the cost effectiveness of providing practical training to GPs in the SAPPHIRE study by Watson 2008. It reported an incremental cost‐effectiveness ratio of GBP 2,813 per QALY gained for trained GPs.

⊕⊕⊖⊖ low2

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
RD: Risk Difference SMD: Standardised Mean Difference CI: Confidence Interval; RR: Risk Ratio

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1 The quality of evidence was downgraded because the results are based on just one study (CBA) with high risk of bias.

2 The quality of evidence was downgraded because the results are based on just one study and the effect size was small.

BSDQ: British Shoulder Disability questionnaire, SF‐36: Short‐form 36 item Health Survey, GBP: Great Britain Pound

Figuras y tablas -
Summary of findings 7. Shoulder pain studies: Summary of findings
Summary of findings 8. Studies on other musculoskeletal conditions: Summary of findings

Professional interventions for GPs on the management of shoulder pain compared to usual care

Patient or population: General practitioners/family doctors involved in the management of patients with other musculoskeletal conditions

Settings: Primary care

Intervention: Professional interventions (targeting physician‐only)

Comparison: Usual care

Outcomes

Impact (including effect sizes wherever available)

No of studies

Certainty of the evidence
(GRADE)

Comments

Health professional (GP) behaviour‐related outcomes

Guideline‐consistent advice during consultation

None of the included studies assessed this outcome

Guideline‐consistent prescribing of medication

Huas 2006 showed that the intervention may result in increased level 3 (WHO classification) analgesic prescribing (SMD 1.2, P=0.02)

⊕⊕⊖⊖ low1

Guideline‐consistent referrals for investigations (e.g.. x‐rays)

None of the included studies assessed this outcome

Guideline‐consistent referrals to other services

None of the included studies assessed this outcome

Number of investigations

Kerry 2000 showed that the intervention may result in little or no reduction in GP knee radiology requests (relative change 10%, not statistically significant).

⊕⊕⊖⊖ low2

Number of referrals to other services

None of the included studies assessed this outcome

Patient outcomes

Functional capacity/activity scores

None of the included studies assessed this outcome

Pain control

Huas 2006 showed that the intervention may result in worse patient‐related outcomes: pain relief scores (SMD 2, P=0.0004)

⊕⊕⊖⊖ low1

Work absence

None of the included studies assessed this outcome

Quality of life

None of the included studies assessed this outcome

Economic outcomes

  • Health service costs (including prescribing costs)

  • Cost effectiveness

None of the included studies assessed these outcomes

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
RD: Risk Difference SMD: Standardised Mean Difference CI: Confidence Interval; RR: Risk Ratio

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1 The quality of evidence was downgraded because the results are based on just one study with high risk of bias.

2 The quality of evidence was downgraded because the results are based on just one study and the effect size was small.

Figuras y tablas -
Summary of findings 8. Studies on other musculoskeletal conditions: Summary of findings
Table 1. Classification of relevant interventions from EPOC taxonomy

Table 1: Classification of relevant interventions from EPOC taxonomy

Intervention

Description

Distribution of educational materials

Distribution of published or printed recommendations for clinical care, including clinical practice guidelines, audio‐visual materials and electronic publications.  The materials may have been delivered personally or through mass mailings.

Educational meetings 

Healthcare providers who have participated in conferences, lectures, workshops or traineeships

Local consensus processes

Inclusion of participating providers in discussion to ensure that they agreed that the chosen clinical problem was important and the approach to managing the problem was appropriate

Educational outreach visits 

Use of a trained person who met with providers in their practice settings to give information with the intent of changing the provider’s practice.  The information given may have included feedback on the performance of the provider(s)

Local opinion leaders

Use of providers nominated by their colleagues as ‘educationally influential’.  The investigators must have explicitly stated that their colleagues identified the opinion leaders

Patient‐mediated

New clinical information (not previously available) collected directly from patients and given to the provider e.g. depression scores from an instrument

Audit and feedback 

Any summary of clinical performance of health care over a specified period of time. The summary may also have included recommendations for clinical action. The information may have been obtained from medical records, computerised databases, or observations from patients

Reminders 

Patient or encounter specific information, provided verbally, on paper or on a computer screen, which is designed or intended to prompt a health professional to recall information.  This would usually be encountered through their general education; in the medical records or through interactions with peers, and so remind them to perform or avoid some action to aid individual patient care.  Computer aided decision support and drugs dosage are included.

Marketing

Use of personal interviewing, group discussion (‘focus groups’), or a survey of targeted providers to identify barriers to change and subsequent design of an intervention that addresses identified barriers

Mass media

(i) Varied use of communication that reached great numbers of people including television, radio, newspapers, posters, leaflets, and booklets, alone or in conjunction with other interventions;  (ii) Targeted at the population level

Other

Patient‐directed (education and reminders to see their primary care physician)

Figuras y tablas -
Table 1. Classification of relevant interventions from EPOC taxonomy
Table 2. Intervention types used in each study (N.B. All interventions evaluated were professional)

Table 2. Intervention types used in each study (N.B. All interventions evaluated were professional)

Intervention methods 1,2 

No. of Studies 

Studies 3

Distribution of educational materials

27

Becker 2008; Bessette 2011; Bishop 2006; Boyd 2002; Broadhurst 2007; Chassany 2006; Ciaschini 2010; Cranney 2008; Dey 2004; Eccles 2001; Engers 2005; Feldstein 2006; French 2013; Hazard 1997; Hollingworth 2002; Kerry 2000; Leslie 2012; Majumdar 2008; Rahme 2005; Robling 2002; Rosemann 2007; Roux 2013; Rozental 2008; Schectman 2003; Solomon 2007a; Stross 1985; Watson 2008

Educational meetings 

10

Becker 2008; Chassany 2006; Engers 2005; French 2013; Gormley 2003; Huas 2006; Rahme 2005; Rosemann 2007; Schectman 2003, Watson 2008

Local consensus processes

0

Educational outreach visits 

6

Becker 2008; Broadhurst 2007; Dey 2004; Robling 2002; Schectman 2003; Solomon 2007a

Local opinion leaders

3

Majumdar 2008; Stross 1985; Schectman 2003

Patient‐mediated

6

Boyd 2002; Ciaschini 2010; Cranney 2008; Huas 2006; Roux 2013; Rozental 2008

Audit and feedback 

4

Eccles 2001; Kerry 2000; Robling 2002; Schectman 2003

Reminders 

11

Bishop 2006; Ciaschini 2010; Cranney 2008; Eccles 2001; Feldstein 2006; Hazard 1997; Lafata 2007; Leslie 2012; Majumdar 2008; Roux 2013; Rozental 2008

Marketing

0

Mass media

0

Patient‐directed4

12

Becker 2008; Bessette 2011; Bishop 2006; Leslie 2012; Ciaschini 2010; Cranney 2008; Feldstein 2006; Lafata 2007; Majumdar 2008; Rosemann 2007; Roux 2013; Solomon 2007a

1. Category of intervention as classified by the EPOC taxonomy EPOC 2007 [9]

2. See Table 1 for definition of each intervention

3. Some studies used more than one intervention type and these are listed against their corresponding category

4. Patient‐directed interventions targeted patients and included patient education and reminders to see their primary‐care physician. These were included in the review only if they were a component of a professional intervention targeting primary‐care physicians

Figuras y tablas -
Table 2. Intervention types used in each study (N.B. All interventions evaluated were professional)
Table 3. Intervention combinations compared to a no‐intervention control group

Table 3. Intervention combinations compared to a no‐intervention control group

Intervention combinations 

No. of comparisons

Study ID

Single component interventions:

Distribution of educational materials

1

Rahme 2005

Patient‐directed

3

Lafata 2007; Leslie 2012; Solomon 2007a

Educational meetings, workshops  

1

Rahme 2005

Multifaceted interventions: Two intervention components

Distribution of educational material + reminders

4

Bishop 2006; Feldstein 2006; Hazard 1997; Leslie 2012

Distribution of educational material + educational outreach visits

4

Broadhurst 2007; Chassany 2006; Dey 2004; Solomon 2007a

Distribution of educational material + educational meeting/workshop

6

Chassany 2006; Engers 2005; French 2013; Rahme 2005; Rosemann 2007; Watson 2008

Distribution of educational material + local opinion leaders

1

Stross 1985

Distribution of educational material + audit/feedback

1

Kerry 2000

Patient‐mediated + educational meeting/workshop

1

Huas 2006

Patient‐directed +reminder

1

Lafata 2007

Patient‐directed + educational material

1

Bessette 2011

Multifaceted interventions: Three intervention components

Patient‐directed + educational material + reminder

3

Bishop 2006; Feldstein 2006, Leslie 2012

Patient‐directed + educational material + educational meeting/workshop

1

Rosemann 2007

Patient‐directed + educational material + educational outreach visit

1

Solomon 2007a

Multifaceted interventions: Four intervention components

Patient‐directed + distribution of educational material + reminder + local opinion leaders

1

Majumdar 2008

Patient‐mediated + distribution of educational material + reminders + patient‐directed (education and reminders)

3

Ciaschini 2010; Cranney 2008; Roux 2013

Multifaceted interventions: Five intervention components

Distribution of educational material + educational meetings/workshops + audit + educational outreach visit + local opinion leaders

1

Schectman 2003

Figuras y tablas -
Table 3. Intervention combinations compared to a no‐intervention control group
Table 4. Intervention combinations compared to a different intervention

Table 4. Intervention combinations compared to a different intervention

Intervention combinations 

No. of comparisons

Study ID

Single component interventions:

Educational meetings/workshops vs distribution of educational material

1

Rahme 2005

Educational meetings/workshops vs a different educational meeting/workshop

1

Gormley 2003

Multifaceted interventions: Two intervention components

Distribution of educational material + patient‐mediated vs the same intervention but less intensive

1

Boyd 2002

Distribution of educational material + educational outreach visit vs distribution of educational material

1

Robling 2002

Distribution of educational material + audit vs distribution of educational material

2

Robling 2002; Eccles 2001

Distribution of educational material + audit vs distribution of educational material + reminder

1

Eccles 2001

Distribution of educational material + outreach vs distribution of educational material + audit

1

Robling 2002

Distribution of educational material + educational outreach visit vs patient‐directed

1

Solomon 2007a

Distribution of educational material + patient‐directed vs the same (more intensive)

1

Bessette 2011

Patient‐directed + reminder vs patient‐directed

1

Lafata 2007

Distribution of educational material + reminder vs distribution of educational material

1

Eccles 2001

Distribution of educational material + reminder vs patient‐mediated

1

Rozental 2008

Distribution of educational material + educational meeting/workshop vs educational meeting/workshop

1

Rahme 2005

Distribution of educational material + educational meeting/workshop vs distribution of educational material

1

Rahme 2005

Multifaceted interventions: Three intervention components

Distribution of educational material + reminders + patient‐directed vs distribution of educational material + reminders

2

Bishop 2006; Feldstein 2006

Distribution of educational material + reminder + patient‐directed vs patient‐directed

1

Leslie 2012

Distribution of educational material + audit + reminders vs distribution of educational material

1

Eccles 2001

Distribution of educational material + audit + reminders vs distribution of educational material + audit

1

Eccles 2001

Distribution of educational material + audit + reminders vs distribution of educational material + reminders

Eccles 2001

Distribution of educational material + audit + outreach vs distribution of educational material + outreach

1

Robling 2002

Distribution of educational material + audit + outreach vs distribution of educational material + audit

1

Robling 2002

Distribution of educational material + audit + outreach vs distribution of educational material

1

Robling 2002

Distribution of educational material + educational meetings/workshops + educational outreach visits vs distribution of educational material

1

Becker 2008

Distribution of educational material + educational outreach visit + patient‐directed vs patient‐directed

1

Solomon 2007a

Distribution of educational material + educational outreach visit + patient‐directed vs distribution of educational material + educational outreach visit

1

Solomon 2007a

Distribution of educational material + educational meeting/workshop + patient‐directed vs distribution of educational material + educational meeting/workshop

1

Rosemann 2007

Multifaceted interventions: Four intervention components

Distribution of educational material + educational meetings/workshops + educational outreach visits + patient‐directed vs distribution of educational material

1

Becker 2008

Distribution of educational material + educational meetings/workshops +educational outreach visits + patient directed vs distribution of educational material + educational meetings/workshops + educational outreach visits

1

Becker 2008

Patient‐mediated + distribution of education material + reminders + patient‐directed (education and reminders) vs patient‐mediated + distribution of education material + reminders + patient‐directed (education and reminders)

1

Roux 2013

Figuras y tablas -
Table 4. Intervention combinations compared to a different intervention
Table 5. Osteoporosis studies: intervention versus no intervention (control), outcome: BMD, dichotomous data

(Study)

Intervention

Int pre (%) 1

C pre (%)2

Int post (%)3

C post (%)4

ARD 5

Risk difference 6

(P value if reported by authors)

Relative % change post 7

Risk ratio 8

(Bessette 2011)*

Patient education and reminder to see their physician (patient directed), education of physician via the patient (distribution of educational material)

14.72%

11.96%

2.8%

23%

1.2

(Bessette 2011)*

Patient education (including video on osteoporosis) and reminder to see their physician, education of physician via the patient (distribution of educational material)

15.81%

11.96%

3.9%

32%

1.3

(Cranney 2008)**

Patient‐specific mailed letter to primary are physician (including guidelines) and patient education and reminder

64/125 (51%)

36/145 (25%)

26.4%

(P< 0.0001)

106%

2.1

(Feldstein 2006)

Patient‐specific Electronic Medical Record (EMR) reminders to primary‐care provider informing them of patient increased risk and guidelines. Sent twice.

40/101 (39.6%)

2/103 (1.9%)

37.7%

(P< 0.01)

1940%

20.4

(Feldstein 2006)

EMR reminder plus patient‐directed intervention: education and reminder

36/110 (32.7%)

2/103 (1.9%)

30.8%

(P< 0.01)

1585%

16.9

(Lafata 2007)**

Patient‐directed: 2 mailings (educational and reminders)

720/3367 (21.4%)

313/2901 (10.8%)

10.6%

(P< 0.001)

98%

2

(Lafata 2007)**

Physician prompt: Electronic Medical Record (EMR) reminder to physician and biweekly mailing plus patient‐directed: 2 mailings (educational and reminders)

1181/4086 (28.9%)

313/2901 (10.8%)

18.1%

(P< 0.001)

168%

2.7

(Leslie 2012)

Physician reminder plus educational material

224/1363 (16.4%)

58/1480 (3.9%)

12.5%

319%

4.2

(Leslie 2012)

Physician reminder plus educational material plus patient‐directed intervention (reminder to see their physician)

258/1421 (18.2%)

58/1480 (3.9%)

14.2%

363%

4.6

(Majumdar 2008)

Patient education, physician patient‐specific reminders by mail/fax, physician guidelines endorsed by opinion leaders

71/137 (51.8%)

24/135 (17.8%)

34%

(P< 0.001)

192%

2.9

(Solomon 2007a)**

Patient directed (3 mailed letters educational)

249/3274 (7.6%)

224/3268 (6.9%)

0.8%

(NS)

11%

1.1

(Solomon 2007a)**

Physician education following an academic‐detailing approach

183/3574 (5.1%)

224/3268 (6.9%)

‐1.7%

(NS)

‐25%

0.7

(Solomon 2007b)**

Combination of both physician and patient education

223/3339 (6.7%)

224/3268 (6.9%)

‐0.2%

(NS)

‐3%

1

1. Intervention group pre‐intervention proportion

2. Control group pre‐intervention proportion

3. Intervention group post‐intervention proportion

4. Control group post‐intervention proportion

5. ARD = [Int post (%) minus C post (%)] minus [Int pre (%) minus C pre (%)]. The direction of effect has been adjusted so that a positive result represents a beneficial intervention outcome, according to Grimshaw 2004.

6. Risk Difference (RD) is the absolute % change post‐intervention = Int post (%) minus C post (%). This is considered to be "small" if ≤ 5%, "modest" if > 5% and ≤10%,"moderate" if > 10% but ≤ 20%, and "large" if > 20%.The direction of effect has been adjusted so that a positive result represents a beneficial intervention outcome, according to Grimshaw 2004.

7. Relative % change post = absolute % change post divided by C post (%). The direction of effect has been adjusted so that a positive result represents a beneficial intervention outcome, according to Grimshaw 2004.

8. Risk ratio (RR) = Int post (%) divided by C post (%)

BMD: bone mineral density; C: control group; Int: intervention group; ARD: adjusted risk difference; NS: not significant

* In the study by Bessette 2011, the outcomes reported above include the participants with a diagnosis following the intervention. The women were considered "diagnosed" if they received a BMD test, if they were informed by their physician that they were suffering from osteoporosis and/or if they were initiated on osteoporosis medication. Therefore, the above percentages do not necessarily mean that the women received a BMD test.

** The data reported above for the studies by Cranney 2008, Lafata 2007 and Solomon 2007b does not account for clustering. We did not have access to sufficient information to adjust the data for clustering.

Figuras y tablas -
Table 5. Osteoporosis studies: intervention versus no intervention (control), outcome: BMD, dichotomous data
Table 6. Osteoporosis studies, intervention versus no intervention (control), outcome:osteoporosis medication, dichotomous data

(Study)

Intervention

Int pre (%) 1

C pre (%)2

Int post (%)3

C post (%)4

ARD 5

Risk difference 6

(P value if reported by authors)

Relative % change post 7

Risk ratio 8

(Bessette 2011)

Patient education (patient directed), education of physician via the patient (for group of patients without diagnosis or treatment at randomisation)

11.79%

7.78%

4%

52%

1.5

(Bessette 2011)

Patient education (including video on osteoporosis), education of physician via the patient (for group of patients without diagnosis or treatment at randomisation)

10.64%

7.78%

2.9%

37%

1.4

(Bessette 2011)

Patient education (patient directed), education of physician via the patient (for group of patients without treatment at randomisation)

13.49%

10.31%

3.2%

31%

1.3

(Bessette 2011)

Patient education (including video on osteoporosis), education of physician via the patient (for group of patients without treatment at randomisation)

12.71%

10.31%

2.4%

23%

1.2

(Bessette 2011)

Patient education, education of physician via the patient where the patient did pass the information on to the physician (for group of patients without treatment at randomisation)

15%

10%

5%

50%

1.5

(Ciaschini 2010)

Patient‐specific evidence‐based recommendations targeted to improve osteoporosis treatment to both the patients and their primary‐care providers

29/52 (55.8%)

16/60 (26.7%)

29.1%

109%

2.1

(Cranney 2008)*

Patient‐specific mailed letter to primary are physician (including guidelines) and patient education and reminder

35/125 (28%)

15/145 (10.3%)

17.7%

(P=0.0002)

171%

2.7

(Feldstein 2006)

Patient‐specific Electronic Medical Record (EMR) reminders to primary‐care provider informing them of patient increased risk and guidelines. Sent twice.

28/101 (27.7%)

5/103 (5%)

22.9%

(P< 0.01)

471%

5.7

(Feldstein 2006)

EMR reminder plus patient‐directed intervention: education and reminder

22/110 (20.2%)

5/103 (5%)

15.1%

(P< 0.01)

312%

4.1

(Lafata 2007)*

Patient‐directed: x2 mailings (educational and reminders)

11/128 (8.6%)

3/51 (5.9%)

2.7%

46%

1.5

(Lafata 2007)*

Physician prompt: Electronic Medical Record (EMR) reminder to physician and biweekly mailing plus Patient‐directed: 2 mailings (educational and reminders)

15/162 (9.3%)

3/51 (5.9%)

3.4%

57%

1.6

(Leslie 2012)

Physician reminder plus educational material

200/1363 (14.7%)

157/1480 (10.6%)

4.1%

38%

1.4

(Leslie 2012)

Physician reminder plus educational material plus patient‐directed intervention (reminder to see their physician)

234/1421 (16.5%)

157/1480 (10.6%)

5.9%

55%

1.6

(Majumdar 2008)

Patient education, physician patient‐specific reminders by mail/fax, physician guidelines endorsed by opinion leaders

30/137 (21.9%)

10/135 (7.4%)

14.5%

(P<0.001)

196%

3

(Roux 2013)

Verbal and written information on osteoporosis to patient and letter with specific management plan sent to their treating physician. Patient reminders at 6 and 12 months. Reminder to physician if patient untreated at 6 months

82/275 (29.8%)

45/199 (22.6%)

151/275 (54.9%)

71/199 (35.7%)

12%

19.2%

(P< 0.005)

54%

1.5

(Roux 2013)

Verbal and written information on osteoporosis to patient and letter with specific management plan sent to their treating physician. Blood tests and BMD test ordered for patient and results sent to the physician. Patient reminders at 4,8 and 12 months and physician reminders at 4 and 8 months if patient remained untreated

65/251 (25.9%)

45/199 (22.6%)

156/251

(62.2%)

71/199 (35.7%)

23.2%

26.5%

(P< 0.005)

74%

1.7

(Solomon 2007a)*

Patient directed (x3 mailed letters educational)

208/3274 (6.4%)

231/3268 (7.1%)

‐0.7%

‐10%

0.9

(Solomon 2007a)*

Physician education following an academic detailing approach

197/3574 (5.5%)

231/3268 (7.1%)

‐1.6%

‐22%

0.8

(Solomon 2007a)*

Combination of both physician and patient education

236/3339 (7.1%)

231/3268 (7.1%)

0

0

1

1. Intervention group pre‐intervention proportion

2. Control group pre‐intervention proportion

3. Intervention group post‐intervention proportion

4. Control group post‐intervention proportion

5. ARD = [Int post (%) minus C post (%)] minus [Int pre (%) minus C pre (%)]. The direction of effect has been adjusted so that a positive result represents a beneficial intervention outcome, according to Grimshaw 2004.

6. Risk Difference (RD) is the absolute % change post‐intervention = Int post (%) minus C post (%). This is considered to be "small" if ≤ 5%, "modest" if > 5% and ≤10%,"moderate" if > 10% but ≤ 20%, and "large" if > 20%.The direction of effect has been adjusted so that a positive result represents a beneficial intervention outcome, according to Grimshaw 2004.

7. Relative % change post = absolute % change post divided by C post (%). The direction of effect has been adjusted so that a positive result represents a beneficial intervention outcome, according to Grimshaw 2004.

8. Risk ratio (RR) = Int post (%) divided by C post (%)

BMD: bone mineral density; C: control group; Int: intervention group; ARD: adjusted risk difference; NS: not significant

* The data reported above for the studies by Cranney 2008, Lafata 2007 and Solomon 2007b does not account for clustering. We did not have access to sufficient information to adjust the data for clustering.

Figuras y tablas -
Table 6. Osteoporosis studies, intervention versus no intervention (control), outcome:osteoporosis medication, dichotomous data
Table 7. Osteoporosis studies intervention versus another intervention, outcome: BMD, dichotomous data

(Study)

Interventions

Int 1 pre (%) 1

Int 2 pre (%)2

Int 1 post (%)3

Int 2 post (%)4

ARD 5

Risk difference6

(P value if reported by authors)

Relative % change post 7

Risk ratio 8

(Bessette 2011)*

Patient education, education of physician via the patient, reminder to family physician versus Patient education (including video on osteoporosis), education of physician via the patient, reminder to family physician

14.72%

15.81%

‐1.1%

‐7%

0.9

(Boyd 2002)

Patient‐specific letter to primary care physician containing information on results and recommendations: standard versus extended letter

25/83 (30.1%)

29/78 (37.2%)

‐7.1%

‐19%

0.8

(Feldstein 2007)

Patient‐specific Electronic Medical Record (EMR) reminders to primary‐care provider informing them of patient increased risk and guidelines (sent twice) versus EMR plus patient‐directed intervention (education and reminder)

40/101 (39.6%)

36/110

(32.7%)

6.9%

21%

1.2

(Lafata 2007)**

Patient‐directed: 2 mailings (educational and reminders) versus physician prompt: Electronic Medical Record (EMR) reminder to physician and biweekly mailing plus patient‐directed: 2 mailings (educational and reminders)

720/3367 (21.4%)

1181/4086 (28.9%)

‐7.5%

‐26%

0.7

(Leslie 2012)

Physician reminder plus educational material versus physician reminder plus educational material plus patient‐directed intervention (reminder to see their physician)

224/1363 (16.4%)

258/1421 (18.2%)

‐1.7%

(NS)

‐9%

0.9

(Rozental 2008)

Patient‐specific letter to primary‐care physician outlining guidelines versus orthopaedic surgeon ordering BMD and forwarding results to primary‐care physician

7/23 (30.4%)

25/27(92.6%)

‐62.2%

‐67%

0.3

(Solomon 2007a)**

Patient‐directed (3 mailed letters educational) versus physician education following an academic‐detailing approach

249/3274 (7.6%)

183/3574 (5.1%)

2.5%

49%

1.5

(Solomon 2007a)**

Patient‐directed (3 mailed letters educational) versus combination of both physician and patient education

249/3274 (7.6%)

223/3339 (6.7%)

0.9%

14%

1.1

(Solomon 2007a)**

Physician education following an academic‐detailing approach versus combination of both physician and patient education

183/3574 (5.1%)

223/3339 (6.7%)

‐1.6%

‐23%

0.8

1. Intervention 1 group pre‐intervention proportion

2. Intervention 2 group pre‐intervention proportion

3. Intervention 1 group post‐intervention proportion

4. Intervention 2 group post‐intervention proportion

5. ARD = [Int 1 post (%) minus Int 2 post (%)] minus [Int 1 pre (%) minus Int 2 pre (%)]. The direction of effect has been adjusted so that a positive result represents a beneficial intervention 1 outcome, according to Grimshaw 2004.

6. Risk Difference (RD) is the absolute % change post‐intervention = Int 1 post (%) minus Int 2 post (%). This is considered to be "small" if ≤ 5%, "modest" if > 5% and ≤10%,"moderate" if > 10% but ≤ 20%, and "large" if > 20%.The direction of effect has been adjusted so that a positive result represents a beneficial intervention 1 outcome.

7. Relative % change post = absolute % change post divided by Int 2 post (%). The direction of effect has been adjusted so that a positive result represents a beneficial intervention 1 outcome, according to Grimshaw 2004.

8. Risk ratio (RR) = Int 1 post (%) divided by Int 2 post (%)

BMD: bone mineral density; Int 1: intervention 1 group; Int 2: Intervention 2 group; ARD: adjusted risk difference; NS: not significant

* In the study by Bessette 2011, the outcomes reported above include the participants with a diagnosis following the intervention. The women were considered "diagnosed" if they received a BMD test, if they were informed by their physician that they were suffering from osteoporosis and/or if they were initiated on osteoporosis medication. Therefore, the above percentages do not necessarily mean that the women received a BMD test.

**The data reported above for the studies by Lafata 2007 and Solomon 2007b does not account for clustering. We did not have access to sufficient information to adjust the data for clustering.

Figuras y tablas -
Table 7. Osteoporosis studies intervention versus another intervention, outcome: BMD, dichotomous data
Table 8. Osteoporosis studies, intervention versus another intervention, outcome: osteoporosis medication, dichotomous data

(Study)

Interventions

Int 1 pre (%) 1

Int 2 pre (%)2

Int 1 post (%)3

Int 2 post (%)4

ARD 5

Risk difference 6

(P value if reported by authors)

Relative % change post 7

Risk ratio 8

(Bessette 2011)

Patient education, education of physician via the patient, reminder to family physician (for group of patients without diagnosis or treatment at randomisation) versus Patient education (including video on osteoporosis), education of physician via the patient, reminder to family physician (for group of patients without diagnosis and treatment at randomisation)

11.79%

10.64%

1.2%

11%

1.1

(Bessette 2011)

Patient education, education of physician via the patient, reminder to family physician (for group of patients without diagnosis or treatment at randomisation) versus Patient education (including video on osteoporosis), education of physician via the patient, reminder to family physician (for group of patients without treatment at randomisation)

13.49%

12.71%

0.8%

6%

1.1

(Boyd 2002)

Patient‐specific letter to primary care physician containing information on results and recommendations: standard versus extended letter

11/104 (10.6%)

14/93 (15.1%)

‐4.5%

‐30%

0.7

(Feldstein 2007)

Patient specific Electronic Medical Record (EMR) reminders to primary care provider informing them of patient increased risk and guidelines (sent twice) versus EMR plus patient‐directed intervention (education and reminder).

28/101 (27.7%)

22/110 (20%)

7.7%

39%

1.4

(Lafata 2007)*

Patient‐directed: 2 mailings (educational and reminders) versus physician prompt: Electronic Medical Record (EMR) reminder to physician and biweekly mailing plus patient‐directed: 2 mailings (educational and reminders)

11/128 (8.6%)

15/162 (9.3%)

‐0.7%

‐7%

0.9

(Leslie 2012)

Physician reminder plus educational material versus physician reminder plus educational material plus patient‐directed intervention (reminder to see their physician)

200/1363 (14.7%)

234/1421 (16.5%)

‐1.8%

(NS)

‐11%

0.9

(Roux 2013)

Verbal and written information on osteoporosis to patient and letter with specific management plan sent to their treating physician. Patient reminders at 6 and 12 months. Reminder to physician if patient untreated at 6 months versus verbal and written information on osteoporosis to patient and letter with specific management plan sent to their treating physician. Blood tests and BMD test ordered for patient and results sent to the physician. Patient reminders at 4,8 and 12 months and physician reminders at 4 and 8 months if patient remained untreated

82/275 (29.8%)

65/251 (25.9%)

151/275 (54.9%)

156/251

(62.2%)

‐11.2%

‐7.2%

(P<0.001)

‐12%

0.9

(Rozental 2008)

Patient specific letter to primary care physician outlining guidelines versus orthopaedic surgeon ordering BMD and forwarding results to primary‐care physician

6/23 (26.1%)

20/27(74.1%)

‐48%

‐65%

0.4

(Solomon 2007a)*

Patient directed (x3 mailed letters educational) versus physician education following an academic detailing approach

208/3274 (6.4%)

197/3574 (5.5%)

0.8%

15%

1.2

(Solomon 2007a)*

Patient directed (x3 mailed letters educational) versus combination of both physician and patient education

208/3274 (6.4%)

236/3339 (7.1%)

‐0.7%

‐10%

0.9

(Solomon 2007a)*

Physician education following an academic detailing approach versus combination of both physician and patient education

197/3574 (5.5%)

236/3339 (7.1%)

‐1.6%

‐22%

0.8

1. Intervention 1 group pre‐intervention proportion

2. Intervention 2 group pre‐intervention proportion

3. Intervention 1 group post‐intervention proportion

4. Intervention 2 group post‐intervention proportion

5. ARD = [Int 1 post (%) minus Int 2 post (%)] minus [Int 1 pre (%) minus Int 2 pre (%)]. The direction of effect has been adjusted so that a positive result represents a beneficial intervention 1 outcome, according to Grimshaw 2004.

6. Risk Difference (RD) is the absolute % change post‐intervention = Int 1 post (%) minus Int 2 post (%). This is considered to be "small" if ≤ 5%, "modest" if > 5% and ≤10%,"moderate" if > 10% but ≤ 20%, and "large" if > 20%.The direction of effect has been adjusted so that a positive result represents a beneficial intervention 1 outcome.

7. Relative % change post = absolute % change post divided by Int 2 post (%). The direction of effect has been adjusted so that a positive result represents a beneficial intervention 1 outcome, according to Grimshaw 2004.

8. Risk ratio (RR) = Int 1 post (%) divided by Int 2 post (%)

BMD: bone mineral density; Int 1: intervention 1 group; Int 2: Intervention 2 group; ARD: Adjusted risk difference; NS: not significant

* The data reported above for the studies by Lafata 2007 and Solomon 2007b does not account for clustering. We did not have access to sufficient information to adjust the data for clustering.

Figuras y tablas -
Table 8. Osteoporosis studies, intervention versus another intervention, outcome: osteoporosis medication, dichotomous data
Table 9. Low back pain studies, intervention versus control, dichotomous data

(Study)

Intervention

Outcome

Int pre (%) 1

C pre (%)2

Int post (%)3

C post (%)4

ARD 5

Risk difference 6

(P value if reported by authors)

Relative % change post 7

Risk ratio 8

(Bishop 2006)

Physician education (guidelines) and 3 patient‐specific reminder letters

Education and reassurance according to guideline 0 ‐ 4 weeks post‐onset

10% (16/162)

7% (10/149)

3.2%

47%

1.5

Exercise according to guideline 0 ‐ 4 weeks post‐onset

38% (62/162)

43% (64/149)

‐4.7%

‐11%

0.9

Appropriate medication according to guideline 0 ‐ 4 weeks post‐onset

85% (138/162)

77% (115/149)

8%

(P=0.14)

10%

1.1

Spinal manipulation according to guideline 0 ‐ 4 weeks post‐onset

2.5% (4/162)

6% (9/149)

‐3.6%

‐59%

0.4

Guideline‐discordant physician recommended treatment 0 ‐ 4 weeks post‐onset

10% (16/162)

17% (25/149)

6.9%

(P=0.05)

41%

0.6

Supervised exercise programme (recommended treatment 5 ‐ 12 weeks post‐onset)

19% (29/154)

14% (21/149)

4.7%

(P=0.11)

34%

1.3

Return to work (recommended treatment 5 ‐ 12 weeks post‐onset)

24% (37/154)

17% (25/149)

7.2%

(P=0.18)

43%

1.4

Refer to interdisciplinary programme (recommended treatment 5 ‐ 12 weeks post‐onset)

4% (6/154)

2% (3/149)

1.9%

94%

1.9

Physiotherapy > 4 weeks (guideline‐discordant)

41% (63/154)

43% (64/149)

2%

5%

1

Continued use of spinal manipulation therapy (guideline‐discordant)

‐(no data available)

33% (49/149)

(P=0.04)

(Bishop 2006)

Physician education, reminders and also patient education and 3 reminders

Education and reassurance according to guideline 0 ‐ 4 weeks post‐onset

6% (9/151)

7% (10/149)

‐0.8%

‐11%

0.9

Exercise according to guideline 0 ‐ 4 weeks post‐onset

53% (80/151)

43% (64/149)

10%

(P=0.05)

23%

1.2

Appropriate medication according to guideline 0 ‐ 4 weeks post‐onset

81% (122/151)

77% (115/149)

3.6%

(P=0.08)

5%

1

Spinal manipulation according to guideline 0 ‐ 4 weeks post‐onset

5% (8/151)

6% (9/149)

‐0.7%

‐12%

0.9

Guideline‐discordant physician recommended treatment 0 ‐ 4 weeks post‐onset

18% (27/151)

17% (25/149)

‐1.1%

‐7%

1.1

Supervised exercise programme (recommended treatment 5 ‐ 12 weeks post‐onset)

18% (26/145)

14% (21/149)

3.8%

(P=0.07)

27%

1.3

Return to work (recommended treatment 5 ‐ 12 weeks post‐onset)

23% (33/145)

17% (25/149)

6%

(P=0.14)

36%

1.4

Refer to interdisciplinary programme (recommended treatment 5 ‐ 12 weeks post‐onset)

0

2% (3/149)

‐2%

‐100%

0

Physiotherapy > 4 weeks (guideline‐discordant)

42% (61/145)

43% (64/149)

0.9%

2%

1

Continued use of spinal manipulation therapy (guideline‐discordant)

3% (4/145)

33% (49/149)

30.1%

(P=0.05)

92%

0.1

(Dey 2004)*

Intervention (aimed at general practitioners): guidelines discussion (educational component), patient information leaflets, access to fast‐track physiotherapy and triage services for patients with persistent symptoms (organisational component) versus usual care (control)*

X‐ray referrals

15.1% (43/284)

13.7% (42/308)

‐1.4%

(P=0.62)

‐10%

1.1

Sickness certificates

17.9 % (34/190)

19.2% (40/206)

1.3%

(P=0.74)

7%

0.9

Prescriptions for opioids or muscle relaxants

18.6% (84/452)

18.7% (92/491)

0.1

(P=0.99)

1

1

Referrals to secondary care

3.4% (33/962)

2.3% (24/1044)

‐1.1%

(P=0.12)

‐49%

1.5

Referrals to physiotherapy or educational programme

26.3% (44/167)

13.8% (25/181)

‐12.6%

(P=0.01)

‐91%

1.9

(Engers 2005)**

Intervention (aimed at general practitioners): guidelines on low back pain, 2‐hour workshop, 2 scientific articles, guidelines on low back pain for occupational physicians, tool for patient education and management‐decision tool. Control group: usual care

Referral to a therapist

22.9% (75/328)

27.4% (79/288)

4.6%

17%

0.8

Prescription of pain medication on a time‐contingent basis

70% (139/328)

69% (130/288)

2.8%

6%

0.9

Handed patient information leaflet

36.9% (121/328)

38.2% (110/288)

‐1.3%

‐3%

1

Advised patient to stay active

95.1% (312/328)

89.2% (257/288)

5.9%

7%

1.1

Advised patient to gradually increase activity

78% (256/328)

65.3% (188/288)

12.8%

20%

1.2

Advised patient which activities to increase at what moment

18% (58/328)

9% (26/288)

8.7%

96%

2

(French 2013)***

Intervention (aimed at general practitioners): Interactive, educational workshops plus educational material disseminated (via DVDs); Control group: usual care**

Number of x‐ray requests out of total number of patients seen

0.83% (67/8,085)

1.02% (80/7,826)

0.2%

(P=0.2)

19%

0.8

Number of CT requests out of total number of patients seen

0.61% (64/10,419)

0.66% (66/10,085)

0.0%

(P=0.6)

7%

0.9

(Hazard 1997)

Intervention (aimed at physicians): notification that patient was at a high risk of disability and guidelines on management. Control group: usual care

3‐month work absence rates

28.6% (8/28)

24% (6/25)

‐4.6%

(NS)

‐19%

1.2

(Schectman 2003)

Intervention (aimed at physicians): guideline on low back pain, 90‐minute educational session on guideline implementation delivered by local opinion leaders and audit report summarising performance against the guideline plus outreach visit. Control group: usual care plus/minus patient education (pamphlet and video)

Lumbosacral X‐ray total utilisation (% of patients based on episode of care)

31%

21%

19%

18%

9%

‐1%

‐6%

1.1

Lumbosacral X‐ray not consistent with guideline

14.5%

8.2%

8.1%

8.6%

6.8%

0.5%

6%

0.9

Lumbosacral CT/MRI total utilisation (% of patients based on episode of care)

7.6%

5.6%

5.6%

7.1%

3.5%

1.5%

21%

0.8

Lumbosacral CT/MRI not consistent with guideline

5.7%

3.5%

3.5%

5.4%

4.1%

1.9%

35%

0.6

Physical therapy referral total utilisation (% of patients based on episode of care)

12%

13%

10%

13%

2%

3%

23%

0.8

Physical therapy referral not consistent with guideline

10%

10.9%

9.2%

12%

1.9%

2.8%

23%

0.8

Specialty referral total utilisation (% of patients based on episode of care)

12%

5.9%

8.6%

7.1%

4.6%

‐1.5%

‐21%

1.2

Specialty referral not consistent with guideline

9.5%

4%

7.1%

5.6%

4%

‐1.5%

‐27%

1.3

1. Intervention group pre‐intervention proportion

2. Control group pre‐intervention proportion

3. Intervention group post‐intervention proportion

4. Control group post‐intervention proportion

5. ARD = [Int post (%) minus C post (%)] minus [Int pre (%) minus C pre (%)]. The direction of effect has been adjusted so that a positive result represents a beneficial intervention outcome, according to Grimshaw 2004.

6. Risk Difference (RD) is the absolute % change post‐intervention = Int post (%) minus C post (%). This is considered to be "small" if ≤ 5%, "modest" if > 5% and ≤10%,"moderate" if > 10% but ≤ 20%, and "large" if > 20%.The direction of effect has been adjusted so that a positive result represents a beneficial intervention outcome, according to Grimshaw 2004.

7. Relative % change post = absolute % change post divided by C post (%). The direction of effect has been adjusted so that a positive result represents a beneficial intervention outcome, according to Grimshaw 2004.

8. Risk ratio (RR) = Int post (%) divided by C post (%)

C: control group; Int: intervention group; ARD: adjusted risk difference; NS: not significant

CT/MRI: computed tomography/magnetic resonance imaging

* Dey 2004 reported the Intercluster Correlation (ICC) for the results (mean cluster size=95.1) and this was used to calculate the above effective sample sizes according to chapter 16.3.4 of the Cochrane Handbook, Higgins 2011a.

** The data reported above for the study by Engers 2005 does not account for clustering. We did not have access to sufficient information to adjust the data for clustering.

***French 2013 reported Intercluster Correlation (ICC for x‐rays 0.004 and for CTs 0.003, mean cluster size=2,154) and this was used to calculate the above effective sample sizes according to chapter 16.3.4 of the Cochrane Handbook, Higgins 2011a

Figuras y tablas -
Table 9. Low back pain studies, intervention versus control, dichotomous data
Table 10. Low back pain studies, intervention 1 versus intervention 2, dichotomous data

(Study)

Intervention 1 versus intervention 2

Outcome

Int 1 pre (%) 1

Int 2 pre (%)2

Int 1 post (%)3

Int 2 post (%)4

ARD 5

Risk difference 6

(P value if reported by authors)

Relative % change post 7

Risk ratio 8

(Bishop 2006)

Physician education (guidelines) and 3 patient‐specific reminder letters versus physician education, reminders and also patient education and 3 reminders

Education and reassurance according to guideline 0 ‐ 4 weeks post‐onset

10% (16/162)

6% (9/151)

3.9%

(NS)

66%

1.7

Exercise according to guideline 0 ‐ 4 weeks post‐onset

38% (62/162)

53% (80/151)

‐14.7%

(P=0.0083)

‐28%

0.7

Appropriate medication according to guideline 0 ‐ 4 weeks post‐onset

85% (138/162)

81% (122/151)

4.4%

(NS)

5%

1.1

Spinal manipulation according to guideline 0 ‐ 4 weeks post‐onset

2.5% (4/162)

5% (13/151)

‐6.1%

(P=0.018)

‐71%

0.3

Guideline‐discordant physician‐recommended treatment 0 ‐ 4 weeks post‐onset

10% (16/162)

18% (27/151)

8%

(P=0.04)

45%

0.6

Supervised exercise programme (recommended treatment 5 ‐ 12 weeks post‐onset)

19% (29/154)

18% (26/145)

0.9%

(NS)

5%

1.1

Return to work (recommended treatment 5 ‐ 12 weeks post‐onset)

24% (37/154)

23% (33/145)

1.3%

(NS)

6%

1.1

Refer to interdisciplinary programme (recommended treatment 5 ‐ 12 weeks post‐onset)

4% (6/154)

0

3.9%

(P=0.02)

Physiotherapy > 4 weeks (guideline‐discordant)

41% (63/154)

42% (61/145)

1.2%

(NS)

3%

1

Continued use of spinal manipulation therapy (guideline‐discordant)

‐ (no data available)

3% (4/145)

(Eccles 2001)*

Feedback on number of spinal radiographs 6 months before and 6 months after the intervention plus guideline dissemination versus guideline dissemination

Lumbar spine radiographs concordant with guidelines

35.4% (64/181)

43.6% (120/275)

‐8.3%

‐19%

0.8

(Eccles 2001)*

Reminder messages on radiograph reports plus guideline dissemination versus guideline dissemination

Lumbar spine radiographs concordant with guidelines

41.2% (35/85)

43.6% (120/275)

‐2.5%

‐6%

0.9

(Eccles 2001)*

Feedback on number of spinal radiographs 6 months before and 6 months after the intervention plus guideline dissemination plus reminder messages on radiograph reports versus guideline dissemination

Lumbar spine radiographs concordant with guidelines

36% (89/247)

43.6% (120/275)

‐7.6%

‐17%

0.8

(Eccles 2001)*

Feedback on number of spinal radiographs 6 months before and 6 months after the intervention plus guideline dissemination versus reminder messages on radiograph reports plus guideline dissemination

Lumbar spine radiographs concordant with guidelines

35.4% (64/181)

41.2% (35/85)

‐5.8%

‐14%

0.9

1. Intervention 1 group pre‐intervention proportion

2. Intervention 2 group pre‐intervention proportion

3. Intervention 1 group post‐intervention proportion

4. Intervention 2 group post‐intervention proportion

5. ARD = [Int 1 post (%) minus Int 2 post (%)] minus [Int 1 pre (%) minus Int 2 pre (%)]. The direction of effect has been adjusted so that a positive result represents a beneficial intervention 1 outcome, according to Grimshaw 2004.

6. Risk Difference (RD) is the absolute % change post‐intervention = Int 1 post (%) minus Int 2 post (%). This is considered to be "small" if ≤ 5%, "modest" if > 5% and ≤10%,"moderate" if > 10% but ≤ 20%, and "large" if > 20%.The direction of effect has been adjusted so that a positive result represents a beneficial intervention 1 outcome.

7. Relative % change post = absolute % change post divided by Int 2 post (%). The direction of effect has been adjusted so that a positive result represents a beneficial intervention 1 outcome, according to Grimshaw 2004.

8. Risk ratio (RR) = Int 1 post (%) divided by Int 2 post (%)

Int 1: intervention 1 group; Int 2: Intervention 2 group; ARD: Adjusted risk difference; NS: not significant

*The data reported above for the study by Eccles 2001 does not account for clustering. We did not have access to sufficient information to adjust the data for clustering.

Figuras y tablas -
Table 10. Low back pain studies, intervention 1 versus intervention 2, dichotomous data
Table 11. Low back pain studies intervention 1 versus intervention 2, continuous data

(Study)

Intervention 1 versus Intervention 2

Outcome

Int 1 pre mean (SD)1

Int 2 pre mean (SD)2

Int 1 post mean (SD)3

Int 2 post mean (SD)4

MD 5

Relative % change 6

Adjusted relative % change7

SMD8

(P value)9

(Becker 2008*)

Physician education: Guideline (in 4 versions including patient leaflet), 3 seminars and academic detailing versus guideline dissemination

Functional capacity measured by Hannover Functional Ability Questionnaire at 6 months

72.9

70.3

2.7

4%

0.1

(P=0.12)

(Becker 2008*)

Physician education (as above) plus practice nurse training in motivational counselling versus guideline dissemination

Functional capacity measured by Hannover Functional Ability Questionnaire at 6 months

73.9

70.3

3.6

5%

0.2

(P=0.032)

(Becker 2008*)

Physician education: Guideline (in 4 versions including patient leaflet), 3 seminars and academic detailing versus guideline dissemination

Days in pain at 6 months

63.3

80.8

17.4

22%

0.2

(P=0.002)

(Becker 2008*)

Physician education (as above) plus practice nurse training in motivational counselling versus guideline dissemination

Days in pain at 6 months

62.9

80.8

17.9

22%

0.2

(P=0.001)

(Becker 2008*)

Physician education: Guideline (in 4 versions including patient leaflet), 3 seminars and academic detailing versus guideline dissemination

Overall activity at 6 months

36.5

33.5

3

9%

0.1

(P=0.203)

(Becker 2008*)

Physician education (as above) plus practice nurse training in motivational counselling versus guideline dissemination

Overall activity at 6 months

36.3

33.5

2.8

8%

0.1

(P=0.230)

(Becker 2008*)

Physician education: Guideline (in 4 versions including patient leaflet), 3 seminars and academic detailing versus guideline dissemination

Days of sick leave at 6 months

13

14.3

1.3

9%

0

(P=0.569)

(Becker 2008*)

Physician education (as above) plus practice nurse training in motivational counselling versus guideline dissemination

Days of sick leave at 6 months

13

14.3

1.3

9%

0

(P=0.584)

(Becker 2008*)

Physician education: Guideline (in 4 versions including patient leaflet), 3 seminars and academic detailing versus guideline dissemination

Quality of life at 6 months

66.6

66.8

‐0.3

0%

0

(P=0.847)

(Becker 2008*)

Physician education (as above) plus practice nurse training in motivational counselling versus guideline dissemination

Quality of life at 6 months

67.5

66.8

0.7

1%

‐‐

0

(P=0.602)

(Becker 2008*)

Physician education: Guideline (in 4 versions including patient leaflet), 3 seminars and academic detailing versus guideline dissemination

Functional capacity measured by Hannover Functional Ability Questionnaire at 12 months

73

71.6

1.4

2%

0.1

(P=0.446)

(Becker 2008*)

Physician education (as above) plus practice nurse training in motivational counselling versus guideline dissemination

Functional capacity measured by Hannover Functional Ability Questionnaire at 12 months

74.6

71.6

3.1

4%

0.1

(P=0.088)

(Becker 2008*)

Physician education: Guideline (in 4 versions including patient leaflet), 3 seminars and academic detailing versus guideline dissemination

Days in pain at 12 months

58.5

71.3

12.8

18%

0.2

(P=0.018)

(Becker 2008*)

Physician education (as above) plus practice nurse training in motivational counselling versus guideline dissemination

Days in pain at 12 months

61.6

71.3

9.8

14%

0.1

(P=0.067)

(Becker 2008*)

Physician education: Guideline (in 4 versions including patient leaflet), 3 seminars and academic detailing versus guideline dissemination

Overall activity at 12 months

46.4

42.9

3.5

8%

0.1

(P=0.202)

(Becker 2008*)

Physician education (as above) plus practice nurse training in motivational counselling versus guideline dissemination

Overall activity at 12 months

45.4

42.9

2.5

6%

0.1

(P=0.396)

(Becker 2008*)

Physician education: Guideline (in 4 versions including patient leaflet), 3 seminars and academic detailing versus guideline dissemination

Days of sick leave at 12 months

6.2

9.3

3.1

34%

0.1

(P=0.256)

(Becker 2008*)

Physician education (as above) plus practice nurse training in motivational counselling versus guideline dissemination

Days of sick leave at 12 months

6.5

9.3

2.8

30%

0.1

(P=0.320)

(Becker 2008*)

Physician education: Guideline (in 4 versions including patient leaflet), 3 seminars and academic detailing versus guideline dissemination

Quality of life at 12 months

68.5

67.7

0.8

1%

0

(P=0.535)

(Becker 2008*)

Physician education (as above) plus practice nurse training in motivational counselling versus guideline dissemination

Quality of life at 12 months

70.4

67.7

2.7

4%

0.1

(P=0.036)

(Becker 2008*)

Physician education: Guideline (in 4 versions including patient leaflet), 3 seminars and academic detailing vs physician education plus practice nurse training in motivational counselling

Functional capacity measured by Hannover Functional Ability Questionnaire at 6 months

72.9

73.9

‐1

‐1%

0

(NR)

(Becker 2008*)

Physician education: Guideline (in 4 versions including patient leaflet), 3 seminars and academic detailing vs physician education plus practice nurse training in motivational counselling

Days in pain at 6 months

63.3

62.9

‐0.4

‐1%

0

(NR)

(Becker 2008*)

Physician education: Guideline (in 4 versions including patient leaflet), 3 seminars and academic detailing vs physician education plus practice nurse training in motivational counselling

Overall activity at 6 months

36.5

36.3

0.2

0%

0

(NR)

(Becker 2008*)

Physician education: Guideline (in 4 versions including patient leaflet), 3 seminars and academic detailing vs Physician education plus practice nurse training in motivational counselling

Days of sick leave at 6 months

13

13.1

0.1

0%

0

(NR)

(Becker 2008*)

Physician education: Guideline (in 4 versions including patient leaflet), 3 seminars and academic detailing vs Physician education plus practice nurse training in motivational counselling

Quality of life at 6 months

66.6

67.5

‐0.9

‐1%

0

(NR)

(Becker 2008*)

Physician education: Guideline (in 4 versions including patient leaflet), 3 seminars and academic detailing vs Physician education plus practice nurse training in motivational counselling

Functional capacity measured by Hannover Functional Ability Questionnaire at 12 months

73

74.6

‐1.7

‐2%

‐0.1

(NR)

(Becker 2008*)

Physician education: Guideline (in 4 versions including patient leaflet), 3 seminars and academic detailing vs Physician education plus practice nurse training in motivational counselling

Days in pain at 12 months

58.5

61.6

3.1

5%

0

(NR)

(Becker 2008*)

Physician education: Guideline (in 4 versions including patient leaflet), 3 seminars and academic detailing vs Physician education plus practice nurse training in motivational counselling

Overall activity at 12 months

46.4

45.4

1

2%

0

(NR)

(Becker 2008*)

Physician education: Guideline (in 4 versions including patient leaflet), 3 seminars and academic detailing vs Physician education plus practice nurse training in motivational counselling

Days of sick leave at 12 months

6.2

6.458

0.3

5%

0

(NR)

(Becker 2008*)

Physician education: Guideline (in 4 versions including patient leaflet), 3 seminars and academic detailing vs Physician education plus practice nurse training in motivational counselling

Quality of life at 12 months

68.5

70.4

‐1.9

‐3%

‐0.1

(NR)

(Eccles 2001)*

Feedback on number of spinal radiographs 6 months before and 6 months after the intervention plus guideline dissemination versus guideline dissemination

Number of lumbar spine radiographs per 1000 patients

7.24 (4.8)

7.53 (4.1)

5.97 (4.2)

6.80 (4.3)

0.83

12%

8%

0.2

(NR)

(Eccles 2001)*

Reminder messages on radiograph reports plus guideline dissemination versus guideline dissemination

Number of lumbar spine radiographs per 1000 patients

7.31 (5.2)

7.53 (4.1)

5.14 (3.7)

6.80 (4.3)

1.66

24%

21%

0.4

(P=0.05)

(Eccles 2001)*

Feedback on number of spinal radiographs 6 months before and 6 months after the intervention plus guideline dissemination plus reminder messages on radiograph reports versus guideline dissemination

Number of lumbar spine radiographs per 1000 patients

8.30 (5.1)

7.53 (4.1)

5.23 (3.7)

6.80 (4.3)

1.57

23%

34%

0.4

(NR)

(Eccles 2001)*

Feedback on number of spinal radiographs 6 months before and 6 months after the intervention plus guideline dissemination versus reminder messages on radiograph reports plus guideline dissemination

Number of lumbar spine radiographs per 1000 patients

7.24 (4.8)

7.31 (5.2)

5.97 (4.2)

5.14 (3.7)

‐0.83

‐16%

‐18%

‐0.2

(NR)

1. Intervention 1 group pre‐intervention mean (standard deviation)

2. Intervention 2 group pre‐intervention mean (standard deviation)

3. Intervention 1 group post‐intervention mean (standard deviation)

4. Intervention 2 group postintervention mean (standard deviation)

5. Mean Difference (MD)=Difference between post‐intervention means. The direction of effect has been adjusted so that a positive result represents a beneficial intervention 1 outcome, according to Grimshaw 2004.

6. Relative percentage change post‐intervention = (Int1 post mean ‐ Int2 post mean)/Int2 post mean. The direction of effect has been adjusted so that a positive result represents a beneficial intervention 1 outcome, according to Grimshaw 2004.

7. Adjusted relative percentage change= (Int1 post mean‐Int2 post mean)‐(Int1 pre mean ‐ Int2 pre mean)/Int2 post mean. The direction of effect has been adjusted so that a positive result represents a beneficial intervention 1 outcome.

8. SMD=Standardised Mean Difference=(Int1 post mean‐Int2 post mean)/SD pooled. The direction of effect has been adjusted so that a positive result represents a beneficial intervention 1 outcome, according to Grimshaw 2004.

9. P value reported by study authors

Int 1: intervention 1 group; Int 2: Intervention 2 group; NR: not reported; SD: standard deviation

*The data reported above for Becker 2008 and Eccles 2001 was adjusted for clustering by the authors

Figuras y tablas -
Table 11. Low back pain studies intervention 1 versus intervention 2, continuous data
Table 12. Low back pain, interrupted time series studies, imaging outcomes

Study

Intervention

Outcome

Mean pre (SD)

Mean post (SD)

Mean post minus mean pre

Relative % change pre to post

SMD pre to post

Mean change in level (p value)

Mean change in slope (p value)

Hollingworth 2002

Educational material

Back x‐rays ordered

1133 (50)

1208.7 (111.5)

‐75.7

‐6.7

‐1.51

‐121.5 (P = 0.167)

6.8 (P = 0.776)

Figuras y tablas -
Table 12. Low back pain, interrupted time series studies, imaging outcomes
Table 13. Osteoarthritis studies: Intervention versus control (continuous data)

(Study)

Intervention

Outcome

Int pre mean (SD)1

C pre mean (SD)2

Int post mean (SD)3

C post mean (SD)4

MD 5

Relative % change 6

Adjusted relative % change7

SMD8

(P value)9

(Chassany 2006)*

GP training on relationships and communication, pain evaluation, prescription and negotiation of a patient contract delivered in a 4‐hour interactive session plus 8 reminders on recommendations

Pain relief (SPID)

315.6 (289.5)

264.7 (242.9)

50.9

19%

19%

0.2

(P< 0.0001)

Intensity of pain in motion on VAS

63.7 (13.8)

62.8 (13.5)

‐29 (23.1)

‐24.8 (21.1)

4.2

17%

‐21%

0.2

(P=0.01)

Lequesne Index

9.2 (2.9)

9.8 (3.2)

‐2.5 (2.5)

‐2.0 (2.4)

0.5

25%

5%

0.2

(P< 0.0001)

WOMAC index pain

9.3 (3.0)

9.6 (2.8)

‐2.9 (3.4)

‐2.2 (2.9)

0.7

32%

‐18%

0.2

(P< 0.0001)

WOMAC index stiffness

4.1 (1.4)

4.0 (1.4)

‐1.2 (1.6)

‐0.8 (1.4)

0.4

50%

‐62%

0.3

(P=0.0004)

WOMAC index physical function

31.2 (10.9)

32.8 (9.5)

‐8.7 (10.7)

‐6.1 (8.8)

2.6

43%

‐16%

0.3

(P< 0.0001)

WOMAC index global score

44.6 (14.4)

46.4 (12.5)

‐12.9 (14.8)

‐9.2 (12.2)

3.7

40%

‐21%

0.3

(P< 0.0001)

Acetaminophen consumption

3400 (800)

2900 (900)

‐500

‐17%

‐17%

‐0.6

(P< 0.0001)

(Rosemann 2007)*

Intervention (aimed at GPs): 2 interactive 8‐hour meetings focusing on arthritis self management, guideline dissemination and patient information material versus control (usual care)

Quality of life (AIMS2‐SF scores) Lower body

2.67 (1.88)

2.65 (1.85)

2.48

2.62

‐0.14

‐5%

‐6%

‐0.1

(P=0.349)

Quality of life (AIMS2‐SF scores) Upper body

1.47 (2.25)

1.33 (2.09)

1.43

1.34

0.09

7%

‐4%

0.1

P=0.694)

Quality of life (AIMS2‐SF scores) Symptom

4.87 (2.13)

4.81 (2.18)

4.51

4.72

‐0.21

‐4%

‐6%

‐0.2

(P=0.119)

Quality of life (AIMS2‐SF scores) Affect

2.89 (1.35)

2.88 (1.33)

2.92

2.83

0.09

3%

3%

0.1

(P=0.610)

Quality of life (AIMS2‐SF scores) Social

4.52 (1.88)

4.69 (1.80)

4.43

4.62

‐0.19

‐4%

0%

‐0.3

P=0.776

GP contacts

4.56 (6.13)

4.82 (6.00)

4.44

4.6

0.16

3%

‐2%

0.1

(P=0.339)

Referrals to orthopaedics

1.58 (3.43)

1.76 (3.52)

1.49

1.75

0.26

15%

5%

0.8

(P=0.153)

Radiographs

0.82 (3.12)

0.79 (2.78)

0.75

0.85

0.1

12%

15%

0.2

(P=0.05)

Non‐medical practitioners

0.11 (3.01)

0.36 (3.28)

0.09

0.32

0.23

72%

‐6%

0.6

(P=0.687)

Physiotherapy

4.70 (9.10)

5.81 (11.10)

4.63

5.77

1.14

20%

1%

2

(P=0.242)

Acupuncture

0.83 (3.45)

0.97 (3.80)

0.8

0.97

0.17

18%

3%

0.2

(P=0.821)

(Rosemann 2007)*

Intervention (aimed at GPs) as above plus patient case management via telephone by practice nurses versus control (usual care)

Quality of life (AIMS2‐SF scores) Lower body

3.01 (2.11)

2.65 (1.85)

2.61

2.62

‐0.01

0%

‐14%

0

(P=0.049)

Quality of life (AIMS2‐SF scores) Upper body

1.68 (2.44)

1.33 (2.09)

1.62

1.34

0.28

21%

‐5%

0.2

(P=0.621)

Quality of life (AIMS2‐SF scores) Symptom

5.02 (2.29)

4.81 (2.18)

4.42

4.72

‐0.3

‐6%

‐11%

‐0.2

(P=0.048)

Quality of life (AIMS2‐SF scores) Affect

3.04 (1.39)

2.88 (1.33)

2.98

2.83

0.15

5%

0%

0.2

(P=0.691)

Quality of life (AIMS2‐SF scores) Social

4.79 (1.80)

4.69 (1.80)

4.736

4.62

0.116

3%

0%

0.1

(P< 0.001)

GP contacts

5.01 (5.78)

4.82 (6.00)

4.9

4.6

‐0.3

‐7%

‐2%

‐0.2

(P=0.823)

Referrals to orthopaedics

1.76 (3.52)

1.76 (3.52)

1.52

1.75

0.23

13%

13%

0.2

(P=0.044)

Radiographs

0.80 (3.01)

0.79 (2.78)

0.71

0.85

0.14

16%

18%

0.4

(P=0.031)

Non‐medical practitioners

0.50 (4.20)

0.36 (3.28)

0.47

0.32

‐0.15

‐47%

‐3%

‐0.4

(P=0.225)

Physiotherapy

5.22 (10.03)

5.81 (11.10)

5.08

5.77

0.69

12%

2%

1.3

(P=0.129)

Acupuncture

0.77 (3.99)

0.97 (3.80)

0.72

1.09

0.37

34%

16%

0.4

(P=0.769)

(Stross 1985)**

Intervention: Educationally‐influential physicians (EIs) led education of primary‐care physicians: self‐study programme including textbook, audiovisual materials and recent articles on osteoarthritis versus control (usual care)

Length of stay for OA patients

8.8

8.4

8.4

8.6

0.2

2%

7%

NR

Length of stay for total hip arthroplasty (THA) patients

17.2

16.6

15.2

16.0

0.8

5%

9%

NR

1. Intervention group pre‐intervention mean (standard deviation)

2. Control group pre‐intervention mean (standard deviation)

3. Intervention group post‐intervention mean (standard deviation)

4. Control group pos‐tintervention mean (standard deviation)

5. Mean Difference (MD)=Difference between post‐intervention means. The direction of effect has been adjusted so that a positive result represents a beneficial intervention outcome, according to Grimshaw 2004.

6. Relative percentage change post‐intervention = (Int post mean ‐ Control post mean)/Control post mean

7. Adjusted relative percentage change= (Int post mean‐Control post mean)‐(Int pre mean ‐ Control pre mean)/Control post mean. The direction of effect has been adjusted so that a positive result represents a beneficial intervention outcome.

8. SMD=Standardised Mean Difference=(Int post mean‐Control post mean)/SD pooled. The direction of effect has been adjusted so that a positive result represents a beneficial intervention outcome, according to Grimshaw 2004.

9. P value reported by study authors

AIMS2‐SF: Arthritis Impact Measurement Scales Short Form
WOMAC: Western Ontario and McMaster Universities Osteoarthritis Index

* There are potential unit of analysis errors in the reported results as the study did not account for clustering and did not provide sufficient data to allow an approximate analysis according to chapter 16.3.4 of the Cochrane Handbook, Higgins 2011a.

**The study did not report standard deviations and therefore we were unable to calculate the SMD. There are potential unit of analysis errors in the reported results as the study did not account for clustering and did not provide sufficient data to allow an approximate analysis according to chapter 16.3.4 of the Cochrane Handbook, Higgins 2011a.

Figuras y tablas -
Table 13. Osteoarthritis studies: Intervention versus control (continuous data)
Table 14. Osteoarthritis studies: intervention versus control (dichotomous data)

(Study)

Intervention

Outcome

Int pre (%) 1

C pre (%)2

Int post (%)3

C post (%)4

ARD 5

Risk difference 6

(P Value if reported by authors)

Relative % change post 7

Risk ratio 8

(Rahme 2005)*

Intervention (aimed at GPs): 90‐minute workshop on management of osteoarthritis versus control group (usual care)

Number of adequate prescription, according to the guidelines

51% (273/536)

47% (675/1437)

56% (251/450)

49% (593/1209)

3%

7%

14%

1.1

(Rahme 2005)*

Intervention (aimed at GPs): decision tree on treatment choices for osteoarthritis patients versus control (usual care)

Number of adequate prescription, according to the guidelines

51% (799/1569)

47% (675/1437)

54% (712/1317)

49% (593/1209)

1%

5%

10%

1.1

(Rahme 2005)*

Intervention (aimed at GPs): 90‐minute workshop and decision tree as above versus control (usual care)

Number of adequate prescription, according to the guidelines

58% (1022/1776)

47% (675/1437)

62% (1008/1634)

49% (593/1209)

2%

13%

26%

1.3

(Rosemann 2007)*

Intervention (aimed at GPs): 2 interactive 8‐hour meetings focusing on arthritis self management, guideline dissemination and patient information material versus control (usual care)

Paracetamol prescriptions

8.9% (31/345)

6.6% (22/332)

16.4%

5.3%

8.7%

11.1%

(<0.001)

209%

3.1

Opioids

5.8% (20/345)

6.9% (23/332)

10.1%

7.9%

3.4%

2.2%

(NS)

28%

1.3

NSAID

40% (138/345)

41.9% (139/332)

44.3%

44.2%

2.0%

0.1%

(NS)

23%

1.0

Homeopathics

6.1% (21/345)

8.1% (27/332)

7.7%

9.8%

‐0.1%

‐2.2%

(NS)

‐22%

0.8

(Rosemann 2007)*

Intervention (aimed at GPs) as above plus patient case management via telephone by practice nurses versus control (usual care)

Paracetamol prescriptions

7.3% (25/345)

6.6% (22/332)

14.1%

5.3%

8.2%

8.8%

(<0.01)

166%

2.7

Opioids

7.3% (25/345)

6.9% (23/332)

16.0%

7.9%

7.8%

8.1%

(< 0.01)

102%

2.0

NSAID

43.3% (149/345)

41.9% (139/332)

49.7%

44.2%

4.3%

5.6%

(0.019)

13%

1.1

Homeopathics

6.7% (23/345)

8.1% (27/332)

9.6%

9.8%

1.2%

‐0.2%

(NS)

‐2%

1.0

(Stross 1985)*

Intervention: Educationally‐influential physicians (EIs) led education of primary‐care physicians: self‐study programme including textbook, audiovisual materials and recent articles on osteoarthritis versus control (usual care)

Management of OA patients with aspirin

39% (9/23)

50% (9/18)

20% (6/30)

28% (5/18)

3%

‐8%

‐28%

0.7

Management of OA patients with NSAIDs

83% (19/23)

78% (14/18)

87% (26/30)

94% (17/18)

‐13%

‐8%

‐8%

0.9

Management of OA patients with systemic corticosteroids

13% (3/23)

17% (3/18)

3% (1/30)

22% (4/18)

15%

19%

(< 0.05)

85%

0.2

Management of OA patients with intra‐articular corticosteroids

17% (4/23)

11% (2/18)

40% (12/30)

11% (2/18)

23%

29%

(<0.05)

260%

3.6

Management of OA patients with physical therapy

87% (20/23)

83% (15/18)

93% (28/30)

83% (15/18)

6%

10%

12%

1.1

Referral of OA patients

39% (9/23)

39% (7/18)

30% (9/30)

33% (6/18)

‐4%

3%

10%

0.9

Pre‐op physical therapy of THA patients

56% (10/18)

46% (12/26)

97% (35/36)

40% (12/30)

48%

57%

(< 0.05)

143%

2.4

Post‐op narcotics of THA patients

72% (13/18)

77% (20/26)

89% (32/36)

93% (28/30)

0%

4%

5%

1.0

Post‐op physical therapy of THA patients

100% (18/18)

100% (26/26)

100% (36/36)

100% (30/30)

0%

0%

0%

1.0

Post‐op complications of THA patients

11% (2/18)

15% (4/26)

6% (2/36)

13% (4/30)

4%

8%

58%

0.4

1. Intervention group pre‐intervention proportion

2. Control group pre‐intervention proportion

3. Intervention group post‐intervention proportion

4. Control group post‐intervention proportion

5. ARD = [Int post (%) minus C post (%)] minus [Int pre (%) minus C pre (%)]. The direction of effect has been adjusted so that a positive result represents a beneficial intervention outcome, according to Grimshaw 2004.

6. Risk Difference (RD) is the absolute % change post‐intervention = Int post (%) minus C post (%). This is considered to be "small" if ≤ 5%, "modest" if > 5% and ≤10%,"moderate" if > 10% but ≤ 20%, and "large" if > 20%.The direction of effect has been adjusted so that a positive result represents a beneficial intervention outcome, according to Grimshaw 2004.

7. Relative % change post = absolute % change post divided by C post (%). The direction of effect has been adjusted so that a positive result represents a beneficial intervention outcome, according to Grimshaw 2004.

8. Risk ratio (RR) = Int post (%) divided by C post (%)

C: control group; Int: intervention group; ARD: Adjusted risk difference; NS: not significant

NSAID: non‐steroidal anti‐inflammatory drug, THA: total hip arthroplasty

* There are unit of analysis errors in the reported results because the available data did not account for the effect of clustering.

Figuras y tablas -
Table 14. Osteoarthritis studies: intervention versus control (dichotomous data)
Table 15. Osteoarthritis studies: intervention 1 versus intervention 2, dichotomous data

(Study)

Intervention 1 versus intervention 2

Outcome

Int 1 pre (%) 1

Int 2 pre (%)2

Int 1 post (%)3

Int 2 post (%)4

ARD 5

Risk difference 6

(P value if reported by authors)

Relative % change post 7

Risk ratio 8

(Rahme 2005)*

Intervention 1 (aimed at GPs): 90‐minute workshop on management of osteoarthritis versus Intervention 2 (aimed at GPs): decision tree on treatment choices for osteoarthritis patients

Number of adequate prescription, according to the guidelines

51% (273/536)

51% (799/1569)

56% (251/450)

54% (712/1317)

1.7%

1.7%

3%

1

(Rahme 2005)*

Intervention 1 (aimed at GPs): 90‐minute workshop on management of osteoarthritis versus Intervention 2 (aimed at GPs): 90‐minute workshop and decision tree

Number of adequate prescription, according to the guidelines

51% (273/536)

58% (1022/1776)

56% (251/450)

62% (1008/1634)

0.7%

‐5.9%

‐10%

0.9

(Rahme 2005)*

Intervention 1 (aimed at GPs):decision tree on treatment choices for osteoarthritis patients versus Intervention 2 (aimed at GPs): 90‐minute workshop and decision tree

Number of adequate prescription, according to the guidelines

51% (799/1569)

58% (1022/1776)

54% (712/1317)

62% (1008/1634)

‐1%

‐7.6%

‐12%

0.9

(Rosemann 2007)*

Intervention (aimed at GPs): 2 interactive 8‐hour meetings focusing on arthritis self management, guideline dissemination and patient information material versus Intervention (aimed at GPs) as above plus patient case management via telephone by practice nurses

Paracetamol prescriptions

8.9% (31/345)

7.3% (25/345)

16.4%

14.1%

0.5%

2.3%

16%

1.2

Opioids

5.8% (20/345)

7.3% (25/345)

10.1%

16.0%

‐4.5%

‐5.9%

‐37%

1.2

NSAID

40% (138/345)

43.3% (149/345)

44.3%

49.7%

‐2.2%

‐5.4%

‐11%

1.2

Homeopathics

6.1% (21/345)

6.7% (23/345)

7.7%

9.6%

‐1.4%

‐1.9%

‐20%

1.2

1. Intervention 1 group pre‐intervention proportion

2. Intervention 2 group pre‐intervention proportion

3. Intervention 1 group post‐intervention proportion

4. Intervention 2 group post‐intervention proportion

5. ARD = [Int 1 post (%) minus Int 2 post (%)] minus [Int 1 pre (%) minus Int 2 pre (%)]. The direction of effect has been adjusted so that a positive result represents a beneficial intervention 1 outcome, according to Grimshaw 2004.

6. Risk Difference (RD) is the absolute % change post‐intervention = Int 1 post (%) minus Int 2 post (%). This is considered to be "small" if ≤ 5%, "modest" if > 5% and ≤10%,"moderate" if > 10% but ≤ 20%, and "large" if > 20%.The direction of effect has been adjusted so that a positive result represents a beneficial intervention 1 outcome.

7. Relative % change post = absolute % change post divided by Int 2 post (%). The direction of effect has been adjusted so that a positive result represents a beneficial intervention 1 outcome, according to Grimshaw 2004.

8. Risk ratio (RR) = Int 1 post (%) divided by Int 2 post (%)

Int 1: intervention 1 group; Int 2: Intervention 2 group; ARD: adjusted risk difference; NS: not significant, NSAID: non‐steroidal anti‐inflammatory drug

* There are unit of analysis errors in the reported results because the available data did not account for the effect of clustering.

Figuras y tablas -
Table 15. Osteoarthritis studies: intervention 1 versus intervention 2, dichotomous data
Table 16. Osteoarthritis studies: intervention 1 versus intervention 2 continuous data

(Study)

Intervention 1 versus Intervention 2

Outcome

Int 1 pre mean (SD)1

Int 2 pre mean (SD)2

Int 1 post mean (SD)3

Int 2 post mean (SD)4

MD 5

Relative % change 6

Adjusted relative % change7

SMD8

(P value)9

(Rosemann 2007)*

Intervention (aimed at GPs): 2 interactive 8‐hour meetings focusing on arthritis self management, guideline dissemination and patient information material versus Intervention (aimed at GPs) as above plus patient case management via telephone by practice nurses

Quality of life (AIMS2‐SF scores) Lower body

2.67 (1.88)

3.01 (2.11)

2.48 (1.1)

2.61 (1.4)

‐0.13

‐5%

0%

‐0.1

Quality of life (AIMS2‐SF scores) Upper body

1.47 (2.25)

1.68 (2.44)

1.43 (1.5)

1.62 (1.3)

‐0.19

‐12%

‐6%

‐0.1

Quality of life (AIMS2‐SF scores) Symptom

4.87 (2.13)

5.02 (2.29)

4.51 (1.0)

4.42 (1.8)

0.09

2%

12%

0.1

Quality of life (AIMS2‐SF scores) Affect

2.89 (1.35)

3.04 (1.39)

2.92 (0.8)

2.98 (0.9)

‐0.06

‐2%

‐1%

‐0.1

Quality of life (AIMS2‐SF scores) Social

4.52 (1.88)

4.79 (1.80)

4.43 (0.6)

4.736 (1.2)

‐0.31

‐6%

‐25%

‐0.3

GP contacts

4.56 (6.13)

5.01 (5.78)

4.44 (1.7)

4.9 (1.6)

0.46

9%

37%

0.3

Referrals to orthopaedics

1.58 (3.43)

1.76 (3.52)

1.49 (0.4)

1.52 (1.3)

0.03

2%

‐9%

0.0

Radiographs

0.82 (3.12)

0.80 (3.01)

0.75 (0.6)

0.71 (0.4)

‐0.04

‐6%

‐1%

‐0.1

Non‐medical practitioners

0.11 (3.01)

0.50 (4.20)

0.09 (0.4)

0.47 (0.4)

0.38

81%

‐45%

0.9

Physiotherapy

4.70 (9.10)

5.22 (10.03)

4.63 (0.6)

5.08 (0.6)

0.45

9%

35%

0.7

Acupuncture

0.83 (3.45)

0.77 (3.99)

0.8 (1.3)

0.72 (1.3)

‐0.08

‐11%

0%

‐0.1

1. Intervention 1 group pre‐intervention mean (standard deviation)

2. Intervention 2 group pre‐intervention mean (standard deviation)

3. Intervention 1 group post‐intervention mean (standard deviation)

4. Intervention 2 group postintervention mean (standard deviation)

5. Mean Difference (MD)=Difference between post‐intervention means. The direction of effect has been adjusted so that a positive result represents a beneficial intervention 1 outcome, according to Grimshaw 2004.

6. Relative percentage change post‐intervention = (Int1 post mean ‐ Int2 post mean)/Int2 post mean. The direction of effect has been adjusted so that a positive result represents a beneficial intervention 1 outcome, according to Grimshaw 2004.

7. Adjusted relative percentage change= (Int1 post mean‐Int2 post mean)‐(Int1 pre mean ‐ Int2 pre mean)/Int2 post mean. The direction of effect has been adjusted so that a positive result represents a beneficial intervention 1 outcome.

8. SMD=Standardised Mean Difference=(Int1 post mean‐Int2 post mean)/SD pooled. The direction of effect has been adjusted so that a positive result represents a beneficial intervention 1 outcome, according to Grimshaw 2004.

9. P value reported by study authors

AIMS2‐SF: Arthritis Impact Measurement Scales Short Form

* There are unit of analysis errors in the reported results because the available data did not account for the effect of clustering.

Figuras y tablas -
Table 16. Osteoarthritis studies: intervention 1 versus intervention 2 continuous data
Table 17. Shoulder studies: intervention versus control, continuous data

(Study)

Intervention

Outcome

Int pre mean (SD)1

C pre mean (SD)2

Int post mean (SD)3

C post mean (SD)4

MD 5

Relative % change 6

Adjusted relative % change7

SMD8

(P value)9

(Watson 2008)

Intervention: 60‐minute lecture on shoulder disorders, handouts, training in injection techniques versus control group (usual care)

British Shoulder Disability Questionnaire (BSDQ)

12.22 (4.21)

13.11 (4.43)

8.51 (0.60)

9.46 (0.82)

0.95

10%

1%

0.2

(P=0.36)

Short form 36 item (SF‐36) Health Survey ‐ physical component score

37.78 (8.69)

35.96 (8.93)

40.55 (0.60)

40.80 (0.90)

‐0.25

‐1%

‐5%

0.0

(P=0.82)

Short form 36 item (SF‐36) Health Survey ‐ mental component score

45.42 (13.33)

44.64 (13.09)

46.81 (0.93)

45.64 (1.28)

1.17

3%

1%

0.1

(P=0.47)

1. Intervention group pre‐intervention mean (standard deviation)

2. Control group pre‐intervention mean (standard deviation)

3. Intervention group post‐intervention mean (standard deviation)

4. Control group pos‐tintervention mean (standard deviation)

5. Mean Difference (MD)=Difference between post‐intervention means. The direction of effect has been adjusted so that a positive result represents a beneficial intervention outcome, according to Grimshaw 2004.

6. Relative percentage change post‐intervention = (Int post mean ‐ Control post mean)/Control post mean

7. Adjusted relative percentage change= (Int post mean‐Control post mean)‐(Int pre mean ‐ Control pre mean)/Control post mean. The direction of effect has been adjusted so that a positive result represents a beneficial intervention outcome.

8. SMD=Standardised Mean Difference=(Int post mean‐Control post mean)/SD pooled. The direction of effect has been adjusted so that a positive result represents a beneficial intervention outcome, according to Grimshaw 2004.

9. P value reported by study authors

Figuras y tablas -
Table 17. Shoulder studies: intervention versus control, continuous data
Table 18. Shoulder studies: intervention 1 versus intervention 2, continuous data

(Study)

Intervention 1 versus Intervention 2

Outcome

Int 1 pre mean (SD)1

Int 2 pre mean (SD)2

Int 1 post mean (SD)3

Int 2 post mean (SD)4

MD 5

Relative % change 6

Adjusted relative % change7

SMD8

(P value)9

(Gormley 2003*)

Shoulder injection training on mannequins versus shoulder injection training on mannequins and real patients

Shoulder injections performed by general practitioner

3.5

3.4

4.5

7.8

‐3.3

‐42%

‐44%

(P=0.02)

Referrals to shoulder injection clinics

2.3

2.0

1.5

0.6

‐0.9

‐150%

‐100%

(P=0.36)

Referrals to physiotherapy

5.9

5.6

4.7

3.2

‐1.5

‐47%

‐38%

(P=0.20)

1. Intervention 1 group pre‐intervention mean (standard deviation)

2. Intervention 2 group pre‐intervention mean (standard deviation)

3. Intervention 1 group post‐intervention mean (standard deviation)

4. Intervention 2 group postintervention mean (standard deviation)

5. Mean Difference (MD)=Difference between post‐intervention means. The direction of effect has been adjusted so that a positive result represents a beneficial intervention 1 outcome, according to Grimshaw 2004.

6. Relative percentage change post‐intervention = (Int1 post mean ‐ Int2 post mean)/Int2 post mean. The direction of effect has been adjusted so that a positive result represents a beneficial intervention 1 outcome, according to Grimshaw 2004.

7. Adjusted relative percentage change= (Int1 post mean‐Int2 post mean)‐(Int1 pre mean ‐ Int2 pre mean)/Int2 post mean. The direction of effect has been adjusted so that a positive result represents a beneficial intervention 1 outcome.

8. SMD=Standardised Mean Difference=(Int1 post mean‐Int2 post mean)/SD pooled. The direction of effect has been adjusted so that a positive result represents a beneficial intervention 1 outcome, according to Grimshaw 2004.

9. P value reported by study authors

* The study does not report SD and therefore we were not able to calculate the SMD

Figuras y tablas -
Table 18. Shoulder studies: intervention 1 versus intervention 2, continuous data
Table 19. Other musculoskeletal conditions studies: Intervention versus control, continuous data

(Study)

Intervention

Outcome

Int pre mean (SD)1

C pre mean (SD)2

Int post mean (SD)3

C post mean (SD)4

MD 5

Relative % change 6

Adjusted relative % change7

SMD8

(P value)9

(Huas 2006)

Training of general practitioners on the use of 2 validated assessment instruments for pain versus control group (usual care)

Pain relief a week after last consultation with general practitioner

41.1 (4.6)

50.7 (4.8)

‐9.6

‐19%

‐2

(P=0.0004)

Pain relief a week after last consultation with general practitioner not including patients on Level 3 analgesics

40.8 (4.0)

50.7 (4.2)

‐9.9

‐20%

‐2.4

(P=0.0001)

Level 1 analgesic treatment (as defined by WHO classification system)

34.7 (10.6)

42.9 (18.4)

29.6 (9.9)

34.2 (12.4)

‐4.6

‐13%

11%

‐0.3

(P=0.38)

Level 2 analgesic treatment (as defined by WHO classification system)

42.2 (5.9)

44.1 (19.6)

35.4 (6.3)

47.7 (8.8)

‐12.3

‐26%

‐22%

‐0.9

(P=0.003)

Level 3 analgesic treatment (as defined by WHO classification system)

7.5 (5.6)

2.5 (2.1)

7.2 (4.7)

1.8 (2.5)

5.4

300%

22%

1.2

(P=0.007)

Co‐analgesics (antidepressants, anxiolytics, anti‐epileptics)

46.0 (7.6)

38.7 (7.5)

38.4 (11.4)

33.0 (15.1)

5.4

16%

‐6%

0.7

(P=0.38)

Other drugs (non‐psychotropic muscle relaxants)

21.6 (7.1)

27.3 (13.5)

19.0 (5.3)

22.9 (11.5)

‐3.9

‐17%

8%

‐0.4

(P=0.34)

Non‐medicinal treatment (physiotherapy, homeopathy, acupuncture, compression bandages, etc)

44.3 (10.2)

44.9 (11.1)

33.8 (11.8)

39.3 (12.5)

‐5.5

‐14%

‐12%

‐0.5

(P=0.30)

1. Intervention group pre‐intervention mean (standard deviation)

2. Control group pre‐intervention mean (standard deviation)

3. Intervention group post‐intervention mean (standard deviation)

4. Control group pos‐tintervention mean (standard deviation)

5. Mean Difference (MD)=Difference between post‐intervention means. The direction of effect has been adjusted so that a positive result represents a beneficial intervention outcome, according to Grimshaw 2004.

6. Relative percentage change post‐intervention = (Int post mean ‐ Control post mean)/Control post mean

7. Adjusted relative percentage change= (Int post mean‐Control post mean)‐(Int pre mean ‐ Control pre mean)/Control post mean. The direction of effect has been adjusted so that a positive result represents a beneficial intervention outcome.

8. SMD=Standardised Mean Difference=(Int post mean‐Control post mean)/SD pooled. The direction of effect has been adjusted so that a positive result represents a beneficial intervention outcome, according to Grimshaw 2004.

9. P value reported by study authors

Figuras y tablas -
Table 19. Other musculoskeletal conditions studies: Intervention versus control, continuous data
Table 20. Other musculoskeletal studies: Intervention versus a different intervention, dichotomous data

(Study)

Intervention 1 versus intervention 2

Outcome

Int 1 pre (%) 1

Int 2 pre (%)2

Int 1 post (%)3

Int 2 post (%)4

ARD 5

Risk difference 6

(P value if reported by authors)

Relative % change post 7

Risk ratio 8

(Robling 2002)*

Guidelines and seminar versus guideline dissemination by post*

Concordant requests

79% (23/29)

79% (32/41)

0%

0%

1

(Robling 2002)*

Guidelines and feedback versus guideline dissemination by post*

Concordant requests

67% (21/32)

79% (32/41)

‐12.1%

‐15%

0.8

(Robling 2002)*

Guidelines, seminar and feedback versus guideline dissemination by post*

Concordant requests

71% (27/37)

79% (32/41)

‐7.6%

‐10%

0.9

(Robling 2002)*

Guidelines and seminar versus guidelines and feedback*

Concordant requests

79% (23/29

67% (21/32)

12.1%

18%

1.2

(Robling 2002)*

Guidelines and seminar versus guidelines, seminar and feedback*

Concordant requests

79% (23/29)

71% (27/37)

7.6%

11%

1.1

(Robling 2002)*

Guidelines and feedback versus guidelines, seminar and feedback*

Concordant requests

67% (21/32)

71% (27/37)

‐4.5%

‐6%

0.9

(Eccles 2001)**

Feedback on number of knee radiographs 6 months before and 6 months after the intervention plus guideline dissemination versus guideline dissemination

Knee radiographs concordant with guidelines

22% (52/240)

25% (83/328)

‐3.6%

‐14%

0.9

(Eccles 2001)**

Reminder messages on radiograph reports plus guideline dissemination versus guideline dissemination

Knee radiographs concordant with guidelines

31% (26/85)

25% (83/328)

5.3%

21%

1.2

(Eccles 2001)**

Feedback on number of knee radiographs 6 months before and 6 months after the intervention plus guideline dissemination plus reminder messages on radiograph reports versus guideline dissemination

Knee radiographs concordant with guidelines

28% (70/252)

25% (83/328)

2.5%

10%

1.1

(Eccles 2001)**

Feedback on number of knee radiographs 6 months before and 6 months after the intervention plus guideline dissemination versus reminder messages on radiograph reports plus guideline dissemination

Knee radiographs concordant with guidelines

22% (52/240)

31% (26/85)

‐8.9%

‐29%

0.7

1. Intervention 1 group pre‐intervention proportion

2. Intervention 2 group pre‐intervention proportion

3. Intervention 1 group post‐intervention proportion

4. Intervention 2 group post‐intervention proportion

5. ARD = [Int 1 post (%) minus Int 2 post (%)] minus [Int 1 pre (%) minus Int 2 pre (%)]. The direction of effect has been adjusted so that a positive result represents a beneficial intervention 1 outcome, according to Grimshaw 2004.

6. Risk Difference (RD) is the absolute % change post‐intervention = Int 1 post (%) minus Int 2 post (%). This is considered to be "small" if ≤ 5%, "modest" if > 5% and ≤10%,"moderate" if > 10% but ≤ 20%, and "large" if > 20%.The direction of effect has been adjusted so that a positive result represents a beneficial intervention 1 outcome.

7. Relative % change post = absolute % change post divided by Int 2 post (%). The direction of effect has been adjusted so that a positive result represents a beneficial intervention 1 outcome, according to Grimshaw 2004.

8. Risk ratio (RR) = Int 1 post (%) divided by Int 2 post (%)

Int 1: intervention 1 group; Int 2: Intervention 2 group; ARD: adjusted risk difference; NS: not significant

*The results have been re‐calculated taking into account the reported Intercluster Correlation (ICC=0.0269) and average cluster size 12.5 according to chapter 16.3.4 of the Cochrane Handbook, Higgins 2011a.

** The data reported above for the study by Eccles 2001 does not account for clustering. We did not have access to sufficient information to adjust the data for clustering.

Figuras y tablas -
Table 20. Other musculoskeletal studies: Intervention versus a different intervention, dichotomous data
Table 21. Other musculoskeletal studies: Intervention versus a different intervention, continuous data

(Study)

Intervention 1 versus Intervention 2

Outcome

Int 1 pre mean (SD)1

Int 2 pre mean (SD)2

Int 1 post mean (SD)3

Int 2 post mean (SD)4

MD 5

Relative % change 6

Adjusted relative % change7

SMD8

(P value)9

(Eccles 2001)*

Feedback on number of knee radiographs 6 months before and 6 months after the intervention plus guideline dissemination versus guideline dissemination

Number of knee radiographs per 1000 patients

7.03 (5.1)

6.67 (3.9)

6.32 (4.0)

7.02 (3.6)

0.7

10%

15%

0.2

(NR)

(Eccles 2001)*

Reminder messages on radiograph reports plus guideline dissemination versus guideline dissemination

Number of knee radiographs per 1000 patients

7.18 (5.0)

6.67 (3.9)

5.22 (3.6)

7.02 (3.6)

1.8

26%

33%

0.5

(P< 0.05)

(Eccles 2001)*

Feedback on number of knee radiographs 6 months before and 6 months after the intervention plus guideline dissemination plus reminder messages on radiograph reports versus guideline dissemination

Number of knee radiographs per 1000 patients

9.34 (6.1)

6.67 (3.9)

5.21 (3.7)

7.02 (3.6)

1.8

26%

64%

0.5

(NR)

(Eccles 2001)*

Feedback on number of knee radiographs 6 months before and 6 months after the intervention plus guideline dissemination versus reminder messages on radiograph reports plus guideline dissemination

Number of knee radiographs per 1000 patients

7.03 (5.1)

7.18 (5.0)

6.32 (4.0)

5.22 (3.6)

‐1.1

‐21%

‐24%

‐0.3

(NR)

1. Intervention 1 group pre‐intervention mean (standard deviation)

2. Intervention 2 group pre‐intervention mean (standard deviation)

3. Intervention 1 group post‐intervention mean (standard deviation)

4. Intervention 2 group postintervention mean (standard deviation)

5. Mean Difference (MD)=Difference between post‐intervention means. The direction of effect has been adjusted so that a positive result represents a beneficial intervention 1 outcome, according to Grimshaw 2004.

6. Relative percentage change post‐intervention = (Int1 post mean ‐ Int2 post mean)/Int2 post mean. The direction of effect has been adjusted so that a positive result represents a beneficial intervention 1 outcome, according to Grimshaw 2004.

7. Adjusted relative percentage change= (Int1 post mean‐Int2 post mean)‐(Int1 pre mean ‐ Int2 pre mean)/Int2 post mean. The direction of effect has been adjusted so that a positive result represents a beneficial intervention 1 outcome.

8. SMD=Standardised Mean Difference=(Int1 post mean‐Int2 post mean)/SD pooled. The direction of effect has been adjusted so that a positive result represents a beneficial intervention 1 outcome, according to Grimshaw 2004.

9. P value reported by study authors

*The above data reported above for Eccles 2001 was adjusted for clustering by the authors

Figuras y tablas -
Table 21. Other musculoskeletal studies: Intervention versus a different intervention, continuous data
Table 22. Summary of median absolute effect sizes (risk difference) of dichotomous outcomes for interventions aiming to increase or decrease a clinical behaviour

Table 23: Summary of median absolute effect sizes (risk difference) of dichotomous outcomes for interventions aiming to increase or decrease a clinical behaviour

Study characteristic: behaviour targeted

Number of comparisons (n studies)

Median absolute effect size

Interquartile range

Range

Increase an existing clinical behaviour according to guidelines

68 (14)

5%

0.6% to 12.6%

‐7.8% to 57.2%

Decrease an existing clinical behaviour according to guidelines

26 (7)

1.1%

‐1.1% to 3%

‐12.6% to 30.1%

Figuras y tablas -
Table 22. Summary of median absolute effect sizes (risk difference) of dichotomous outcomes for interventions aiming to increase or decrease a clinical behaviour
Table 23. Summary of median effect sizes (risk difference) of dichotomous outcomes for interventions aiming to increase or decrease a clinical behaviour (including only comparisons from Low Back Pain studies)

Table 24: Summary of median effect sizes (risk difference) of dichotomous outcomes for interventions aiming to increase or decrease a clinical behaviour (including only comparisons from Low Back Pain studies)

Study characteristic: behaviour targeted

Number of comparisons (n studies)

Median absolute effect size

Interquartile range

Range

Increase an existing clinical behaviour according to guidelines

18 (2)

3.7%

‐0.8% to 6.9%

‐4.7% to 12.8%

Decrease an existing clinical behaviour according to guidelines

23 (6)

0.5%

‐1.1% to 2.4%

‐12.6% to 30.1%

Figuras y tablas -
Table 23. Summary of median effect sizes (risk difference) of dichotomous outcomes for interventions aiming to increase or decrease a clinical behaviour (including only comparisons from Low Back Pain studies)
Table 24. Summary of median effect sizes (risk difference) of dichotomous outcomes for interventions aiming to increase or decrease a clinical behaviour (including only comparisons from Osteoarthritis studies)

Table 25: Summary of median effect sizes (risk difference) of dichotomous outcomes for interventions aiming to increase or decrease a clinical behaviour (including only comparisons from Osteoarthritis studies)

Study characteristic: behaviour targeted

Number of comparisons (n studies)

Median absolute effect size

Interquartile range

Range

Increase an existing clinical behaviour according to guidelines

18 (3)

6.3%

‐0.2% to 10%

‐7.8% to 57.2%

Decrease an existing clinical behaviour according to guidelines

3 (1)

7.8%

6.1% to 13.4%

4.4% to 18.9%

Figuras y tablas -
Table 24. Summary of median effect sizes (risk difference) of dichotomous outcomes for interventions aiming to increase or decrease a clinical behaviour (including only comparisons from Osteoarthritis studies)
Comparison 1. Meta‐analysis of osteoporosis studies evaluating physician and patient interventions versus usual care

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Bone Mineral Density Show forest plot

3

3386

Risk Ratio (M‐H, Fixed, 95% CI)

4.44 [3.54, 5.55]

2 Osteoporosis medication Show forest plot

5

4223

Risk Ratio (M‐H, Fixed, 95% CI)

1.71 [1.50, 1.94]

Figuras y tablas -
Comparison 1. Meta‐analysis of osteoporosis studies evaluating physician and patient interventions versus usual care
Comparison 2. Meta‐analysis of osteoporosis studies evaluating physician‐only interventions versus usual care

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Bone mineral density Show forest plot

2

3047

Risk Ratio (M‐H, Fixed, 95% CI)

4.75 [3.62, 6.24]

2 Osteoporosis medication Show forest plot

2

3047

Risk Ratio (M‐H, Fixed, 95% CI)

1.52 [1.26, 1.84]

Figuras y tablas -
Comparison 2. Meta‐analysis of osteoporosis studies evaluating physician‐only interventions versus usual care
Comparison 3. Meta‐analysis of osteoporosis studies evaluating physician only interventions versus physician and patient interventions

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Bone mineral density Show forest plot

2

2995

Odds Ratio (M‐H, Fixed, 95% CI)

0.93 [0.77, 1.12]

2 Medication Show forest plot

2

2995

Risk Ratio (M‐H, Fixed, 95% CI)

0.93 [0.79, 1.10]

Figuras y tablas -
Comparison 3. Meta‐analysis of osteoporosis studies evaluating physician only interventions versus physician and patient interventions